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Summary
1. The aim o f  this study was to investigate the roles o f hypertension, 0C2- 
adrenoceptors and neurotransmission in the regulation o f  rat blood vessel 
responses.
2. Experiments were carried out using the tail artery and aorta o f  
spontaneously hypertensive rats (SHR), and comparisons were made with 
vessels from the normotensive control strain, Wistar Kyoto (WKY).
3. Rings o f aorta and proximal tail artery from SHR were heavier than 
those from WKY, despite being cut to the same length. This indicated a 
structural difference, so the histology o f the vessels was examined using light 
microscopy.
4. Both the wall thickness and lumen diameter o f the aorta were greater in 
SHR compared to WKY, but there was no difference in wall thickness to lumen 
ratio. The area o f the medial layer was increased in SHR relative to control.
5. There was no difference in the wall thickness o f the proximal part o f the 
tail artery between SHR and WKY rats, but the lumen diameter was reduced in 
SHR relative to control, giving a greater wall thickness to lumen ratio. The 
media area was decreased in SHR compared to WKY.
6 . Wall thickness was increased and lumen diameter decreased in the distal 
part of the tail artery from SHR compared to WKY, giving a greater wall 
thickness to lumen ratio. The media area was increased in SHR compared to 
WKY.
7. Mechanical responses to drugs were investigated in the aorta and 
proximal tail artery from SHR and compared to responses obtained in vessels 
from WKY rats, using both isometric tension and perfusion pressure recording.
8 . In the aorta, isometric tension responses to the vasoconstrictor 
phenylephrine (PE; 10"9-3xl0"5M) were lower in rings from SHR compared to 
responses in rings from WKY, with a lower maximum response. There was no 
difference in the EC50 for PE between SHR and WKY. In contrast, responses to 
the endothelium-dependent vasodilator carbachol (10*9-3 x l0 '5M) were greater 
in rings from SHR compared to relaxations in rings from WKY, with a greater 
maximum response and a lower EC50 . Using the endothelium-independent 
vasodilator sodium nitroprusside (SNP) there was no difference between 
hypertensive and control rats at the lower end o f the concentration-response 
curve (3xlO _11-K )-8M). At the higher concentrations (3xlO '8-3xlO '^M ) 
however, aortic rings from SHR were more responsive to SNP than were rings 
from WKY rats, with a greater maximum relaxation, although the EC50 was 
unchanged. There was no difference in the vasorelaxant response to the 13- 
adrenoceptor agonist isoprenaline (3 x l0 'l ° - 10"5M) between hypertensive and 
control rats.
9. In tail artery rings, isometric tension responses to PE (10"8-3 x l0 '5M), 
noradrenaline (NA ; 10'9 - 10_5M) and U K -14,304 (3xlO~10 - 3 x l0 '5M) were 
greater in SHR compared to WKY with an increased maximum response, but 
there was no difference in the EC5 0  Yohimbine (50nM) produced a rightward 
shift in the concentration-response curve to U K -14,304 in tail artery rings from 
both SHR and WKY rats.
10. In perfused segments o f rat tail artery the response to NA was much 
greater in vessels from SHR than in vessels from WKY. When expressed as a
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percentage o f the maximum response achieved however, responses in vessels 
from SHR were lower than in those from WKY.
11. The relaxations produced by SNP (3x’10 - 3xlO"5M) and isoprenaline 
(10 -8 - KHM ) were lower in tail artery rings from SHR compared to those in 
rings from WKY. In vessels from hypertensive rats, SNP did not fully relax the 
PE-induced precontraction, whereas isoprenaline did not fully relax the 
precontraction in either hypertensive or control rats. Carbachol produced little 
or no response in either group o f rat.
12. The biochemical response underlying NA-induced contraction in the rat 
tail artery was investigated by measuring accumulation o f  total inositol 
phosphates in response to NA. The basal phosphoinositide (PI) hydrolysis was 
higher in vessels from SHR than in those from W KY, and 10‘5M NA, which 
had produced increased contractile responses, gave a greater stimulation o f PI 
hydrolysis in vessels from hypertensive rats as compared to control.
13. Preliminary experiments were carried out with rats o f two different age 
groups (12-17 weeks and 6-9 weeks).
14. When tail artery segments were cannulated at one end ("single 
cannulation") and perfused with Krebs solution at a constant rate, the response 
to NA (10 ' 3 - lOOfig) was greater in older rats than in younger rats. The 
response to field stimulation (Supramaximal voltage 80V, 50 pulses, 0.4ms 
duration, 0.5-80Hz) tended to be greater in older than in younger rats.
15. When tail artery segments were cannulated at both ends ("double 
cannulation") and perfused with drug solution at a constant rate, there was no
difference in the response to either NA (10'8 - 10"5M) or to KC1 (0.01-0.05M) 
between older and younger rats.
16. The single cannulation experiment was repeated, but with the addition 
of a heating coil between the reservoir and the cannula. This time there was no 
difference in the response to NA between older and younger rats.
17. Part o f the study investigated the contractions mediated y ia  post­
junctional (X2-adrenoceptors in rat tail artery rings.
18. In the proximal tail artery, concentration-response curves (CRC's) to 
clonidine (10"8 - 10_5M) and to UK-14,304 (10-10 - 3xlO '5M) were obtained. 
Yohimbine (30nM) produced a rightward shift in the clonidine CRC, with a 
greater effect at the lower end o f the curve. In the distal tail artery, mounted as 
ring preparations on a myograph, the CRC to U K -14,304 was biphasic. This 
curve became monophasic in the presence o f yohimbine (50nM ), which 
produced a rightward shift in the first phase but did not affect the second phase.
19. Low concentrations o f clonidine (lOnM) and U K -14,304 (50nM) 
produced little or no response in rat tail artery rings. When the vessels were 
precontracted with arginine-vasopressin (AVP; 0.4mU m l'1) or PE (0.5|iM) (the 
"precontracting agonists") and then relaxed with 3-isobutyl- 1-methylxanthine 
(IBMX; 10|iM), the responses to clonidine and to U K -14,304 in the presence of 
these drugs were markedly enhanced. The response to clonidine was also 
enhanced in the presence of KC1 (0.03M) and IBMX, indicating that activation 
of a receptor by the precontracting agonist was not necessary in producing this 
enhancement
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20. The response to clonidine (lOnM) was also enhanced when IBMX was 
added to the organ bath before AVP, indicating that the order o f drug addition 
was not important for the enhancement to be observed.
21. The effects o f vasodilators other than IBMX were also investigated. The 
response to clonidine was increased in the presence o f  A V P and diltiazem  
(2|iM ). The response to U K -14,304 was increased in the presence o f  AVP and 
either forskolin (36nM), dibutyryl cyclic AMP (0.2mM) or SNP (O.lpM). The 
response to UK-14,304 was also increased in the presence o f PE and SNP.
22. The responses to clonidine and to U K -14,304 enhanced under the 
described conditions were markedly inhibited or abolished by yohimbine 
(50nM). Unlike clonidine or U K -14,304, the response to a low concentration 
(0.2|iM ) o f the ai-adrenoceptor agonist PE was not potentiated in the presence 
o f AVP and IBMX. When the protocol using AVP and IBMX was repeated in 
the presence o f  prazosin (50nM), the enhanced response to clonidine was 
unaffected. These results are consistent with the hypothesis that the enhanced 
responses to clonidine and to UK-14,304 were mediated via 0C2-adrenoceptors.
23. There was a positive correlation between the size o f the potentiated 
response to clonidine or to U K -14,304 and the size o f the response to the 
precontracting agonist. In addition, when the time between AVP/IBM X and 
clonidine addition increased, there was a corresponding decrease in the size o f  
the enhanced response to clonidine, which matched the decline in the response 
to AVP alone which occurred over time.
24. W hen v esse ls  were precontracted with A V P , PE or 5- 
hydroxytryptamine (5-HT; 50nM) then relaxed with IBMX, the enhanced 
response to U K -14,304 was abolished by the AVP antagonist (p-mercapto-p,p-
cyclopenta-m ethylenepropionyl1, O-Me-Tyr2, Arg^)-vasopressin (MCVP; 
35nM), prazosin (0.1|iM ) or ketanserin (50nM) respectively. The enhanced 
response was unaffected by an antagonist not specific for the precontracting 
agonist, but was abolished in all cases by yohimbine (50nM).
25. Part o f this study investigated the nature o f the neurotransmission in the 
rat tail artery, including the possibility o f  NA/ATP (adenosine 5'-triphosphate) 
co-transmission. The concentration-response curve to exogenous NA was 
shifted to the right by prazosin (0.1 p.M). Exogenous ATP (3 x l0 -7 - 3xl0"3M) 
produced a rapid response which was not maintained but declined sharply, and 
was inhibited by a,P-methylene ATP (a,p  -MeATP; 0.5p.M).
26. Field stimulation-induced contractions (supramaximal voltage 50V, 
10Hz for Is, pulse width 0.1ms) were abolished by tetrodotoxin (TTX; 0.1 |iM). 
The frequency-response curve (FRC; 0.1-40Hz) was biphasic, peaking first at
5-10Hz and then at 30-40Hz. Responses at all frequencies were abolished by 
prazosin (O .lfiM ) but unaffected • by a ,p -M e A T P  (0 .5 |iM ). A lower 
concentration o f prazosin (5nM) reduced the contraction to trains o f stimuli at 
10Hz and the residual response was abolished by yohimbine (50nM).
27. Field stimulation-induced contractions (supramaximal voltage 50V, 
10Hz for Is, pulse width 0.1ms) were inhibited by yohimbine (50nM), 
clonidine (50nM) and U K -14,304 (50nM). Yohimbine curtailed the duration of 
the response, but clonidine and U K -14,304 prolonged the response.
28. The response to field stimulation was tested following precontraction 
with AVP and subsequent relaxation by IBMX. Under these conditions, 
previously shown to enhance contractions mediated via <X2-adrenoceptors, there
was no change in the amplitude o f  the field stimulation-induced contraction, but 
the response was prolonged.
29. Following the abolition o f  the response to 10Hz with prazosin, a 
biphasic response was revealed in the presence o f AVP and IBMX. The second, 
more prolonged component o f this response was abolished by yohimbine 
(50nM ), leaving the first component, a spike. This initial spike was almost 
completely abolished by a , (3 -M eA TP (0.5pM).
30. Field stimulation (Supramaximal voltage 50V, 10 pulses, 0.1ms, 0.1- 
40Hz) was examined in tail artery rings from SHR and WKY rats. In both 
groups o f rat the FRC was biphasic, reaching a plateau at 2-10H z, with 
responses again increasing from 10-40Hz.
31. Responses at the lower frequencies (0.1Hz, 0.2Hz) were greater in SHR 
compared to WKY. Following two consecutive repetitions o f  the FRC, 
responses at 0.1-2Hz diminished in vessels from SHR, while responses from 
WKY were well-maintained at each frequency. In SHR, responses at 0.1-0.2Hz 
increased in the presence of a ,p  -M eATP (lpM ) but returned to control in the 
FRC following a second addition o f a ,p  -MeATP. In WKY, a ,p -  MeATP had 
no effect on the response to field stimulation at any o f the frequencies 
examined.
32. In rats pretreated with reserpine or 6-hydroxydopamine (6 -OHDA), field 
stimulation (supramaximal voltage 70V; 0.5Hz, 10Hz or 20Hz, pulse width
0.4ms, 10 pulses) produced a prolonged, monophasic contraction which was not 
frequency-dependent. This response did not diminish with repetition, and was 
unaffected by TTX (O.ljiM), prazosin (O.lpM), yohimbine (50nM) or a ,p -  
MeATP (ljJ-M).
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Introduction
GENERAL
The main function o f the blood vessels is to transport oxygen and 
nutrients to the cells and tissues o f the body, and to deliver waste products to 
their sites o f excretion. Blood vessels also serve as a communication system  
whereby substances such as hormones are transported from sites o f release to 
target tissues, and constitute part o f the body’s defences against invading 
pathogens, the immune system. In addition, the thermoregulatory properties of 
blood vessels serve as an important homeostatic mechanism for maintaining a 
constant body temperature (Vander, Sherman & Luciano, 1990; Rang & Dale, 
1991).
Blood vessels are regulated by various mechanisms, which act in 
concert to ensure that they respond appropriately. These mechanisms involve 
neurotransmitters, hormones and locally-released substances, whose effects are 
complex and may be interrelated. For example, the sensitivity of blood vessels 
to the neurotransmitter, noradrenaline (NA), is regulated by corticosteroids and 
tri-iodothyronine (Gibson, 1981). Some regulatory mechanisms, such as those 
concerned with neurotransmission, are quickly activated and of transient 
duration, whilst others, such as hormone-induced sensitivity changes (Gibson 
& Pollock, 1975) are activated more slowly and exert a more persistent 
influence. Because o f their nature and complexity, there is considerable scope 
for alteration or derangement of vascular regulatory mechanisms. Moreover, it 
appears that explanation o f the phenomenon o f essential hypertension, a major 
pathological condition affecting the vasculature, will depend on clarification of 
how these various mechanisms act and interact.
BLOOD VESSEL STRUCTURE
Blood vessel walls consist o f three layers, the intima, the media, and the 
adventitia. The inner layer, the intima, is com posed o f  a single layer o f  
endothelial cells lining the entire circulatory system, and may also contain some 
smooth muscle cells. Vascular smooth muscle cells are mainly located in the 
media, together with connective tissue such as elastin and collagen. The 
outermost layer, the adventitia, contains sympathetic nerve endings and 
connective tissue (Figure 1).
The proportion o f these components varies according to the type of 
blood vessel, whose structure is related to its function. In the systemic 
circulation for example, the aorta has thick walls with a high proportion o f  
elastic tissue and a large radius, and serves as a low-resistance conduit 
conducting blood to the various organs. In contrast, the thick-walled muscular 
arterioles with smaller radii are the major site o f  resistance to flow  in the 
vascular tree, and are involved in the maintenance o f systemic blood pressure 
(Vander, Sherman & Luciano, 1990).
There is evidence that blood vessel structure is altered in hypertension 
(Short, D., 1966; Folkow, 1982; Jespersen et al.. 1985). In addition, changes 
in the properties o f the endothelium (Vanhoutte & Luscher, 1987; Yin, Chu & 
Beilin, 1992) and smooth muscle (Mulvany et al.. 1980; Bendhack, Sharma & 
Bhalla, 1992) and in the innervation o f blood vessels (Ferrone et al.. 1979; 
Kawasaki, Cline & Su, 1984) have been reported in vascular diseases such as 
hypertension. The precise nature of these changes however is far from clear.
Blood vessels often exhibit altered responses to stimuli in hypertension 
(for reviews, see Winquist, Webb & Bohr, 1982; Marin, 1993). Many factors 
have been implicated, for example alterations in the release of, or response to, 
neurotransmitters (Ekas & Lokhandwala, 1981; Marin, 1993), or changes in 
receptors on the smooth muscle cell membrane, such as the a-adrenoceptors
Figure 1. Schematic representation of a blood vessel wall.
A=Adventitia; N=Nerve net; S M C =  Smooth muscle cells; EL=Internal elastic 
lamina; EC=endothelial cells.
(Adapted from Lee. 1993).
(Fukuda et al.. 1983; Sanchez et al.. 1986), the latter perhaps being determined 
by the former. In order to gain insight into how the responsiveness o f  vascular 
smooth muscle can be regulated by such factors, in hypertension or otherwise, 
it is important to understand the processes underlying vascular smooth muscle 
contraction and relaxation.
BLOOD VESSEL CONTROL MECHANISMS
The vascular smooth muscle cell is the main site of action for vasoactive 
substances, for example circulating hormones, and agents liberated from the 
endothelium and sympathetic nerves. Bundles o f  smooth muscle fibres are 
arranged in a circular or helical fashion around the blood vessel wall (Vander, 
Sherman & Luciano, 1990) and respond to stimuli by contracting or relaxing, 
thus producing vasoconstriction or vasodilatation respectively. An important 
concept is that, as with virtually all physiological systems, blood vessel calibre 
is the resultant o f a variety of excitatory and inhibitory influences, which are 
dynamic in nature and subject to moment to moment, and long term, regulation.
VASOCONSTRICTION
Contraction o f smooth muscle is less well characterised than that o f  
striated muscle (Kamm & Stull, 1985), but there are common features such as 
the dependence on calcium ions (Ca2+; Filo, Bohr & Ruegg, 1965), the 
presence o f actin and myosin, overlapping thick and thin filaments with 
crossbridges (Somlyo & Somlyo, 1975; Johansson, 1978; Murphy, 1982; van 
Breemen et al.. 1986), and a length-tension relationship (Vander, Sherman & 
Luciano, 1990). These features suggest that smooth muscle contraction occurs 
by a sliding-filament mechanism similar to that in skeletal and cardiac muscle.
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Figure 2. Schem atic representation o f the enzym e cascade leading to 
vascular smooth m uscle contraction. Cytosolic calcium (Ca2+) complexes 
with calmodulin to dephosphorylate and thus activate myosin light chain 
kinase (MLCK). This enzyme phosphorylates and thus activates myosin, 
which combines with actin to initiate cellular contraction.
It is now widely accepted that the major messenger o f  contractile 
activation is calcium (Somlyo & Himpens, 1989), which initiates the enzyme 
cascade leading to smooth muscle contraction (Figure 2; Sobieszek, 1977; 
Adelstein & Einsenberg, 1980; Somlyo & Himpens, 1989). Changes in 
vascular smooth muscle tone occur as a result o f changes in the level o f  
intracellular free calcium ([Ca2+]i) or in the sensitivity o f the contractile 
apparatus to a constant level o f [Ca2+]i (Murphy, 1982; van Breemen et al.. 
1986; Somlyo & Himpens, 1989; Somlyo et al. 1990; Kobayashi et al.. 1991). 
[Ca2+]i may be increased by entry from the extracellular compartment via  
voltage-operated calcium channels (VOCs; activated by a change in membrane 
potential) or receptor-operated channels (ROC's; activated by receptor 
occupation by agonists) (Bolton, 1979; van Breemen, Aaronson & 
Loutzenhiser, 1979). In addition, a Ca2+ influx in the absence o f excitation 
exists, termed the "calcium leak" (van Breemen et al.. 1986).
As well as these extracellular sources, Ca2+ is released from intracellular 
stores such as the sarcoplasmic reticulum by inositol 1,4,5-trisphosphate 
(InsP3). This second messenger is  a product o f the phosphoinositide (PI) 
signalling pathway, which was discovered after the initial chance finding that 
hormones have effects on PI metabolism (Hokin & Hokin, 1953; 1955). Since 
then it has become apparent that a large number o f agonists can stimulate an 
increase in the metabolism o f membrane phosphoinositides (Michell, 1975; 
Berridge, 1984), including NA (UchidaetaL, 1982), 5-hydroxytryptamine (5- 
HT; Fain & Beridge, 1979), arginine-vasopressin (AVP; Creba et al.. 1983; 
Rhodes et al. 1983), angiotensin II (All; Billah & Michell, 1979) and platelet- 
derived growth factor (PDGF; Habenicht et al.. 1981).
4
2  -D '
- I
I I
£3 • 
•  «
O•H e
CMP
C M P -P h o sp h atid a te
Ptd OH Diac y lg W ce 'o
P h o s p h a t id i c  ac id)
(C D P -O A G )
Ptdlns»3)P
P tdlns PtdlnsU JP Ptdlns(4,5)P?
ins(4)P lnsd.4)P ln s(1 ,4 ,5 )P
Ins'. 1 .3 .4 .5 ;P 4
Inst DP lns(1.3>P
4  Lipu
l5 = i -
Inst 1,3,4IP
Inst 1,4.SIP, 
D ephosphorylation
InsP ./lnsP
Pathw ay
Inst 1.3.4IP,
lns(3,4)P
Figure 3. The phosphoinositide cycle.
The main routes of metabolism in the phosphoinositide cycle are represented. 
R=receptor; Gp=G=protein. (Adapted from Berridge & Irvine, 1989).
THE PHOSPHOINOSITIDE (PI) PATHWAY
The phosphatidylinositols are a class o f  membrane phospholipids which 
comprise less than 10% of the total phospholipid content in animal cells, but are 
the most metabolically active (Williamson, 1986), and are now recognised to be 
very important in signal transduction.
Initially, it was believed that the predominant inositol-containing lipid, 
phosphatidylinositol (Ptdlns), was split by phospholipase C (PLC) to form 
diacylglycerol (DAG) and inositol 1-phosphate. However, it has since been 
shown that the initial reaction is hydrolysis o f  the Ptdlns derivative, 
phosphatidylinositol-4,5-bisphosphate (PtdInsP2), by the G-protein-linked 
enzyme PLC. This yields the products DAG and InsP3 (Michell et al. 1981; 
Berridge, 1983), both of which have second messenger functions.
InsP3 is very effective in releasing Ca2+ from intracellular stores 
(Berridge, 1983), probably from a Ca2+ pool in the endoplasmic reticulum  
(Burgess et al.. 1983; Streb et al.. 1984), and this Ca2+ contributes to the 
contraction produced by an agonist. InsP3 is then rapidly dephosphorylated to 
inositol and re-incorporated to Ptdlns in the membrane, allowing the cycle to 
continue (Figure 3).
Extensive study o f the metabolic pathway for InsP3 has revealed the 
formation o f highly phosphorylated, cyclic derivatives o f the inositol 
phosphates (Batty et al.. 1985), and o f another possible second messenger, 
in osito l 1,3,4,5-tetrakisphosphate (InsP4 ). InsP4 , either alone or in 
com bination with InsP3 , may have a role in promoting slow entry o f  
extracellular Ca2+, and has been shown to control the transfer o f Ca2+ between 
intracellular pools (Irvine & Moore, 1986).
DAG, the other "arm" of this bifurcating signalling pathway, stimulates 
the enzyme protein kinase C (PKC; Nishizuka, 1984), thus initiating various 
protein phosphorylation reactions. The role of PKC in vascular smooth muscle
contraction is as yet unclear, but it may be linked to phosphorylation, and 
subsequent activation o f the contractile proteins (Kamm et al.. 1989).
The whole cascade and the physiological functions o f all the compounds 
released are far from elucidated, but it is clear that the phosphoinositide 
signalling system may be important in the regulation o f vascular smooth muscle 
by virtue o f its effects on calcium mobilisation and PKC activation. 
Accordingly, the PI pathway may be important in conditions where blood 
vessel control is altered, such as hypertension (Heagerty & Ollerenshaw, 
1987).
Many o f the studies on PI metabolism in hypertension have used the 
erythrocyte as a model system (Kiselev et al.. 1981; Koutouzov et al.. 1982; 
Riozzi et al.. 1987), following evidence that in essential hypertension there are 
abnormalities in the erythrocyte membrane handling o f uni- and divalent cations 
(Postnov et al.. 1977; Postnov, 1990; Swales, 1991). One model o f human 
essential hypertension is the spontaneously hypertensive rat (SHR), which is 
genetically predisposed to the condition (Okamoto & Aoki, 1963). Several 
pieces o f  evidence indicate that erythrocyte membranes from SHR have an 
altered turnover of membrane phosphoinositides, as measured by the rate o f  
[32P] incorporation into phosphatidylinositol 4-phosphate (PtdlnsP) and 
PtdInsP2 (Kiselev et al.. 1981; Koutouzov et al.. 1982). Interestingly, studies 
in erythrocyte membranes from hypertensive patients showed no difference in 
phosphoinositide metabolism from control subjects, as measured by the rate o f 
[32P] incorporation into PtdlnsP and PtdInsP2. However, in normotensive 
offspring o f hypertensive patients, erythrocyte membrane phosphoinositide 
activity was greatly enhanced (Riozzi et al.. 1987). These authors concluded 
that PI metabolism was increased in subjects genetically at risk o f hypertension, 
before the blood pressure rises, and that once the blood pressure was 
established, PI metabolism was normal. This would suggest that the
phosphoinositide system may have a role in the genesis o f hypertension, but the 
picture as yet is far from clear.
VASORELAXATION
The ability o f NA and other vasoconstrictors to contract blood vessels is 
opposed by the action o f vasorelaxants, either by an endothelium-dependent, or 
an endothelium-independent, mechanism. Endothelium-dependent relaxation 
was first demonstrated in 1980, when Furchgott & Zawadzki showed that the 
endothelial lining was essential for the vasodilator action of acetylcholine (ACh) 
in isolated arterial strips or rings from rabbit. ACh acts on muscarinic receptors 
on the endothelial cells to release a compound which Furchgott & Zawadzki 
termed "endothelium-derived relaxing factor" (EDRF). This compound then 
diffuses to the underlying vascular smooth muscle cells, possibly via a carrier 
molecule such as a sulphur-containing amino acid (Ignarro et al.. 1981), where 
it induces vascular smooth muscle relaxation by activating guanylate cyclase, 
producing a rise in guanosine 3': 5’-cyclic monophosphate (cyclic GMP) levels 
(Rapoport & Murad, 1983; Vanhoutte et al.. 1986; Waldman & Murad, 1987; 
Garthwaite, Charles & Chess-Williams, 1988).
It is now generally accepted that EDRF is nitric oxide (NO) or a related 
compound (Ignarro et al.. 1987; Kahn & Furchgott, 1987; Palmer, Ferridge & 
Moncada, 1987; Moncada, Radomski & Palmer, 1988), and several substances 
acting on the appropriate receptors on the endothelial cell membrane can 
stimulate its release, including 5-HT, histamine, thrombin, AVP, substance P, 
bradykinin and the calcium ionophore A23187 (Vane, Gryglewski & Botting,
1987).
Exogenous vasorelaxants which do not require the presence o f a 
functional endothelium act directly on the vascular smooth muscle itself. 
Nitrovasodilators such as glyceryl trinitrate (GTN) and sodium nitroprusside
(SNP) diffuse into the muscle cells where they are metabolised to NO (Bennet 
& Marks, 1984), thus stimulating guanylate cyclase and elevating cyclic GMP 
levels within the cell. In contrast, p-adrenergic agonists such as salbutamol act 
on p2-adrenoceptors on the cell membrane, which are coupled to adenylate 
cyclase via the stimulatory G-protein, Gs (Gilman, 1987), raising cellular 
adenosine 3':5'-cyclic monophosphate (cyclic AMP) levels.
CYCLIC NUCLEOTIDES AND VASCULAR RELAXATION
Originally, it was believed that cyclic AMP promoted smooth muscle 
relaxation, while cyclic GMP promoted smooth muscle contraction (Goldberg, 
O'Dea & Haddox, 1973). It is now known that both o f these cyclic nucleotides 
are involved in vascular smooth muscle relaxation (Ignarro & Kadowitz, 1985; 
Waldman & Murad, 1987).
The role of cyclic AMP as a second messenger was first revealed by the 
work o f Sutherland and his colleagues in the late 1950’s. They demonstrated 
that a heat-stable factor was generated in liver membranes following hormone 
treatment, and that this factor, cyclic AMP, led to a marked glycogen  
phosphorylase activity in the previously unresponsive supernatant fraction. 
Since then, it has been shown that cyclic AMP regulates many different kinds o f  
cellular function.
In vascular smooth muscle, cyclic AMP produces relaxation by reducing 
intracellular Ca2+ levels which have been raised by contractile agonists (Lincoln 
& Cornwell, 1991). Possible mechanisms of Ca2+ reduction include inhibition 
of Ca2+ influx and activation o f Ca2+ sequestration (Meisheri & van Breemen, 
1982; Hwang & van Breemen, 1987; Abe & Karaki, 1988, 1989). In addition, 
cyclic AMP may relax vascular smooth muscle by reducing the sensitivity o f the 
contractile elements to Ca2+ (Abe & Karaki, 1989). Furthermore, cyclic AMP 
has been shown to inhibit the action o f the contractile proteins by
phosphorylating myosin light chain kinase, thus converting the enzyme to its 
inactive form (Adelstein & Einsenberg, 1978).
The cyclic GMP system has been less extensively studied than the cyclic 
AMP pathway, which was the first second messenger system to be discovered. 
Like cyclic AMP however, it is thought that cyclic GMP relaxes vascular 
smooth muscle by lowering intracellular calcium levels (Cornwell & Lincoln, 
1989). This may be achieved by various mechanisms including stimulation o f  
Ca2+ uptake into stores (Twort & van Breemen, 1988), activation o f the 
plasmalemmal Ca2+ pump and Ca2+ extrusion (Vrolix et al.. 1988), and 
inhibition of InsP3-induced Ca2+ release from the sarcoplasmic reticulum  
(Meisheri, Taylor & Saneii, 1986). The major mediator o f cyclic GMP action is 
thought to be protein kinase G (PKG; Cornwell & Lincoln, 1989; Butt et al. 
1993).
It is generally understood that cyclic AMP produces its effects via  
activation of protein kinase A (PKA), which mediates the cellular response by 
protein phosphorylation (for review, see Taylor, Buechler & Yonemoto, 1990). 
In most cell types however, cyclic AMP leads to an increase in [Ca2+]j (Black et 
al.. 1989; Lau & Bordeau, 1989; Staddon & Hansford, 1989). This is clearly 
not the case in vascular smooth muscle cells (Walter, 1981) and platelets 
(Waldman et al.. 1986), and it is interesting that both o f these cell types are rich 
in PKG (Lincoln & Cornwell, 1991). It is possible therefore that in vascular 
smooth muscle cyclic AMP activates PKG in addition to PKA, with the former 
action underlying the reduction in [Ca2+]i.
Cyclic AMP and cyclic GMP are important and powerful mediators of 
vascular smooth muscle relaxation and subsequent vasodilatation. Alterations in 
the regulation o f these second messengers may therefore have functional 
consequences in hypertension, which has often been associated with a reduced 
ability o f blood vessels to relax (Lockette, Otsuka & Carretero, 1986; Mayhan, 
Faraci & Heistad, 1987; Luscher et al.. 1988).
Several studies in aortic smooth muscle from SHR have shown a 
reduced sensitivity to p-adrenoceptor agonists, when compared to muscle from 
normotensive, Wistar Kyoto (WKY) control rats (Triner et al.. 1975; Cohen & 
Berkowitz, 1976; Godfraind & D ieu, 1978). Possible reasons include 
alterations in p-receptor density or coupling to adenylate cyclase, in adenylate 
cyclase activity, or in activity o f the phosphodiesterases, a family o f  enzymes 
which metabolise cyclic nucleotides (Silver, Michalak & Kochmund, 1985).
A study on the role o f PKA in the reduced sensitivity to p-agonists in 
SHR (Silver, Michalak & Kocmund, 1985) showed that there was no 
difference in the rate and extent o f PKA activity between hypertensive and 
control rats, although arterial relaxation was markedly reduced in the SHR as 
compared to control. This suggests that a change in a component other than 
PKA is responsible for the reduced relaxation. Alternatively, this finding may 
support the hypothesis o f Lincoln & Cornwell (1991), that PKG, rather than 
PKA, mediates cyclic AMP-induced vasodilatation in vascular smooth muscle.
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NEUROCHEMICAL TRANSMISSION
The autonomic nervous system is one o f  the major physiological 
mechanisms controlling blood vessel diameter. The density o f innervation o f  
each blood vessel varies according to its location and function. The aorta is a 
conducting vessel and receives little innervation, whereas the main artery o f the 
rat tail, a thermoregulatory organ, responds rapidly to electrical field stimulation 
as a consequence o f its dense adrenergic innervation (Sittiracha, McLachlan & 
Bell, 1987).
The term "autonomic nervous system" was first proposed by Langley in 
1898, and included both the sympathetic and parasympathetic divisions (Dale, 
1954). The existence o f the autonomic nervous system has in fact been 
recognised for several centuries. In 1732, the Danish anatomist W inslow  
applied the term "sympathetic" to the peripheral nerves (Bowman & Rand, 
1981), which he believed regulated the interrelationships, or "sympathies" o f  
organs in the body. Our present-day understanding of the anatomy and 
physiology o f the autonomic nervous system is based on the work o f Gaskell 
and Langley. Gaskell (1886) demonstrated the functional connection through 
the white rami communicantes between the central nervous system and the 
sympathetic chains, and the connections o f  the grey rami to spinal nerves. 
Gaskell labelled the cranial, sacral and thoracolumbar outflows from the 
prevertebral and other ganglia as the "involuntary nervous system".
The process by which signals are transmitted from the nerve to the 
effector tissue was the focus of much attention in the late 1800's. Du Bois 
Reymond (1877) proposed two alternative theories, the electrical theory and the 
humoral theory. The electrical theory, which held that transmission was brought 
about by the spread of nerve action currents to the tissue, was more generally 
believed. However, a key observation by Elliot (1904) was that degeneration o f  
sympathetic nerve terminals did not abolish the sensitivity o f smooth muscle
preparations to adrenaline (which the electrical theory predicted) but actually 
enhanced it. The humoral theory, which proposes that chemicals with specific 
actions are released from nerves, was then favoured, particularly since it 
explained the observation that both excitation and inhibition can be produced in 
one tissue by stimulation o f both sympathetic and parasympathetic nerves 
(Loewi, 1921).
The chemical transmitter of the sympathetic nervous system was long 
believed to be adrenaline. This is true o f the frog heart, where Loewi showed 
that sympathetic stimulation released a substance capable o f accelerating a 
second heart. Later studies in other preparations, however, showed that the 
effects o f injected adrenaline were not identical to the effects o f  sympathetic 
stimulation. The theory arose that adrenaline is released and combines with an 
excitatory or an inhibitory substance in the receptors to form two new  
complexes. These complexes, "Sympathin E" in cells excited by the transmitter, 
and "Sympathin I" in those inhibited by the transmitter, would then be the active 
substances (Cannon & Rosenblueth, 1933).
This early prediction o f - the intracellular production o f  second  
messengers was not recognised as such at the time, and the theory, which was 
only partially correct, was not generally accepted (Dale, 1954). The identity of 
the sympathetic transmitter was later revealed to be NA (von Euler, 1946).
The concept o f chemical transmission was applied to parasympathetic 
fibres, following observations that the effects o f the alkaloid muscarine and 
parasympathetic nerve stimulation were very similar, and could be blocked by 
atropine. The most likely candidate for the parasympathetic transmitter was 
shown to be ACh (Dale, 1914; Loewi, 1921; Dale & Dudley, 1929).
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NON-ADRENERGIC, NON-CHOLINERGIC (NANC) TRANSMISSION
The main transmitters liberated from the post-ganglionic sympathetic 
and parasympathetic nerves o f mammals are, respectively, NA and ACh. Over 
the years however, it has become increasingly evident that there are other 
substances which can function as neurotransmitters. Early studies hinted at such 
possibilities, indeed as far back as 1898, Langley noted that vagal stimulation o f  
the stomach produced relaxation. This response was found to be "atropine- 
resistant" (McSwiney & Robson, 1929). Several other studies found that 
responses to parasympathetic nerve stimulation persisted in the presence o f  
atropine (Langley & Anderson, 1895; Bayliss & Starling, 1899). The 
introduction o f adrenergic neurone blocking drugs such as guanethidine 
revealed analogous responses from stimulation o f  some nerves which were 
anatomically sympathetic, but insensitive to block by these drugs.
Such anomalous effects could not be explained in terms o f the 
"classical" transmitters NA and ACh. Experiments in the guinea pig taenia coli, 
for example, showed that following blockade o f both adrenergic and cholinergic 
responses to nerve stimulation, large, transient hyperpolarisations were 
produced. These electrical responses, termed "inhibitory junction potentials" 
(i.j.p.s), were accompanied by relaxations (Bumstock et al. 1963, 1964). Thus 
the idea arose that "non-adrenergic, non-cholinergic" (NANC) nerves exist.
Since the 1960s, NANC nerves have been reported in a wide variety o f  
organs and species, such as the gastrointestinal tract and rat anococcygeus 
muscle (Bumstock, Campbell & Rand, 1966; Gillespie, 1972), guinea pig 
trachea (Cobum & Tomita, 1973), rabbit portal vein (Hughes & Vane, 1967), 
and other parts o f the cardiovascular system (Bumstock, 1969).
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A systematic search for the identity o f neurotransmitters other than NA  
and ACh then began. For a substance to be regarded as a neurotransmitter, it 
must fulfil certain criteria (Eccles, 1964), namely
(i)It must be synthesised and stored in nerve terminals,
(ii)It should be released during nerve stimulation,
(iii)There should be enzymes that inactivate the "transmitter” and/or an 
uptake system for the transmitter or its breakdown products,
(iv)Post-junctional responses should be produced by the exogenous 
"transmitter" that mimic responses to nerve stimulation,
and (v) drugs should produce parallel blocking or potentiating effects on the 
responses to both exogenous transmitter and nerve stimulation.
Several substances were investigated, including catecholam ines, 
histamine, 5 -H T , prostaglandins, various amino acids and some polypeptides. 
Most were rejected because, for example, specific blocking drugs for these 
compounds did not affect the nerve-mediated response, or their action was by 
stimulation o f nerves and not by a direct action on smooth muscle (Bumstock, 
1979). However, evidence accumulated that a likely contender for a non- 
adrenergic, non-cholinergic transmitter was a purine nucleotide, probably 
adenosine 5'-triphosphate (ATP; Bumstock et al.. 1970; Bumstock, Dumsday 
& Smythe, 1972).
Nerves which use ATP as the main transmitter were termed "purinergic" 
(Bumstock, 1971), and the purinergic nerve hypothesis was formulated when 
Bumstock proposed a model for the storage, release and inactivation o f  ATP 
from purinergic nerves (Bumstock, 1972). Since then, there has been evidence 
both for and against the purinergic nerve hypothesis (Bumstock, 1979; Stone, 
1981; Gillespie, 1982). In the stomach and oesophagus in particular, 
discrepancies arose in the ability of ATP to mimic the response to NANC nerve
stimulation (Gillespie, 1972; Ohga & Taneike, 1977; Daniel, Crankshaw & 
Sama, 1979). This may be explained by the fact that ATP is rapidly broken 
down to adenosine monophosphate (AMP) and adenosine, thus accounting for 
its low potency (Ambache et al.. 1977a; 1977b). In addition, ATP is a 
ubiquitous compound with a key role in cell metabolism and many workers 
were reluctant to accept an additional transmitter role for such a compound. 
However, Su, Bevan & Bumstock (1971) demonstrated that tritium-labelled 
adenosine was taken up by stomach and intestine preparations and converted to 
[3H]-ATP. Analysis o f the radioactivity in frozen sections showed that when 
the tissue was incubated in low concentrations o f [3H]-adenosine, most o f  the 
label was stored in ATP in nerves, thus supporting a role for ATP as a 
neurotransmitter.
Hints that substances other than ATP could function as the chemical 
messenger from NANC nerves came from morphological examination o f  
neurones in the 1970s. Electron microscope studies revealed that some nerves 
contained a complex mixture o f vesicles, suggesting that they may contain more 
than one transmitter (Gabella, 19.72; Cook & Bumstock, 1976). Further 
histological studies, including fluorescence histochemistry, advanced the 
investigations, and in 1980, Hockfelt et al. described autonomic nerves 
containing various polypeptides.
Polypeptides and purines such as ATP may therefore function as NANC  
neurotransmitters in the autonomic nervous system. In addition, there is 
evidence that other compounds may fulfil such a role, including 5-HT (Wood & 
Mayer, 1979), y-amino butyric acid (GABA; lessen et al.. 1979) and dopamine 
(Bell, 1982).
Recognition of NANC transmission marked a major advance in the 
study of autonomic control, and provided the basis for the next significant step
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in our understanding o f chemical transmission - the phenemenon o f  co­
transmission.
CO-TRANSMISSION
The concept that a neurone may use more than one transmitter is now  
known as the co-transmitter hypothesis (Bumstock, 1976). It was possibly first 
proposed by Koelle in 1955, as an attempt to account for the effects o f  nerve 
stimulation which are often difficult to explain in terms of a single transmitter 
hypothesis.
For many years however, it was widely believed that a nerve cell makes 
and releases only one transmitter, and this became known as Dale's Principle. 
This is in fact a misconception o f Dale's original proposal, which was that each 
neurone releases the same transmitter at all its synapses (Dale, 1935). Indeed, 
there is no example o f  a neurone known to release different transmitters at 
different terminals (Segal, 1983; Eccles, 1986). This however does not exclude 
the possibility that more than one transmitter can be liberated from each terminal 
(Eccles, 1986).
Following the early work o f Bum and Rand (1965), there is now  
considerable evidence for the co-existence o f purines or peptides together with 
classical neurotransmitters (Chan-Palay & Palay, 1984; O'Donohue et al.. 
1985). However, co-existence o f more than one substance in a nerve terminal 
does not necessarily imply that each substance functions as a neurotransmitter. 
Nevertheless, it is now generally accepted than in many tissues the "classical" 
transmitters (NA and ACh) are stored together with the putative transmitters, 
and are co-released on nerve stimulation to act together post-junctionally.
Such a system provides sophisticated control o f the target organ. The 
role of co-transmission in the control of target tissues such as vascular smooth
muscle is regulated by processes including ageing (Bao, Eriksson & Stjame, 
1989a) and hypertension (Vidal, Hicks & Langer, 1986). There is consequently 
a need to re-assess the existence and importance o f co-transmission in many 
situations. One tissue on which there are conflicting reports about the existence 
and significance o f co-transmission, is the rat tail artery.
THE RAT TAIL ARTERY
The rat tail is a major thermoregulatory organ (Dawson & Keber, 1974) 
with a complex vascular system (Gemmell & Hales, 1977). Blood flow through 
the tail is modified by changes in vascular resistance regulated mainly by 
variation in sympathetic discharge (Sittiracha, McLachlan & Bell, 1987). The 
main ventral artery, which lies superficially in a midline groove between the 
flexor muscle groups, is innervated by a dense varicose plexus o f noradrenergic 
axons (Sittiracha, McLachlan & Bell, 1987). This vessel is often used as an 
example of a resistance vessel in studies of vasoactive drugs and mechanisms of 
sympathetic nervous control (Wade & Beilin, 1970; Surprenant, Neild & 
Holman, 1983; Medgett & Langer, 1984).
Both NA and ATP have been proposed to mediate contractions in 
response to sympathetic nerve stimulation in the rat tail artery (Sneddon & 
Bumstock, 1984a; Bao, Eriksson & Stjame, 1989a, 1989b, 1989c, 1990; Bao, 
1993), providing support for co-transmission in this vessel. Many studies 
however, do not address the possibility o f ATP as a transmitter in this vessel 
(Cheung, 1984; Medgett, 1985; Papanicolaou & Medgett, 1986; Rajanayagam, 
Medgett & Rand, 1990). These studies focus on aspects o f NA-mediated 
responses to nerve stimulation without considering possible effects o f ATP, 
while the previous group of studies were enthusiastic in their support. An 
investigation by Kotecha and Neild (1987) used an interesting approach to 
address the question o f co-transmission in the rat tail artery. It has been shown
that denervation causes an increase in receptors for the neurotransmitter 
(Axelsson & Thesleff, 1959; Kuffler, Dennis & Harris, 1971). Kotecha & 
Neild therefore reasoned that following denervation, an increase in receptors for 
a , |3-Methylene ATP (a,|3-M eA TP), which binds to ATP receptors (P2x- 
purinoceptors; Bumstock & Kennedy, 1985), would be consistent with these 
receptors being involved in neurotransmission. However, no evidence for an 
increase in receptors was found.
Clearly the issue for co-transmission in the rat tail artery has not been 
resolved. One o f the main reasons for the controversy is that many blood 
vessels lack a distinct relationship between the electrical and mechanical 
responses to nerve stimulation (Bumstock, 1988).
In some preparations, NA/ATP co-transmission has been relatively well 
characterised, the rodent vas deferens being one of the best known examples. In 
the rodent vas deferens, following stimulation o f the hypogastric nerve, a fast 
electrical response is produced on the post-junctional smooth muscle surface. It 
is now thought that this excitatory junction potential (e.j.p.) is mediated by ATP 
(Bumstock, 1988), and underlies the initial twitch contraction o f a biphasic 
mechanical response (Meldrum & Bumstock, 1983; Bumstock, 1988). The 
second, slower phase o f contraction is mediated by NA released from the same 
nerve, and probably the same vesicle, as ATP (Meldrum & Bumstock, 1983; 
Burnstock, 1988). The relevant phases o f the response, both electrical and 
mechanical, are blocked by the appropriate antagonists. Both the twitch 
contraction and e.j.p. are inhibited by a,(3-MeATP, a stable analogue o f ATP 
which is thought to act by desensitising the receptor which mediates ATP- 
induced contraction, the P^x-purinoceptor (Kasakov & Bumstock, 1982). The 
slow contraction is inhibited by adrenergic antagonists such as prazosin, an a r  
adrenoceptor blocker and phentolamine, an a-antagonist which is non-selective 
for the a r  or a 2-adrenoceptor subtype (McGrath, Brown & Wilson, 1989).
In many blood vessels however, the nature o f chemical transmission is 
much less well characterised. Excitatory junction potentials can be elicited in 
vascular smooth muscle such as the rat tail artery by stimulation o f  the 
perivascular nerves. Like the vas deferens, a distinctive feature o f  the e.j.p.s is 
their resistance to a-adrenergic blocking agents (Holman & Suprenant, 1980; 
Cheung, 1982). In contrast to the vas deferens however, in some blood vessels 
the e.j.p. is completely blocked by ATP antagonists, while the mechanical 
response is barely affected (Bumstock, 1988). Such dissociation between 
electrical and mechanical responses is not compatible with a causative 
relationship between the two, and leads to questions regarding the role or 
relevance o f such an electrical change which apparently has little role in the 
ultimate response o f the tissue, i.e. contraction.
An alternative hypothesis to co-transmission has been put forward to 
explain the origin o f responses to nerve stimulation which are resistant to a -  
adrenoceptor blockade. A further subtype o f adrenoceptor, the "gamma” (y) 
receptor, was proposed to mediate such responses (Hirst & Jobling, 1989). In 
guinea pig arterioles, the contraction evoked by NA when applied to regions 
distant from the sympathetic nerves was mediated by a-adrenoceptors. In 
contrast, when NA was applied close to the sympathetic nerves, the response 
was resistant to a-adrenoceptor blockade (Hirst & Neild, 1980; 1981).This 
response was attributed to activation o f  a novel adrenoceptor, the y-receptor. 
The theory received little support however, and was not pursued. Nevertheless, 
it did give rise to important questions regarding the receptor subtypes involved 
in the post-junctional response to neurally-released transmitter.
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RECEPTOR CLASSIFICATION
An early experiment by Bernard (1857) showed that nicotine applied to 
a certain part o f a skeletal muscle surface produced twitching, and that this 
effect was prevented by curare. This prompted Langley (1905) to postulate the 
existence o f  a "receptor substance" located on the muscle rather than on the 
nerve endings. He also proposed that this "receptive substance" could exist in 
more than one form in autonomic effector cells.
Advances in receptor classification often came with the use o f  
antagonists. Experiments by Dale (1914) showed that following blockade o f 
muscarinic receptors by atropine, the nicotinic effects o f ACh were revealed, 
thus demonstrating two different types o f receptor for ACh. Similarly, a parallel 
with adrenergic receptors was shown (Dale, 1913). Dale's "adrenaline reversal" 
experiment demonstrated that adrenaline produces two different types of effect, 
vasoconstriction and vasodilatation, and that one could be converted into 
another depending on the experimental conditions. On injection o f adrenaline 
into a cat, the arterial pressure rose. Dale showed that this vasoconstrictor 
component disappeared if the animal was first injected with an ergot derivative, 
and noticed that adrenaline then caused a fall, instead o f a rise, in arterial 
pressure. It was later recognised that certain ergot alkaloids act as a-receptor 
antagonists, and that Dale's adrenaline reversal experiment reflected the 
unmasking o f the (3 effects o f adrenaline by a-receptor blockade. This 
experiment provided an early illustration o f an important concept in physiology 
and pharmacology, namely, that the observed responses are not fixed and often 
depend on the experimental conditions.
Later work beginning with Ahlquist (1948) showed that several 
subclasses of adrenoceptor exist in the body. Ahlquist found that the rank order 
o f potencies o f various catecholamines fell into two distinct patterns and 
postulated the existence of two kinds of receptor, a  and (3, with the following
order o f potency : a:- (NA) > adrenaline (adr) > isoprenaline (isop); p :-isop > 
adr > NA.
However, the classification o f  a -  and p-adrenoceptors was not 
generally accepted until the introduction o f specific P-adrenoceptor antagonist 
drugs, beginning with dichloroisoprenaline (Powell & Slater, 1958) followed  
by pronethalol (Black & Stephenson, 1962) and propranolol (Black et al.. 
1964). Lands et al. (1967) subsequently showed that p-adrenoceptors could be 
further divided into Pi- and p2-subtypes.
A similar degree of selectivity among drugs acting on a-adrenoceptors 
has now been recognised, and these are generally subdivided into a i— and (X2-  
adrenoceptors. Dubocovich & Langer (1974) found that a-adrenoceptors could 
be subdivided on the basis of their differential sensitivity to the alkylating agent 
phenoxybenzamine. This followed the discovery that pre-synaptic a-receptors 
differed from the post-junctional a-receptors (Starke, 1972; Langer, 1973). It 
was subsequently proposed that the post-junctional receptors should be termed 
a i  and the pre-junctional, a 2 (Langer, 1974; Berthelsen & Pettinger, 1977).
For many years it was thought that receptors were confined to the post- 
synaptic membranes of the cells on which the neurotransmitters acted (Dale, 
1952). Since then however, nerve terminals have been found to contain a wide 
variety o f receptor types (Stjame, 1975; Langer, 1977; Starke, 1977; 1981), 
which influence transmitter release (Starke, 1977; Westfall, 1977).
Experiments on the perfused cat spleen (Brown & Gillespie, 1956; 
1957) demonstrated that drugs could increase sympathetic transmitter overflow. 
It was later shown that activation o f pre-junctional a-adrenoceptors by 
transmitter noradrenaline reduces noradrenaline release, and that interruption of 
this "negative feedback loop" by a 2-adrenoceptor antagonists results in an 
increased transmitter outflow (Starke, 1977; 1981).
The original anatomical classification o f adrenoceptor subtypes has now 
been rejected in favour of a more pharmacological approach. Studies using
specific a-adrenoceptor antagonists such as prazosin, which is highly selective 
for the cti-subtype (Cambridge & Davey, 1980), revealed responses in the 
vascular smooth muscle o f rat and cat which were resistant to blockade of a i-  
adrenoceptors (Bentley, Drew & W hiting, 1977; Cambridge, D avey & 
Massingham, 1977). These contractile responses were thought to be mediated 
via a sub-population o f a-adrenoceptors, and support the conclusion that a 2- 
adrenoceptors are located not only on nerve terminals but also post-junctionally 
on target tissues (Docherty, MacDonald & McGrath, 1979; Timmermans, Kwa 
& van Zwieten, 1979). The functional role o f the post-junctional a2-  
adrenoceptor is not as clear-cut as that o f the ai-adrenoceptor however, and 
many gaps in the literature still exist. These must be filled before the role of the 
a 2-adrenoceptor in post-synaptic events, such as regulation o f  the 
responsiveness o f vascular smooth muscle, is fully accepted.
POST-JUNCTIONAL ALPHA2-ADRENOCEPTORS
Since the original differentiation between a - and [3- adrenoceptors by 
Ahlquist (1948) and the subsequent recognition o f a r  and a 2-adrenoceptor 
subdivision (Langer, 1974), various forms o f  technical progress have 
suggested further subdivisions. The advent o f radioligand binding techniques 
enabled investigators to measure directly the binding o f  a-adrenoceptor- 
selective agents to their receptors. This led to the discovery that both a r  and 
a 2-adrenoceptors could be subdivided further into at least two additional 
subtypes (Bylund, 1988; Minneman, 1988). Molecular and genetic techniques 
have since reported three clones o f  an a 2-adrenoceptor from human DNA. 
These clones are the c^-ClO (Kobilka et al.. 1987; Fraser et al.. 1989), the oc2- 
C2 (Lomasney et al.. 1990; Weinshank et al.. 1990) and the o^-C4 (Regan et 
al.. 1988), with 10, 2 and 4 denoting chromosomal number. These genes 
encode for the cc2 a ->  oc2 b -  and a 2 c - adrenoceptor subtypes respectively. An 
a^-adrenoceptor subtype has also been reported but it is thought that the gene 
encoding this subtype is a rat homologue o f the human oc2A-adrenoceptor 
(MacKinnon, Spedding and Brown, 1994). Porcine and rat analogues o f these 
clones have also been reported (Guyer et al.. 1990; Zeng et al.. 1990). 
Similarly, three different a  j-adrenoceptor clones have been discovered 
(Harrison, Pearson & Lynch, 1991).
This information should be interpreted cautiously however, and the 
relevance o f such molecular data to functional receptors mediating physiological 
responses must not be overestimated.
For a long time, a!-adrenoceptors were thought to be the only post­
junctional adrenergic receptor subtype involved in the response o f  a blood 
vessel to circulating or neurally-released sympathomimetic agents. It is only in 
the last decade or so that the involvement o f a 2-adrenoceptors in such 
responses has been recognised. Experiments demonstrating effects mediated via
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post-junctional a 2-adrenoceptors have generally been conducted in situ in 
preparations such as the pithed rat (McGrath, 1982), conscious or pithed rabbits 
(Hamilton & Reid, 1980), and in the perfused hind limb o f the rabbit (Madjar, 
Docherty & Starke, 1980) or dog (Langer, Massingham & Shepperson, 1981).
There is much less evidence available from in vitro experiments. The 
first report from an in vitro study for a vascular smooth muscle c^-adrenoceptor 
was in the dog (De M ey & Vanhoutte, 1981). Venous smooth muscle was 
found to respond to a r  or c^-adrenoceptor agonists but arterial smooth muscle 
only to a j .  The effects o f antagonists tended to support this but were 
complicated by the presence o f non-competitive antagonism. At this stage 
therefore the classification o f "post-junctional a 2-adrenoceptors" was still 
tentative.
Evidence from further in vitro work is steadily accumulating however 
that a-adrenoceptors do exist on vascular smooth muscle, as shown in the rat 
tail artery with selective labelling by tritiated clonidine (Weiss, Webb & Smith, 
1983). Moreover, the authors suggested that these receptors do indeed have a 
functional role in mediating contraction of the vascular smooth muscle.
More recently, post-junctional a 2-adrenoceptors have been 
demonstrated in vitro in human blood vessels (Nielsen et al.,1992) where they 
mediate vasoconstriction.
It is now generally accepted that ai-adrenoceptor activation leads to 
smooth muscle contraction both by promoting Ca2+ influx via Ca2+ channels on 
the plasma membrane, and by stimulating PI hydrolysis (Han, Abel & 
Minneman, 1987). It has been proposed that these effects are mediated via 
different subtypes o f ai-adrenoceptor, the ccia- and aiB -adrenoceptor  
respectively (Han, Abel & Minneman, 1987).
Despite the growing awareness that a 2- as well as ai-adrenoceptor 
activation causes vascular smooth muscle to constrict, the mechanisms 
underlying (^-adrenoceptor-mediated contraction are relatively unknown. Such
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contractions have been difficult to demonstrate in vitro, and an interesting 
feature o f some recent studies is that they are dependent upon a degree o f  
vascular smooth muscle stimulation by some other receptor system (Dunn, 
McGrath & W ilson, 1991). In the isolated vascular bed o f the rat tail for 
example, the c^-agonist U K -14,304 was virtually inactive when added alone. 
In the presence o f  the hormone vasopressin, pressor responses to U K -14,304 
were uncovered which were prazosin-resistant, but sensitive to inhibition by 
rauwolscine, an ^-antagonist (Templeton e ta l.. 1989). Similarly, contractions 
to U K -14,304 were revealed following precontraction o f the rat tail vascular 
bed with the peptide endothelin -1 (Et-1; MacLean & McGrath, 1990). An 
analogous phenomenon has been described in the rabbit isolated distal 
saphenous artery, where contractions to U K -14,304 were dependent on prior 
exposure to the hormone A ll or to the selective aj-adrenoceptor agonist 
phenylephrine (PE; Dunn, McGrath & Wilson, 1989; 1991).
Clearly, whether or not a response to an c^-adrenoceptor agonist is seen 
depends on the conditions under which the experiment is conducted. Several 
intriguing questions arise - why are other substances (e.g. A VP, A ll, Et-1) 
apparently required before ^-adrenoceptor-mediated contractions are seen, and 
is this linked to the observation that such contractions are more easily (although 
not exclusively) demonstrated in vivo rather than in vitro?
In the light o f both the a r  and the o^-adrenoceptor being involved in 
vascular smooth muscle contraction, certain aspects o f vascular control should 
be reconsidered. It is tempting to speculate on the possibility that prazosin- 
resistant contractions to sympathetic nerve stimulation, previously attributed to 
the action of co-transmitter ATP, may be mediated by the o^-adrenoceptor. This 
however may be a simplistic explanation o f the discrepancies in the purinergic 
hypothesis. Nevertheless, it is clear that the question o f co-transmission in
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blood vessels must be re-examined in order to understand more fully how the 
responsiveness o f vascular smooth muscle is regulated by neural control.
SENSITIVITY CHANGES IN AUTONOMIC EFFECTORS
Smooth muscle sensitivity is not fixed, but is subject to change under 
certain circumstances, and can be influenced by both the autonomic nerves and 
the endocrine glands. One o f the earliest observations o f  changes in effector 
sensitivity involved surgical denervation (Budge, 1855). This procedure 
resulted in a phenomenon which came to be known as supersensitivity.
(i) Supersensitivity.
Supersensitivity occurs when the amount o f stimulant required to 
produce a response is less than normal (Cannon & Rosenblueth, 1949; 
Trendelenburg, 1972; Westfall, 1981), and generally results from removal o f  a 
tonic stimulus.
The type o f supersensitivity, most commonly seen in smooth muscle 
occurs when the responses to submaximal doses o f an agonist are increased, 
but the maximum response is unchanged. This is reflected in a leftward 
displacement o f the concentration-response curve for one or more agonists 
(Cannon & Rosenblueth, 1949). Another type of supersensitivity is reflected in 
an increased maximum response o f the target tissue (Pollock et al.. 1972; 
Gardiner, Gibson & Pollock, 1974; Gibson & Pollock, 1975). Mechanisms 
underlying an increased sensitivity include loss o f inactivation o f an agonist 
(“deviation” supersensitivity; Fleming, 1975), an increase in receptor number 
(Bito & Dawson, 1970), or changes in intracellular events distal to agonist- 
receptor interaction (Fleming, 1968).
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(ii) Subsensitivity.
Subsensitivity o f a tissue to a receptor agonist (desensitisation) results in 
a rightward displacement o f the concentration-response curve for that agonist 
(Rang & Ritter, 1970). In addition, a reduction in the maximum response can 
be interpreted as subsensitivity (Waud, 1975). Two types o f desensitisation are 
recognised, namely homologous and heterologous.
The term heterologous desensitisation describes the non-specific 
reduction in sensitivity that occurs when cells are incubated with one agonist 
and subsequently found to be subsensitive not only to that agonist, but to 
several others (Su, Cubeddu & Perkins, 1976). Heterologous desensitisation 
involves functional uncoupling o f  the' receptors in the absence o f sequestration 
or down-regulation (Harden, 1983).
Homologous desensitisation is the term used to described the specific 
desensitisation that occurs when cells are re-challenged with the same agonist 
used in the initial exposure. In this situation agonists other than that used in the 
initial exposure produced a normal response (Su et al.. 1976). In the case o f  (i- 
adrenoceptors, this type o f desensitisation is thought to involve the 
sequestration o f the receptors away from the plasma membrane. The 
sequestered receptors may then undergo degradation (Harden, 1983).
Alterations in receptor sensitivity therefore provide a means o f  
regulating the responsiveness o f  vascular smooth muscle. One o f the most 
important situations in which sensitivity can change is in hypertension, a major 
pathological disease affecting the vasculature.
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HYPERTENSION
Hypertension is characterised by an elevated systemic arterial blood 
pressure and is caused by an increased total peripheral resistance (Folkow et al, 
1970; Lund-Johansen, 1980). This increased resistance is mainly due to 
changes that occur in small arteries and arterioles, particularly o f the splanchnic 
region (Folkow, 1982). The mechanisms responsible for this phenomenon are 
still poorly understood but may include hypertrophy and hyperplasia o f vascular 
smooth muscle and alterations in the release or response to neural or humoral 
factors that cause vasoconstriction or vasodilation (Komer, 1982).
The structural changes associated with hypertension were in fact noted 
from a very early date (Bright, 1836 and Johnson, 1868; cited by Sivertsson,
1988), but initially were regarded as having little functional importance. The 
haemodynamic impact was only estimated from morphological data, and it was 
concluded that the structural changes were too slight and too inconstant to cause 
the blood pressure elevation (Castleman & Smith wick, 1943). It was not until 
the haemodynamic effects of such structural alterations were studied (Folkow, 
Grimby & Thulesius, 1958; Conway, 1963; Sivertsson, 1970) that the 
significance o f these vascular changes was realised. Indeed, Folkow (1982) and 
Sivertsson (1988) support the view  that an increased responsiveness to 
vasoconstrictors in hypertension can be accounted for by structural changes 
alone. This is in contrast to evidence compiled by Winquist, Webb & Bohr 
(1982), who reviewed studies describing both functional and structural 
abnormalities in hypertension. It is now generally accepted that functional and 
structural factors are important in both the initiation and maintenance of 
hypertension.
However, there is great debate surrounding the precise nature of 
changes that occur in the sensitivity o f vascular smooth muscle in hypertension. 
Much of the controversy has arisen from differences in experimental design,
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including the model and time-course o f hypertension studied, as w ell as the 
technique, agonist, and tissue utilised (Winquist, Webb & Bohr, 1982; Marin, 
1993). It is not surprising therefore that a great variety o f results have been 
reported in the literature.
Several studies found a decrease in endothelium-dependent relaxation in 
hypertension (Winquist et al.. 1984; Lockette, Otsuka & Carretero, 1986), and 
a decrease in P-adrenoceptor-mediated vasorelaxation firmer et al.. 1975).
Other investigations however noted an increase in the response o f  
vasculature from hypertensive animals (Werber & Fink, 1985; Webb, Vander & 
Henry, 1987) and humans (Hollenberg & Adams, 1976) to the vasodilator 
acetylcholine. These findings are somewhat surprising but have been suggested 
to be an adaption to the hypertension, as they clearly do not have a causative 
role. Still other studies report no difference in the vasodilator response to ACh 
between the mesenteric microvasculature o f rats with steroid hypertension and 
their normotensive controls (King & Webb, 1988).
Similar conflicting results concerning vasoconstrictors in hypertension 
have also been reported. Various .blood vessels and vascular beds from  
hypertensive animals and humans have been shown to exhibit increased, 
decreased, or indeed no change in sensitivity when compared to their 
normotensive controls (Clineschmidt et al.. 1970; Hermsmeyer, 1976; Swamy 
& Triggle, 1980; Aalkjaer £i_aL 1987; Hoick, 1988; King & Webb, 1988; 
1991).
Hypertension is clearly a complex phenomenon. Further studies must be 
carried out to elucidate the nature of the sensitivity o f vascular smooth muscle in 
hypertension. A systematic investigation is necessary before the discrepancies 
in the literature in this regard can be resolved.
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AIMS OF THE STUDY
The responses o f vascular smooth muscle are regulated by many 
factors, including receptors, neurotransmitters and disease processes such as 
hypertension. These factors are not independent o f  one another but are 
interconnected. Investigation o f all these aspects of vascular control w ill seek to 
answer the following questions
1) Is the sensitivity o f blood vessels from hypertensive rats altered with 
respect to vessels from control animals, and if  so, how?
2)Do a 2-adrenoceptors exist on the smooth muscle o f the rat tail artery? 
If so, what are the conditions required to demonstrate contractions 
mediated by these receptors, and what is their mechanism o f action?
3)What is the nature of the neurotransmission in the rat tail artery? Does 
co-transmission have a role, and if so, is its involvement altered in 
hypertension?
30
Materials and Methods
1. EXPERIMENTAL ANIMALS
Preliminary experiments were carried out with two groups o f male 
Wistarrats: (a) "older rats": 300-350g, 12-17 weeks, and (b) "younger rats": 
145-225g, 6-9 weeks. For experiments where comparisons between older and 
younger rats were not being made, animals were usually 300-400g (10-12 
weeks) or 180-240g (6-8  weeks). Experiments were also carried out with 
spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) control rats 
(200-300g, 10-12 weeks), supplied by Harlan Olac or Charles River.
Animal Pretreatments
(a) Reseroine
Rats were treated with reserpine, dissolved in vehicle (glacial acetic 
acid) and injected intraperitoneally (0.75 mg kg-1, i.p.) daily for 7 days. 
Control rats received daily injections o f the vehicle only. Experiments were 
carried out over the following two weeks.
(bl 6-Hvdroxvdopamine (6 -OHDA)
Rats were treated with 6 -OHDA as follows :- 
2 x 25 mg kg-1 on day 1 
2 x 100 mg kg-1 on days 3-5 
Control rats received an equivalent volume o f saline. Experiments were carried 
out over the following two weeks.
2. MEASUREMENT OF BLOOD PRESSURE
Systolic blood pressure was measured in conscious rats by the tail cuff 
method. The rats were maintained in a warming chamber at 37°C  for 15
minutes, prior to blood pressure measurement. Each rat was held in a restrainer 
and an inflatable cuff placed around the base of the tail. The cuff was inflated by 
means o f a motor driven piston, and a pressure transducer, placed distal to the 
cuff, allowed the pulse o f the tail artery to be detected accurately and displayed 
on a calibrated oscilloscope (Figure 12).
The point at which the tail arteiy pulse was blocked showed the systolic 
blood pressure and this was confirmed when the applied pressure fell and the 
arterial pulse reappeared.
3. MECHANICAL RESPONSES OF TISSUES
A. Aortic Rings
Rats were killed by stunning and exsanguination. The chest wall was 
cut along the midline and the thoracic cavity exposed. The descending thoracic 
aorta was removed, placed in a Krebs-filled petri dish and cleared o f fat and 
connective tissue. Four adjacent transverse aortic rings (3-4mm) were obtained 
from each aorta, weighed and suspended between stainless steel hooks in 25ml 
organ baths containing Krebs' bicarbonate solution o f the follow ing  
composition (mM): NaCl (118.1), KC1 (4.7), M gS 0 4 (1.0), KH2P 0 4 (1.2), 
C aC l2 (2 .5 ), NaHCC>3(25.0) and glucose (11.1). The Krebs solution was 
maintained at 37°C by a thermostat and gassed continuously with 95% O2 : 5% 
C 0 2. The initial resting tension was adjusted to two grams and rings allowed to 
equilibrate for 90 minutes prior to the start o f experiments. Isometric tension 
was measured using Statham force/displacement transducers and recorded on a 
Grass Polygraph (model 79D).
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B. Isolated, perfused tail artery
Rats were killed as described, and the tails were cut o ff and skinned. 
Two 20mm segments o f the proximal part o f the main ventral artery were 
dissected from the ventral groove, and transferred to a Krebs-filled petri dish. 
The remaining length o f artery was not used. Tail artery segments were 
perfused using modifications o f  the method o f M edgett and Rajanayagam 
(1984), as follows:
(a) Single cannulation
In preliminary experiments, each artery segment was cannulated at one 
end with a fine polythene cannula. The artery was then passed through a pair of 
Ag/AgCl ring electrodes attached to a perspex holder, and the assembly inserted 
into a 25ml Krebs-filled organ bath, gassed and heated as before. The cannula 
was connected to a silicone rubber tube, through which Krebs buffer was 
pumped from a reservoir at a constant rate (0.5 or 1ml min-1) by a Watson 
Marlow constant output pump, that had been previously calibrated. Preparations 
were allowed to equilibrate for 60 minutes prior to the start o f experiments. 
Drugs were injected by bolus injection into the thick-walled rubber tubing, 
immediately preceding the cannula. The resistance o f the artery to perfusion was 
measured by a Statham pressure transducer and the perfusion pressure was 
displayed on a Grass polygraph.
In later experiments, this arrangement was modified by addition of a 
heating coil between the reservoir and the cannula to maintain the temperature of 
the perfusing Krebs solution at 37°C.
(bl Double cannulation
For all other perfusion experiments each artery segment was cannulated 
at both ends, with the second cannula allowing the perfusate to pass out of the 
organ bath without superfusion. Drugs were administered either in the
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perfusing solution until each response reached equilibrium, or as a bolus 
injection.
C. Tail artery rings 
(a.) Proximal tail artery
Rings (3-4mm) o f proximal tail artery were weighed, and mounted 
under lg  tension on a combined electrode and tissue holder. This was inserted 
into a 25ml organ bath containing Krebs solution, gassed and heated as 
described. One electrode was outside the artery lumen and the other inserted 
through the lumen to act as a fixed point for tension measurement. A  stainless 
steel triangle inserted though the artery lumen was attached via a thread to a 
Statham force-displacement transducer, and isometric tension responses were 
displayed on a Grass polygraph. The artery rings were allowed to equilibrate 
for 60 minutes, then tension was removed and reapplied ( lg  as before) and the 
organ bath washed out and refilled. After a further 60 minutes equilibration, 
experiments were initiated.
(bl Distal tail artery
The tail artery was dissected out from the ventral groove along the entire 
length o f the tail, then 3-4mm rings obtained from the distal part o f the tail 
artery, 10-20mm from the tip. These rings were mounted on a small vessel, 
automated myograph. The method was adapted from that o f Mulvany and 
Halpem (1976), using the myograph simply as a scaled-down organ bath in 
which to measure isometric tension responses from very small segments of 
blood vessel.
Using a dissecting microscope, the vessel segments were threaded onto 
two 40fim stainless steel wires attached, respectively, to a tension transducer 
and a micrometer translator under lg  resting tension. The myograph chamber 
was filled with Krebs solution maintained at 37°C  and gassed with 95% O2 : 
5% CO2. As with the proximal tail artery rings in the organ bath, the distal tail
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artery rings were allowed to equilibrate for 2  hours, with washout and re-setting 
o f tension after the first hour, before any experimental procedures. Drugs were 
injected directly into the myograph chamber, and changes in isometric tension 
displayed on a Linseis chart recorder.
Addition o f drugs
For experiments measuring isometric tension, drugs were injected 
directly into the organ bath. Concentration-response curves were carried out in 
two ways: a) Cumulatively, with each successive concentration o f drug added 
when the response to the preceding concentration reached a plateau, or b) in the 
wash-out manner, with each concentration left in contact with the tissue until the 
response had peaked, then washed out. The next concentration was added when 
the preceding response returned to baseline.
For vasorelaxants, arteries were first precontracted with PE (EC75), 
then cumulative concentration-response curves obtained.
When experiments were carried out in the presence o f an antagonist, the 
antagonist was added to the organ bath at least 15 minutes before addition o f the 
agonist, or as detailed in the Results.
For perfusion pressure experiments, concentration-pressure curves were 
obtained by either a) perfusion to equilibrium, where increasing concentrations 
o f drug were perfused once the response to the previous concentration had 
reached a plateau, or b) by bolus injection, where increasing concentrations 
were injected into the Krebs-perfused artery once the preceding response had 
returned to baseline.
All other experimental protocols were as detailed in the Results.
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Electrical field stimulation
Studies on the mechanical responses to electrical field stimulation in the 
rat tail artery were carried out using a Palmer square-wave stimulator. Non- 
cumulative frequency-response curves were constructed using a constant 
number o f pulses (10), by varying the time o f stimulation. The pulse width was 
0.1 or 0.4ms, and the voltage supramaximal (usually 50V). The responses to 
trains o f  stimuli (10 Hz for Is, 50V, 0.1ms, every 100s) were also studied. 
Other stimulation protocols were as detailed in the Results.
Expression o f results
Results were expressed in a variety o f ways, using the following units 
as appropriate: g tension; g mg-1 tissue; Amm Hg; % maximum response; % o f  
the maximum response to PE.
4. BIOCHEMICAL RESPONSES OF TISSUES
Phosphatidvlinositol 4.5 -bisphosphate (PtdInsP2l hydrolysis in the Rat Tail 
Artery.
The involvement o f PtdInsP2 hydrolysis in the mechanical response to 
noradrenaline in vitro was assessed by radiochemical measurement o f total 
inositol phosphates released from segments of rat tail arteries incubated with 
myo-[2-3H]-inositol.
A. Preparation of Ion Exchange Columns
Ion exchange resin (Dowex 1 x 8 - 400, chloride form) was prepared by 
washing with the following solutions: distilled water (11), NaOH (2M, 21), 
distilled water (21), formic acid (2M, 0.21), then distilled water until pH 4.5-5 
was obtained. This produced the formate form of resin, which was added in 
lm l aliquots to chromatography columns made from 5ml Pasteur pipettes, the
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tips o f which were plugged with glass w ool. Columns were prepared by 
washing with ammonium formate (2.4M, 15ml), followed by distilled water 
until pH 4.5-5 was obtained. The products o f  PtdInsP2 hydrolysis were 
examined using a modified version o f the method o f Akhtar & Abdel-Latif 
(1986).
B. Production and Measurement o f Total Inositol Phosphates
Segments o f rat tail artery (10mm) were weighed, and washed in ice- 
cold Krebs solution. Each segment was then placed in a test tube bubbled with 
95% C>2 : 5% CO2 and the following procedures carried out in a shaking water 
bath at 37°C. Tissues were pre-incubated in Krebs solution for 15-30 minutes, 
then labelled with 8 |iC i ml-1 inositol (in Krebs) for 2  hours. PtdInsP2 
hydrolysis was stimulated by incubation with NA (10_6M, 10*5M, 45-60  
minutes), in Krebs solution containing lOmM LiCl to inhibit inositol phosphate 
phosphatase (InsP phosphatase) and hence prevent the breakdown o f InsP to 
inositol and subsequent recycling of the PI cycle (Hallcher & Sherman, 1980). 
The reaction was terminated by addition o f  a chloroform/methanol mixture 
( 1 : 2 ,  v/v) and tissues homogenised in hand-held glass Potter-Elvehjem  
homogenisers. The test tubes containing the homogenised tissue were 
centrifuged at 2000g for 5 minutes at room temperature, then the lower organic 
phase discarded. The upper aqueous phase containing the inositol phosphates 
was taken for analysis.
Samples o f the aqueous phase were applied to the previously-prepared 
Dowex resin columns, and washed with the following solutions: 20ml water, to 
elute [3H ]-inositol, 15ml o f  ammonium formate (50m M ), to elute 
glycerophosphoinositides, and finally 8ml o f ammonium formate (lM )/formic 
acid (0.1M) mixture, to elute the [3H]-inositol phosphates.
A 1ml sample of the final eluate was added to scintillation fluid (Ecosint, 
10ml) and total radioactivity determined by liquid scintillation counting
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(Hewlett-Packard 2000CA Tri-carb). Results were expressed as disintegrations 
per minute (d.p.m.) per mg o f tissue (wet weight).
5. HISTOLOGICAL EXAMINATION OF TISSUES
Blood vessel structure was studied using light microscopy, to compare 
the morphology o f the aorta and tail artery from hypertensive animals with 
vessels from control animals.
A. Fixing
Blood vessels were dissected as described, then 1cm segments fixed in 
4% buffered formalin (paraformaldehyde). This was prepared by mixing 4g  
formaldehyde with 90ml distilled water and 10ml lOx phosphate-buffered saline 
(PBS, containing 1.3M NaCl, 70mM Na2HP0 4  and 30mM NaH2PC>4 ; any 
precipitates or crystals formed were filtered off). The milky-white solution was 
stirred with a magnetic stirrer at 60°C  for 1 hour, until the solution became 
clear.
B. Sectioning and staining
After fixing, the vessels were sectioned and stained by David Russell 
and Dr. J. McGadey, o f  the Anatomy Department, University o f Glasgow. 
Vessels were embedded in wax blocks, then from each segment, 5 x 50|im  
transverse sections were cut on a microtome. The sections were floated in a 
water bath and mounted onto slides, which were left overnight in a 37°C  oven 
to ensure sections were fixed securely.
Sections o f rat tail artery were stained using Masson's trichrome 
technique, which stains nuclei blue/black, cytoplasm and muscle red, and 
connective tissue green. Sections o f rat aorta were stained using Epple, which 
stains elastin purple, nuclei red, cytoplasm reddish orange, and connective 
tissue green. Coverslips were then mounted on the slides using the plastic 
mounting agent, DPX.
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C, Examination
The slides were examined under a light microscope. Each section was 
projected onto paper and the image traced around to produce a drawing o f  the 
transverse section. Drawings were analysed using a Tandon computer and the 
Biquant System IV software package (R & M Biometrics). The parameters 
measured were media thickness, lumen diameter, media thickness to lumen ratio 
and media area (of a transverse section).
6 . DRUGS USED
The following drugs were used: acetylcholine (Sigma), adenosine 5'- 
triphosphate (Sigm a), 5-brom o-6-[2-im idazolin-2-ylam ino]-quinoxaline  
bitartrate (UK -14,304; Pfizer), carbamylcholine chloride (carbachol; Sigma), 
clonidine hydrochloride (Sigma), N 6, 2'-0-dibutyryladenosine 3':5'-cyclic 
monophosphate (Sigma), diltiazem hydrochloride (Sigma), forskolin (Sigma), 
6 -hydroxydopamine hydrobromide (Sigma), 5-hydroxytryptamine (creatinine 
sulphate complex; Sigma), [3H]-inositol (Amersham International), 3-isobutyl- 
1-methylxanthine (Sigma), DL-isoprenaline sulphate (Sigma), ketanserin 
(S ig m a ), lith ium  h yroch lor id e (S ig m a ), [ p - m e r c a p t o - p ,  p- 
cyclopentamethylenepropionyl1, O-Me-Tyr2, Arg8]-vasopressin (Sigma), oc,p- 
methylene ATP (Sigma), L-noradrenaline hydrochloride (Sigm a), L- 
phenylephrine hydrochloride (Sigm a), prazosin hydrochloride (Pfizer), 
reserpine base (Sigma), sodium nitroprusside (British Drug H ouses), 
tetrodotoxin (Boehringer), yohimbine hydrochloride (Sigma).
A ll drugs were prepared in Krebs solution, with the follow ing  
exceptions: Ketanserin was made up in abslolute alcohol and then diluted with 
Krebs, so that the final concentration o f ethanol in the organ bath did not exceed 
0.01%. Isoprenaline and noradrenaline were dissolved in Krebs solution 
containing 0.3mM L-ascorbic acid, to prevent oxidation and breakdown of
these catecholamines. Prazosin and yohimbine were dissolved in Krebs solution 
following ultrasonication. Reserpine was prepared in glacial acetic acid.
7. STATISTICAL ANALYSIS
All results were expressed as the mean + standard error o f the mean (% +
S.E.M.), for the number o f observations, n. Statistical comparisons o f  the data 
were carried out using Student's t-test, the Mann-Whitney non-parametric t-test, 
or the paired t-test as appropriate, and a probability (P) o f  0.05 or less was 
considered significant.
The following standard designation was applied to represent levels o f  
significance:
* P < 0.05 
* * P < 0.01 
* * * P  <0.001
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Results
PARTI
PRELIMINARY EXPERIMENTS IN THE PERFUSED RAT TAIL ARTERY
In the first part o f this study, the effects o f drugs and field stimulation 
were studied in rats o f two age groups, "older rats" (12-17 weeks, 300-350g) 
and "younger rats" (6-9 weeks, 145-225g).
A) RAT WEIGHT AND SYSTOLIC BLOOD PRESSURE
Male Wistar rats o f two different age groups were weighed, and their 
systolic blood pressure (SBP) measured by the tail cuff method. Older rats were 
significantly heavier than rats in the younger age group (331±12g, c.f. 189+7g; 
PcO.OOl), and there was a close positive correlation between rat age and weight 
(r=0.956; Figure 4a). The SBP o f the older rats was significantly higher than 
that of the younger rats (128±2mmHg cf. 114+3mmHg; P<0.05), but both sets 
of measurements were in the normotensive range. There was also a positive 
correlation between rat weight and SBP ( r -0.375; Figure 4b), but this was not 
statistically significant.
B) PERFUSION PRESSURE MEASUREMENTS
1) Single cannulation
In preliminary experiments, segments o f rat tail artery were cannulated 
at one end with a fine polythene cannula , passed through a pair o f  Ag/AgCl 
ring electrodes and inserted into an organ bath. Artery segments were perfused 
with Krebs solution at a constant flow rate (0.5 or 1ml min-1) so that changes in 
vessel diameter were manifested as changes in perfusion pressure (PP).
a) Effect of noradrenaline:
Bolus injections of NA (lO'MOOjig) produced dose-related increases in 
perfusion pressure (Figure 5). Responses o f vessels from the older, heavier rats
(300-350g) were greater than those from the younger, lighter rats (145-225g), 
with an increased maximum response (263.7+24.0 mmHg c.f. 151.9+14.9  
mmHg , P<0.01). In addition, the ECsoin older rats was lower than that 
obtained in younger rats ( 0.07+0.0lp.g c.f. 0.63±0.05 Jig , P<0.01).
b) Electrical field stimulation:
Electrical field stimulation (supramaximal voltage 80V , 50 pulses, 
0.4ms duration, 0.5-80H z) produced frequency-dependent increases in 
perfusion pressure in tail artery segments (Figure 6 ). The frequency-response 
curves obtained in arteries from both older and younger rats were biphasic, with 
the first peak at 5-10Hz and the second at 20-40Hz. At the lower frequencies 
(0.5-2Hz) there was clearly no difference in response between the two groups 
of rat. At higher frequencies (5-80Hz) responses from the older rats tended to 
be greater than those from younger rats (Maximum response 115.6+38.2  
mmHg c.f. 60.5+6.6 mmHg). These values were not statistically significant 
however (P>0.05) due to the large variation in the responses from the older age 
group of rat.
2) Double cannulation
In other perfusion experiments, rat tail artery segments were cannulated 
at both ends, with the second cannula allowing the perfusate to pass out o f the 
organ bath without superfusion. The effects o f drugs were studied in rats of 
two age groups as above, using two different flow rates, 0.5ml min-1 and 1ml 
min-1.
a) Effect of noradrenaline:
Perfusion o f NA through the tail artery lumen in increasing  
concentrations (10*8 -10'5M) produced corresponding increases in perfusion 
pressure (Figures 7,8,9). At each flow rate, there was no difference in the
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EC50 or maximum response to NA between older and younger rats (Table la). 
In both age groups, responses at 0.5ml min'1 were significantly lower than at 
lm l min-1 (Figures 8,9), with a greater EC50 at the lower flow rate (P<0.05), 
but there was no difference in the maximum response to NA when perfused at 
two different flow rates (Table lb).
b) Effect o f KC1:
KC1 (lm l m in 1) produced concentration-dependent increases in 
perfusion pressure (Figure 10). Responses to KC1 were much smaller than 
those to NA and occurred over a much higher and narrower concentration range 
(0.01-0.05M  c.f. 10'8 -10*5M). As with NA, there was no difference in the 
response to KC1 between arteries from older and younger rats (EC50 0.09 + 
0.01 M and 0.09 + 0 .01M respectively; maximum response 90.2 ±  10.5mmHg 
and 114.7 +.12.6 mmHg respectively).
3) Sing/e cannulation (modified set-up)
When NA was administered as bolus injections in the Krebs-perfused 
tail artery (single cannulation), vessels from older rats were more responsive 
than were those from younger rats (Figure 5). This difference however was not 
seen when arteries were cannulated at both ends and NA perfused through the 
vessel lumen (Figure 7). It was therefore decided to repeat the single 
cannulation experiment, but this time the method was improved by the addition 
o f a heating coil between the reservoir and the cannula to maintain the 
temperature o f the perfused Krebs solution at 37°C. In addition, the Krebs 
solution in the reservoir, as well as that in the organ bath, was oxygenated.
Effect o f noradrenaline:
NA (10_3-100(J.g) produced dose-dependent increases in perfusion pressure but
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using this modified set-up there was no difference in the response to NA  
between older (12-17 weeks) and younger (6-9 weeks) rats (Figure 11).
Preliminary experiments with rats of different ages initially showed that 
isolated blood vessels from older rats were more responsive to contractile 
agonists than vessels from younger rats. Later experiments revealed that there 
was no difference in the sensitivity o f older and younger rats. It was therefore 
decided to investigate the responsiveness o f isolated blood vessels from 
hypertensive rats. The model o f  hypertension studied was the SHR, and 
responses were compared to those obtained in the normotensive control strain, 
WKY.
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Figure 4. Correlations between rat age and weight (A), and rat w eight and 
systo lic  b lood pressure (SBP) (B). As rat age increased, there was a 
corresponding increase in rat weight (A). The SBP, measured by the tail cuff 
method, did not rise significantly with rat weight (B).
300 n
250 -
200 -S'
» 150-
cu
a
* 100 -
a
*
50 -
l o l-3 ■2 2 3-4
l o g  D o s e  NA (u g )
Figure 5. Dose-response curve to noradrenaline (NA) in the perfused rat tail 
artery. Segments of rat tail artery were cannulated at one end and perfused with 
Krebs solution at 1ml min-1. NA was administered as bolus injections into the 
rubber tubing immediately preceding the cannula. Responses from the older rats 
(12-17 weeks; --# --)  were significantly higher than those from the younger rats 
(6-9 weeks; —O -  ) as indicated by .asterisks (*, P<0.05; **, PcO.Ol). Each point 
represents the mean ±  s.e.m. o f at least 8 observations. Where no error bars are 
shown, errors are contained within the symbols. (PP = perfusion pressure).
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Figure 6 . Freauencv-response curve in the perfused rat tail artery. Segments 
of rat tail artery were cannulated at one end and perfused with Krebs solution at 
lm l min*1. Electrical field stimulation (supramaximal voltage 80V, 50 pulses, 
0.4ms duration, 0.5-80Hz) was then applied. At the higher frequencies (5-80Hz) 
responses from the older rats (12-17 weeks, black bars) tended to be greater than 
those from younger rats (6-9 weeks, hatched bars) but the difference was not 
statistically significant (P>0.05). Each bar represents the mean ±  s.e.m. o f at least 
6 observations.
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Figure 7. Concentration-response curve to NA in the perfused rat tail artery .
Segments o f rat tail artery were cannulated at both ends and perfused with 
noradrenaline (NA) at 1ml min-1 in increasing concentrations. There was no 
difference in response between arteries from older (12-17 weeks; —# —) and 
younger (6-9 weeks; --O --) rats. Each point represents the mean ±  s.e.m. o f at 
least 6  observations. Where no error bars are shown, errors are contained within 
the symbols.
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Figure 8 . The effect of flow rate oil the concentration-response curve to NA in 
the perfused rat tail artery (i). Segments o f tail artery from 12-17-week old rats 
were cannulated at both ends and perfused with NA at either 1ml min-1 or 0.5ml 
min-1. Responses to NA at 1ml min-1 ( — # — ) were greater than responses to NA at 
0.5m l m in 1 (—O —) (*; P<0.05). There was no difference in the maximum  
response. Each point represents the mean + s.e.m. o f at least 6  observations. Where 
no error bars are shown, errors are contained within the symbols.
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Figure 9. The effect of flow rate on the concentration-response curve to NA in 
the perfused rat tail artery (ii). Segments o f tail artery from rats (6-9 weeks old) 
were cannulated at both ends and perfused with NA at either 1ml min*1 or 0.5ml 
min'1. Responses to NA at 1ml min-1 were greater than responses to NA at
0.5m l min-1 (—O —) (*; P <0.05).,There was no difference in the maximum  
response. Each point represents the mean + s.e.m. o f at least 6 observations. Where 
no error bars are shown, errors are contained within the symbols.
a)EC50 Flow Rate
Age o f Rat lm l min-1 0 5 m l min-1
6-9 weeks ‘ 0.76±0.07 1.8±0.20 *
12-17 weeks 0.63±0.06 1.15±0.12 *
b)Maxiimim Response Flow Rate
Age o f Rat lm l min'1 0 5 m l min-1
6-9 weeks 213.5±25.4 203.4±12.0 NS
12-17 weeks 192.0+9.7 176.2+11.6 NS
Table 1. EC 50 values in |iM (a) and maximum responses in m m Hg (b) in 
rat tail artery in response to NA. Segments o f rat tail artery were cannulated 
at both ends and perfused with NA at 0.5ml min*1 and lm l min'1. There was 
no difference between the two groups o f rat in the EC50 or the maximum  
response, at either flow rate. However, the EC50 for NA was significantly 
lower at lm l min*1 than at 0.5ml min*1 in both older and younger rats (*, 
P<0.05). There was no difference in the maximum response to NA when 
perfused at two different flow rates, in either older or younger rats (NS = not 
significant).
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Figure 10. C oncentration-response curve to KCl in the perfused rat tail 
artery. Segments of rat tail artery were cannulated at both ends and perfused with 
KCl in increasing concentrations. There was no difference in the response between 
arteries from older (12-17 weeks; - - # — ) and younger (6-9 weeks; —O —) rats. 
Each point represents the mean + s.e.m. o f at least 6 observations. Where no error 
bars are shown, errors are contained within the symbols.
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Figure 11. Dose-response curve to NA in the perfused rat tail artery (modified 
set-up). Segments o f rat tail artery were cannulated at one end and perfused with 
Krebs solution from a reservoir at lm l min*1. The set-up was modified from 
previous experiments by inserting an additional heating coil between the reservoir 
and the cannula, and oxygenating the Krebs in the reservoir. NA was administered 
as bolus injections into the rubber tubing immediately preceding the canula. There 
was no difference in response between arteries from older rats (12-17 weeks,--# --)  
or younger rats (6-9 weeks, —O —)• Each point represents the mean + s.e.m. o f at 
least 6 observations. Where no error bars are shown, errors are contained within 
the symbols.
PARTII
THE RESPONSIVENESS OF BLOOD VESSELS TO VASOACTIVE  
AGENTS IN HYPERTENSION
A) BLOOD PRESSURE MEASUREMENT
Systolic blood pressure (SBP) was measured in conscious SHR, WKY  
and Wistar rats by the tail cuff method. The SBP o f the SHR rats (194+5.0  
mmHg) was higher than that o f the two control strains, WKY and Wistar 
(137±4mmHg and 121+3 mmHg respectively) (PcO.OOl; Figures 12, 13). The 
SBP of WKY rats was higher than that o f Wistar rats (PcO.Ol), but both were 
in the normotensive range.
Both the rat isolated tail artery and the aorta were studied, as examples o f a 
resistance vessel and a conducting vessel respectively.
B) STRUCTURE OF RAT BLOOD VESSELS
Aortic rings from hypertensive rats were heavier than those from control 
rats (6.9+0.4mg, c.f. 4.8+0.35mg, PcO.OOl; Figure 14a), despite being cut to 
the same length (3-4mm). Proximal tail artery rings from hypertensive rats were 
heavier than those from control rats (0.65+0.05g, c.f. 0.38+0.03g, PcO.OOl; 
Figure 14b), despite being cut to the same length (3-4mm).
These measurements suggested that there was a structural difference in 
the tail artery and aorta from SHR and WKY rats. This was studied using light 
microscopy.
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Figure 12. T ypical blood pressure record ings from  a sp on tan eou sly  
hypertensive rttf (SHR; A) and a normotensive, Wistar Kyoto (W KY) rat (B), 
m easured by the tail cuff method. Arrows denote the point at which pulse 
oscillations stopped, indicating the systolic blood pressure. In (A), the screen was 
calibrated to read 40mmHg at the left hand edge. Pressure is shown to increase 
from left to right, and each horizontal division represents 20mmHg.
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Figure 13. Systolic blood pressure (SBP) m easured in conscious rats. SHR
(n=8) had a higher systolic blood pressure than either WKY (n=8) or Wistar 
(n=10) rats. Asterisks represent significant differences between groups o f rat 
joined by a horizontal bar ( ** , PcO.Ol; *** , PcO.OOl). Each bar represents the 
mean + s.e.m. for the indicated number o f rats.
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Figure 14. W eights o f artery rings from SHR and W KY rats. Rings o f aorta or 
rat tail artery (RTA; proximal region) were cut to a standard length (3-4mm). 
Rings o f both aorta (A) and proximal tail artery (B) were heavier in SHR 
compared to WKY (***; PcO.OOl). Each bar represents the mean + s.e.m. o f 20-26 
observations.
B|
fa
300p m
Figure 15. Transverse sections of the aorta from SHR (A) and W KY rats (B).
Sections were stained with Epple, showing the elastic fibres of the aorta as purple 
rings. Both the wall thickness and lumen diameter were increased in aortae from 
SHR as compared to those from WKY.
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Figure 16. Transverse sections of the proximal tail artery from SHR (A) and 
W KY rats (B). Sections were stained with Masson, showing the nuclei blue/black, 
cytoplasm  and muscle purple/red, and connective tissue pale blue/green. There 
was no difference in the wall thickness between vessels from hypertensive and 
normotensive rats, but the artery wall from SHR appeared to have more layers of 
cells than that from WKY. The lumen diameter was decreased in SHR compared 
to WKY.
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Figure 17. Transverse sections of the distal tail artery from SHR (A) and 
WKY rats (B). Sections were stained with Masson, showing the nuclei blue/black, 
cytoplasm  and muscle purple/red, and connective tissue pale blue/green. The 
artery wall thickness was increased in hypertensive rats compared to control and 
there also appeared to be more layers of cells in SHR relative to control. The 
lumen diameter was decreased in SHR compared to WKY.
1) Aorta
The wall thickness of the aorta was greater in SHR when compared to 
WKY control rats (77.66±1.20 pm  c.f. 64.63+1.04 pm; P<0.01), but the 
lumen diameter was greater in SHR compared to WKY (1252.05±16.69pm cf. 
1176.69+9.60pm; PcO.Ol) (Figure 15). The media area was increased in SHR 
relative to control (331450.6+2445.83pm 2, c.f. 272845.5+4987.23 pm 2; 
P<0.001). There was no difference in the wall thickness to lumen ratio between 
hypertensive and control rats (0.06+0.006 and 0.05+0.005 respectively).
2) Tail artery
a) Proximal:
There was no difference in the wall thickness o f the proximal part o f the 
tail artery between SHR and WKY rats (84.64+0.95pm  and 86.20+6.0pm  
respectively), but the lumen diameter was reduced in SHR relative to control 
(85 .63+1.64pm cf. 121.25+4.94pm; P<0.001) (Figure 16). The media area 
was reduced in SHR relative to control (46921.7 8 ± 9 4 3 .5 6 p m 2, c.f. 
53287.8+2479.7pm2; PcO.OOl). The wall thickness to lumen ratio was greater 
in SHR relative to control (0.99+0.08 c.f. 0.71+0.05; P<0.05).
b) Distal:
In the distal part of the tail artery, the wall thickness was greater in SHR 
compared to WKY control rats (69.61+0.95pm  c.f. 52.8+0.67pm; PcO.OOl), 
and the lumen diameter was reduced in SHR relative to control (87.92+2.54pm  
cf. 127.64 +2.39pm; PcO.OOl) (Figure 17). The media area was increased in 
SHR compared to control (35339.78+932.47pm 2, c.f. 30987.46+971.74 pm2; 
Pc0.05). The wall thickness to lumen ratio was greater in SHR compared to 
WKY control rats (0.79±0.06 cf. 0.41±0.03; PcO.OOl).
The above results of the histological measurements are summarised in Table 2.
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C) MECHANICAL RESPONSES OF BLOOD VESSELS 
1) Aorta
Aortic rings (3-4mm) were mounted in organ baths and changes in 
isometric tension were recorded in response to vasoactive agents.
a) Phenylephrine:
Increasing concentrations o f  PE (10_9- 3 x l 0 ' 5M) produced  
corresponding increases in tension. Responses in aortic rings from hypertensive 
rats were lower than those from WKY control rats, with a lower maximum  
response (0.76+0.06g mg-1 c.f. 1.29+0.04g mg-1: PcO.OOl) (Figure 18). 
There was no difference in the EC50 between hypertensive and control rats 
(0.04+0.006|iM  c.f. 0.02+0.004p.M respectively).
For studies using vasorelaxants, aortic rings were first precontracted 
with the EC75 concentration o f PE, which in SHR was 0.2|iM  and in WKY  
was O.lpM, producing responses o f 0.58g mg*1 and 0.97g mg-1 respectively.
b) Carbachol:
Increasing concentrations o f carbachol (10_9-3 x l0 - 5M) produced 
corresponding relaxations of the PE-induced precontraction. Relaxations in 
aortic rings from hypertensive rats were greater than those from WKY control 
rats (Figure 19), with a greater maximum inhibition o f  the precontraction 
(106.4+2.1% , c.f. 76.4+4.5%; PcO.OOl), and a lower EC50 (0 .10±0.01pM , 
c.f. 0 .20± 0.02p.M; PcO.Ol).
c) Sodium nitroprusside:
Increasing concentrations o f SNP (3 x l0 'n  - 3 x l0 _6M) produced 
corresponding relaxations of the PE-induced precontraction. At the lower end o f  
the concentration-response curve (3 x l0 -11 - 10~8M) there was no difference
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between aortic rings from SHR and WKY rats (Figure 20). At the higher 
concentrations however (3x l0 -8 - 3 x l 0 6M), aortic rings from SHR were more 
responsive to SNP than were rings from WKY rats, with a greater maximum  
inhibition o f the precontraction (127.8+3.1% , c.f. 107.0+1.60%; PcO.OOl). 
There was no difference in the EC50 for SNP between SHR and WKY  
(1.80+0.2nM  c.f. 1.02+0.2nM; P>0.05).
d) Isoprenaline:
Increasing concentrations o f  isoprenaline (3 x l0 -10-10_5M) produced 
corresponding relaxations o f the PE-induced precontraction. There was no 
difference between hypertensive and control rats in the relaxation o f aortic rings 
in response to isoprenaline (Figure 21 ; maximum responses 111.7+5.5% and 
113.2+4.7% respectively; EC50 0.42+Q.04nM and 0.49+0.05nM respectively).
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Figure 18. Concentration-response curve to PE in rat aortic rings. Responses 
were expressed as the tension developed per mg o f tissue. Responses to PE in 
aortic rings from SHR were lower than in those from WKY rats ( ~ 0 ~ )
(3-10nM: **, P<0.01; 30nM-30|iM: ***, PcO.OOl). Each point represents the 
mean + s.e.m o f at least 6 observations. Where no error bars are shown, the errors 
are contained within the symbols.
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Figure 19. C oncentration-response curve to carbachol in rat aortic rings.
Responses were expressed as the percentage relaxation o f the PE-induced (EC75) 
precontraction. Responses to carbachol in rings from SHR were greater
than in those from WKY control rats ( ~ O —) (*, P<0.05; **, P<0.01; ***, 
PcO.OOl). Each point represents the mean + s.e.m. o f  at least 6  observations. 
Where no error bars are shown, the errors are contained within the symbols.
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Figure 20. Concentration-reponse curve to sodium  nitroprusside (SNP) in rat 
aortic rings. Responses were expressed as the percentage relaxation o f the PE- 
induced (EC75) precontraction. At the lower concentrations o f SNP there was no 
difference in the relaxation between vessels from SHR and WKY control
rats (" O " ). At higher concentrations of SNP, aortic rings from SHR were more 
responsive to SNP than were rings from WKY rats (**, P<0.01; ***, P<0.001). 
Each point represents the mean + s.e.m. o f at least 6  observations. Where no error 
bars are shown, the errors are contained within the symbols.
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Figure 21. Concentration-response curve to isoprenaline in rat aortic rings.
Responses were expressed as the percentage relaxation o f the PE-induced (EC75) 
precontraction. There was no difference in the response to isoprenaline in aortic 
rings between SHR and WKY control rats ( - -O -) . Each point represents
the mean + s.e.m. o f at least 6 observations. Where no error bars are shown, the 
errors are contained within the symbols.
2) Tail artery
The proximal part o f the tail artery was used to investigate responses to 
vasoactive agents from SHR and WKY rats.
a) Phenylephrine:
Increasing concentrations o f  PE (10 *8 - 3xlO_5M ) produced  
corresponding increases in tension. Responses in tail artery rings from 
hypertensive rats were greater than those from WKY control rats (Figure 22) 
with an increased maximum response (2.73 ±  0.32g mg-1 c.f. 1.72+0.13g mg' 
1; P<0.05). The EC50 was unchanged between hypertensive and control rats 
(0.46+0.05fiM and 0.54+0.05p.M respectively).
b) UK-14,304:
Increasing concentrations o f UK-14,304 (3xlO_10-3xlO-5M) produced 
corresponding increases in tension in rat tail artery rings. When responses were 
expressed as changes in tension, tail artery rings from SHR were more 
responsive to U K -14,304 than were rings from WKY, with an increase in the 
maximum response (0.72+Q.09g, c.f. 0.42+0.09g; P<0.05) (Figure 23a; Table 
3b). There was no difference in the EC50 for U K -14,304 between hypertensive 
and control rats (0.54+0.07|iM  and 0.57±0.06jiM  respectively; Table 3a). In 
contrast, when responses were expressed as the tension developed per mg of 
tissue (Figure 23b), there was no difference in the maximum response to UK-
14,304 between SHR and WKY rats (1.20+0.06g mg-1 and 0 .98+ 0 .14g mg-1 
respectively; P>0.05).
Yohimbine (50nM) produced a small but significant rightward shift in 
the concentration-response curve for U K -14,304 in tail artery rings from both 
SHR and WKY rats (Figure 24). In both groups o f rat, the shift was non- 
parallel, with a greater effect at the lower end o f the concentration-response 
curve. The EC5 0  for UK-14,304 was increased in both SHR and WKY rats in
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the presence o f yohimbine (P<0.05), but the maximum response to U K -14,304 
was unchanged (Table 3).
c) Noradrenaline:
(i) Tension recording
NA (1 0 9-10‘5M) produced concentration-dependent increases in tension 
in rat tail artery rings. When responses were expressed as changes in tension 
per mg o f tissue (Figure 25a), tail artery rings from SHR were more responsive 
to NA than were rings from WKY, with an increase in the maximum response 
(0.50±0.03g m g 1 cf. 0.36+0.07g mg-1; P<0.05. When these isometric tension 
responses were expressed as a percentage o f the maximum reponse however, 
there was no difference between hypertensive and control rats (Figure 25b), 
with similar EC50 values (0.59±0.06|iM  and 0.46±0.06p.M respectively).
(ii) Perfusion pressure recording
The effect o f NA was also studied in the perfused tail artery, where 
blood vessel segments were cannulated at both ends and perfused ( 1ml m in 1) 
with increasing concentrations o f  NA (10_9-1 0 '5M ). This produced  
corresponding increases in perfusion pressure. When expressed in absolute 
units, i.e. in mmHg, responses at the higher end o f the concentration-response 
curve were greater in tail artery segments from SHR than in those from WKY 
(P<0.01; Figure 25c). A maximum response was not achieved in the SHR, so 
the EC50 could not be calculated. The EC50 for NA in the perfused tail artery of 
WKY was 0.56±0.07jiM, which was not significantly different from the value 
obtained in tail artery rings o f WKY following tension recording. When 
responses were expressed as a percentage o f the maximum (in the case o f SHR, 
the highest response achieved), responses in vessels from SHR were lower 
than in those from WKY (P<0.05; Figure 25d).
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For studies using vasorelaxants, tail artery rings were precontracted 
with the EC75 f° r PE, which in SHR was 2 .05+0.28JIM and in W KY was 
1.66+0.30pM . These concentrations were not significantly different, and 
produced responses o f 2.19+0.22g m g 1 and 1.29+0. lOg m g 1 respectively. 
Responses to vasorelaxants were expressed as the percentage relaxation o f the 
PE-induced precontraction.
d) Sodium nitroprusside:
Increasing concentrations o f SNP (3xlO -10 - 3 x l0 _5M) produced 
corresponding relaxations o f the PE-induced precontraction (Figure 26a). 
Responses in tail artery rings from SHR were lower than in those from WKY  
rats, with a decreased maximum response (82.0+4.1% , c.f. 97.3+2.8% ; 
P<0.01). There was no difference in the EC50 for SNP between hypertensive 
and control rats (40.77+5.20nM and 34.08 +3.53nM respectively).
e) Carbachol:
The endothelium-dependent vasodilator carbachol (10 '8 - 3xl0*5M) 
produced little or no relaxation in tail artery rings from either hypertensive or 
normotensive rats (Figure 26b). The threshold was 10_5M in each group. The 
highest concentration of carbachol added (3xl0~5M) produced relaxations o f 7.9 
+ 3.7% and 4.8+3.1% in SHR and WKY respectively. There was no evidence 
o f contraction in response to carbachol in either group o f rat.
f) Isoprenaline:
Isoprenaline (lO-8 - 1(HM) produced relaxation in tail artery rings from 
SHR and WKY, with a threshold o f 3 x l0 -7 - 10_6M (Figure 26c). A maximum 
response was not achieved in either group o f rat as the response was still 
increasing at 10_4M, the highest concentration o f isoprenaline which could be 
added to the organ bath, so the EC50 could not be calculated. Responses in
vessels from SHR were lower than those in vessels from WKY (P<0.05), the 
highest relaxations achieved being 41.0 ±  4.1% and 62.4 + 5.3% respectively.
D) BIOCHEMICAL RESPONSES OF BLOOD VESSELS 
Phosphoinositide (PI) hydrolysis
The biochemical response underlying NA-induced contraction was 
investigated by measuring accumulation o f total inositol phosphates in response 
to NA (Figure 27). The basal level o f PI hydrolysis in tail artery segments from 
SHR was significantly higher than in those from WKY rats (168.6+7.99 dpm 
mg-1 tissue, c.f. 109.39+8.78 dpm mg-1 tissue; P<0.001). NA (lO-6,1 0 ‘5M) 
produced a concentration-dependent increase in PI hydrolysis in rings from 
both groups o f rats. At 1 0 6M NA, there was no difference in PI hydrolysis 
between the two groups o f rat. At 1 0 5M however, NA produced a 
significantly greater stimulation o f  PI hydrolysis in vessels from SHR than in 
v esse ls  from  WKY rats (2888.73+ .187.33  dpm m g - 1 tissue, c.f. 
1734.4+133.85 dpm mg-1 tissue; P<0.001).
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Figure 22. C oncentration-response curve to PE in rat tail artery rings.
Contractions were expressed as the tension developed per mg o f tissue. Responses 
in tail artery rings from SHR (— ) were greater than in those from WKY  
control rats (—O --) (*; P<0.05). Each point represents the mean + s.e.m. o f 6  
observations. Where no error bar is shown, the errors are contained within the 
symbols.
0.8
0.6
tn
C
•3 0.4
flO
cs
0.2
0.0
-10 -7 6-9 -8 •5 4
log [UK] (M)
1.5
<D
3
Cl)
CD
•H
■P 1.0
iH
c
o•H
0)
Ga)
H 0.0
-10 ■7 -6 ■5 4-9 -8
log [UK] (M)
Figure 23. Concentration-response curve to UK -14,304 (UK) in rat tail artery 
rings. Responses were expressed both as the tension developed (A) and as the 
tension developed per mg of tissue (B). When expressed as tension, responses to 
UK in tail artery rings from SHR were greater than in those from control
WKY rats ( - 0 - )  (*, P<0.05). When expressed as the tension developed per mg 
of tissue, there was no difference between tail artery rings from SHR and WKY 
rats in the response to UK. Each point represents the mean + s.e.m. of at least 6  
observations. Where no error bars are shown, the errors are contained within the 
symbols.
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Figure 24. The effect of yohimbine (50nM) on the response to U K -14,304 (UK) 
in rat tail artery rings. Control concentration-response curves to UK were carried 
out ) and repeated in the presence o f yohimbine in tail artery rings
from SHR (upper panel) or control WKY rats (lower panel). Responses were 
expressed as a percentage o f the maximum response. Yohimbine inhibited the 
response to UK in tail artery rings from both SHR and W KY (*, P<0.05). 
Yohimbine produced a non-parallel, rightward shift in the UK curve in both 
groups of rat, but did not affect the maximum response. Each point represents the 
mean + s.e.m. o f at least 6 observations. Where no error bars are shown, the errors 
are contained within the symbols.
a)
EC50
SHR
WKY
Control
0.54+0.07|iM
0.57±0.06|iM
+ Yohimbine
1.01±0.01|iM  * 
1.02±0.01{iM *
b)
Maximum Response
SHR
WKY
Control
0.72±0.09g
0.42±0.09g
+ Yohimbine
0.75±0.10g NS 
0.37±0.10g NS
Table 3. Table summarising the effect of yohim bine on the response to UK14,- 
304 in tail artery rings from SHR and W K Y rats. A concentration-response 
curve to U K -14, 304 was carried out and repeated in the presence o f yohimbine, 
(a) The EC50 for UK-14,304 was increased in the presence o f yohimbine in vessels 
from both SHR and WKY (*, P<0.05). (b) Yohimbine did not affect the maximum 
response to UK-14,304 in either group of rat (NS = not significant). Each value 
represents the mean + s.e.m. of at least 6 observations.
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Figure 25. Concentration-response curves to NA in the rat tail artery. NA was
administered either by cumulative addition into organ baths, where isometric 
tension was measured in artery rings (A, B), or by lumenal perfusion (1ml min-1 ) 
in segments o f tail artery, where rises in perfusion pressure (PP) were measured 
(C, D). In artery rings, tension responses to NA were greater in SHR than
in WKY rats (—O —) (*» P<0.05; A), but when expressed as a percentage o f the 
maximum response there was no difference between SHR and WKY in the 
response to NA (B). In perfused artery segments (C, D) the rise in perfusion 
pressure in response to NA was greater in arteries from SHR than in
arteries from WKY rats (—O --) (**> P<0.01 ; C). When expressed as a percentage 
of the maximum response, responses from SHR were lower than those from WKY 
(*, P<0.05; D). Each point represents the mean + s.e.m. o f at least 6  observations. 
Where no error bars are shown, the errors are contained within the symbols.
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Figure 26. Concentration-response curves to vasorelaxants in tail artery rings 
from  SHR and W KY rats. Responses were expressed as the percentage 
relaxation o f the PE-induced (EC75) precontraction. Responses to SNP (A) or to 
isoprenaline (C) in rings from SHR were lower than those in rings from WKY (A: 
**, P<0.01; C: *, P<0.05). There was little or no response to carbachol in vessels 
from either SHR or WKY (B). Each point represents the mean + s.e.m. o f at least 5 
observations. Where no error bars are shown, the errors are contained within the 
symbols = SHR; — O — = WKY).
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Figure 27. NA-stimulated phosphoinositide (PI) hydrolysis in rat tail artery  
rings. 1cm segments of artery from SHR or control WKY rats were labelled with 
(m yo-3H)-inositol and incubated with Krebs buffer containing lithium chloride 
(10mM) with or without NA for 1 hour. Vessels were then homogenised and the 
inositol phosphates extracted, separated on Dowex columns and measured in a 
liquid scintillation counter. The results were expressed as disintegrations per 
minute (DPM) per mg of tissue. The basal level of PI hydrolysis was higher in tail 
arteries from SHR than in those from WKY rats (*** , PcO.OOl). 10_6M NA  
increased the PI hydrolysis in tail arteries from both SHR and WKY rats (**, 
P<0.01), but there was no difference between the two groups o f rat. 10_5M NA  
produced a greater stimulation of PI hydrolysis in tail arteries from SHR than in 
those from WKY rats (***, P<0.001). Each bar represents the mean + s.e.m. o f 6 
observations.
PARTin
INVESTIGATION OF RESPONSES MEDIATED VIA PQST-JIJNCTIQNAL 
ALPHA2 -ADRENOCEPTORS IN VASCULAR SMOOTH MUSCLE.
Contractions mediated via post-junctional ct2-adrenoceptors on vascular 
smooth muscle are often difficult to demonstrate. This part o f  the study 
investigated the conditions required to potentiate contractions o f  the rat tail 
artery in response to (X2-adrenoceptor agonists. Rings o f  tail artery were 
suspended in organ baths, and changes in isometric tension measured in 
response to a 2-adrenoceptor agonists, alone and in combination with other 
drugs.
A ) C O N C E N T R A T IO N -R E SPO N SE  CUR VES TO A L P H A 2- 
ADRENOCEPTOR AGONISTS
1) Proximal tail artery
a) Clonidine
Clonidine (10-8 -10'5M) produced concentration-dependent increases in tension 
(Figure 28). The a 2-adrenoceptor antagonist yohimbine (30nM) produced a 
non-parallel rightward shift in the concentration-response curve to clonidine, 
with a greater effect at the lower end o f the curve (Figure 28). The maximum 
response to clonidine (1.11+.0.31 g) was unaffected in the presence o f  
yohimbine (1.24+0.25g), but the EC50 was increased in the presence of 
yohimbine as compared to control (0 .18± 0 .03 |iM , c.f. 0 .0 7 + 0 .0 l |iM ;  
P<0.05).
b) U K -14,304
U K -14,304 (10 ' 10 - 3xl0*5M) produced concentration-dependent
increases in tension in rat tail artery rings (Figure 29), with an ECso o f  
0.41+0.05|lM .
2) Distal tail artery
Segments o f  rat tail artery taken from the distal part o f the tail were 
mounted as ring preparations on a myograph and a concentration-response 
curve to U K -14,304 (10*10-3xl0"5M) carried out. The curve was biphasic, with 
the first phase from 10' 10 - 10-7M (Figures 29, 30). The EC50 for this part o f 
the curve was 2.18+0.32nM . Following the plateau at 10-7 - 3xlO_7M UK- 
14,304, responses to increasing concentrations o f UK increased and reached a 
second plateau at 3 x l0 '5M. The EC50 for the second part o f the curve was 
30.0+6.2|iM .
Yohimbine (50nM) was added to the organ bath and the U K -14,304 
concentration-response curve repeated 20 minutes later (Figure 30). The curve 
was monophasic in the presence o f yohimbine, which produced a 174-fold 
rightward shift (P<0.001) in the first, phase o f the curve but did not affect the 
second phase. The EC50 for U K -14,304 in the presence o f yohimbine was 
0.38+0.45|iM .
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Figure 28. The effect of yohimbine on the concentration-response curve to 
clonidine in ra t tail artery rings. A control curve to clonidine was carried out 
and repeated in the presence o f yohimbine (30nM; —O —)* Responses were 
expressed as increases in isometric tension (A) and as a percentage o f the 
maximum response (B). Yohimbine reduced the response to clonidine at the lower 
end of the curve (*, P<0.05; **, P<0.01) but did not affect either the maximum 
response or the concentration at which this was achieved. Each point represents the 
mean + s.e.m. of 6 observations. Where no error bars are shown, the errors are 
contained within the symbols.
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Figure 29. Concentration-response curve to UK-14,304 in ra t tail artery rings.
The lower concentrations o f U K -14,304 (UK; 0.1-100nM ) produced a smaller 
response in artery rings taken from the proximal part o f  the tail than in
rings taken from the distal part o f the tail (--O --) (*» P<0.05). There was no 
difference in the response to the higher concentrations o f  UK (0.3-30pM) between 
rings from the proximal or distal regions o f the vessel. Each point shows the mean 
+ s.e.m. o f at least 5 observations. Where no error bars are shown, the errors are 
contained within the symbols.
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Figure 30. The effect of yohimbine on the concentration-response curve to UK-
14,304 in ra t tail artery rings taken from die distal part of the tail. When responses 
were expressed as changes in tension (A), the control curve (--O --) was biphasic, with 
the first maximum at 10*7M U K -14,304 (UK) and the second at 3 x l0 '5M UK. 
Responses to the lower concentrations o f UK (0.3-100nM ) were reduced in the 
presence o f yohimbine (50nM) but responses to the higher concentrations of
UK (0.3-30|liM) were unaffected. Responses were also expressed as a percentage o f the 
maximum response achieved at the first plateau, i.e. at 10_7M UK (B). Each point 
shows the mean + s.e.m. of at least 5 observations. Where error bars are not shown, the 
errors are contained within the symbols. Asterisks indicate a significant reduction in 
the response to UK following yohimbine pretreatment (*, P<0.05; **, P<0.01; ***, 
P<0.001).
B)POTENTIATION OF RESPONSES TO ALPHA2-ADRENOCEPTOR  
AGONISTS
This part o f the study investigated some o f  the conditions under which 
enhanced responses to a 2-adrenoceptor agonists could be demonstrated, in 
order to understand the possible mechanisms o f  cc2-adrenoceptor-mediated 
contraction.
A protocol was established where a low  concentration o f  a 2~ 
adrenoceptor agonist (clonidine, lOnM, or U K -14,304, 50nM) was added to 
rings o f rat tail artery, producing little or no response. This was then washed 
from the organ bath and the vessel contracted with a vasoconstrictor (the 
"precontracting agonist"). This contraction was relaxed with a vasodilator, and 
addition of the a 2-adrenoceptor agonist at this point, in the presence o f the 
precontracting agonist and the vasodilator, now produced a large contraction.
1) Concentration-response curves fo r  the precontracting agonists:
a) Vasopressin
AVP (4xlO _3-12m U ml*1) produced concentration-dependent 
contractions, with an EC50 o f  0.20+0.03mU ml-1 (Figure 31a). Based on this, 
the concentration o f AVP used to precontract the rat tail artery was 0.4mU ml-1.
b) Phenylephrine
PE (10‘9-3xl0*5M) produced concentration-dependent contractions, 
with an EC50 o f 0.42+0.05JJ.M (Figure 31b). Based on this, the concentration 
of PE chosen to precontract the rat tail artery was 0.5|iM.
55
c) KC1
KC1 (0.01-0.1M) produced concentration-dependent contractions which 
were biphasic, with a peak and plateau (Figure 31c). The EC50 for the peak 
phase o f  the response was 0.03+0.003M , and for the plateau phase was 
0.04+0.005M . Based on this, the concentration o f  KC1 chosen to precontract 
the rat tail artery was 0.03M.
d) 5-Hydroxytryptamine
5-HT (10'9-3 x l0  6M) produced concentration-dependent increases in 
tension, with an EC50 o f 68.0+7.2nM  (Figure 3 Id). Based on this, the 
concentration o f 5-HT chosen to precontract the rat tail artery was 50nM.
2) The effect o f  different precontracting agonists:
The first series o f experiments assessed the abilities o f different 
precontracting agonists to enhance responses to the ot2-adrenoceptor agonists, 
clonidine and UK -14,304. The precontraction was inhibited by addition o f the 
non-selective phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX; 
10|iM ), then clonidine (lOnM) or U-14,304K (50nM ) was added. The 
response under these conditions was compared to the control response to 
clonidine or U K -14,304 alone.
Enhancement o f the response to clonidine
a) Vasopressin as the precontracting agonist
Clonidine alone produced little or no response (0.07+0.0 lg). In the 
presence o f AVP and IB MX, the response to clonidine was increased to 
0 .73+ 0 .lOg (P<0.001), an increase of 871.8+151.2%, and was inhibited by 
the oc2-adrenoceptor antagonist yohimbine (50nM: PcO.Ol). Further addition of
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clonidine produced little response (Figures 32a, 33).
b) Phenylephrine as the precontracting agonist
Clonidine alone produced little or no response (0.03+0.0 lg ). In the 
presence o f PE and IBMX, the response to clonidine was increased to 
0.50+0.06g (P<0.001), an increase o f 810.4+93.9% , and was inhibited by 
yohimbine (50nM; PcO.001). Further addition o f clonidine produced little 
response (Figures 32b, 34).
c) KC1 as the precontracting agonist
Clonidine alone (lOnM) produced little or no response (0.05+0.01 g). In 
the presence o f KC1 and IBMX, the response to clonidine was increased to 
0.28+0.04g, an increase o f 231.5+65.3% (P<0.01), and was inhibited by 
yohimbine (50nM; P<0.01). Further addition o f clonidine produced little 
response (Figures 32c, 35).
d) Effect of prazosin
The protocol using AVP as the precontracting agonist was repeated in 
the presence of the ai-adrenoceptor agonist prazosin (50nM), which was added 
to the organ bath 20 minutes before the experiment. Prazosin had no effect on 
the size o f the control response to clonidine (0 .0 2 + 0 .0 lg  before prazosin; 
0 .0 2 + 0 .0 1 g after prazosin), or on the enhanced response to clonidine  
(0.48+0.05g before prazosin; 0.42+0.05g after prazosin). (Figure 36).
Enhancement of the response to UK-14.304
a) Vasopressin as the precontracting agonist
UK-14,304 alone produced little or no response (0.08+0.04g). In the 
presence of AVP (0.4mU ml-1) and IBMX (lOfiM), the response to UK-
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14,304 was increased (PcO.OOl) and often biphasic, with an initial peak which 
stabilised at a plateau. The enhanced response to U K -14,304 was, for peak then 
plateau, 1.12+.0.12g then 1 .01+0.12g, increases o f  870+272%  and 
745+212.7% respectively. This enhanced response was blocked by yohimbine 
(50nM; P<0.001). (Figures 37a, 38).
b) Phenylephrine as the precontracting agonist
U K -14,304 alone produced little or no response (0.02+0.02g). In the 
presence o f PE and IBMX, the response to U K -14,304 was increased to 
0.69+0.1 lg  (P<0.001), an increase o f 2650%. This enhanced response was 
blocked by yohimbine (50nM; P<0.001). (Figures 37b, 39).
Lack o f enhancement o f the response to phenylephrine
The possibility that responses mediated via ai-adrenoceptors could be 
potentiated in a similar way, was investigated using the ai-adrenoceptor agonist 
PE. PE (0.2fiM) alone produced little or no response (0 .15+0.0 lg ). In the 
presence of AVP and IBMX, the response to PE was no different from control 
(0.20+0.02g), while the response to clonidine was enhanced (0.82+0.08g, c.f. 
0.12+0.01g control; PcO.OOl). This enhanced response to clonidine was 
blocked by yohimbine (50nM, PcO.OOl; Figures 40, 41).
3)The effect o f reversing the order o f vasoconstrictor and vasodilator:
The protocol was altered so that IBMX was added to the organ bath 
before AVP, to determine if  the order o f drug addition was important in 
producing an enhanced response to UK-14,304. Addition o f IBMX (10|iM) did 
not alter the tone of the tail artery rings. AVP (0.4mU ml*1) now produced a 
small contraction (0.21+0.05g) in the presence of IBMX. UK-14,304 (50nM)
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added at this point produced a response larger than the control response to UK-
14,304 alone (0.85+0.1 lg  c.f. 0.16+0.03g, PcO.Ol). This enhanced response 
was inhibited by yohimbine (50nM; P<0.01). (Figure 42).
Ar)The effect o f  different vasodilators:
The next series o f experiments assessed the abilities o f different 
vasodilators to enhance responses to clonidine and to UK-14,304. Tail artery 
rings were precontracted with AVP (0.4mU m l1) then relaxed with a variety o f  
agents which act either via cyclic nucleotide-related mechanims, or by blocking 
calcium channels. The response to clonidine or to U K -14,304 under these 
conditions was compared to the control response to clonidine or U K -14,304 
alone.
a) Diltiazem as the vasodilator
Clonidine alone (lOnM) produced little or no response (0.004+0.003g). 
The calcium channel antagonist diltiazem (2p.M) reduced the A VP-induced 
precontraction (0.54+0.05g) to 0.19+0.04g (PcO.Ol). In the presence o f AVP  
and diltiazem the response to clonidine was increased to 0.34+0,07, an increase 
o f 3650% (PcO.Ol), and was blocked by yohimbine (50nM; Pc0.05) (Figures 
43a, 45a).
b) Forskolin as the vasodilator
U K -14,304 alone (50nM) produced little or no response (0.09+Q.03g). 
The adenylate cyclase activator forskolin (36nM) reduced the AVP-induced 
precontraction to 0.14+0.06g (PcO.Ol). In the presence o f AVP and forskolin 
the response to U K -14,304 was increased to 0.91+0.09, an increase o f  
799+167%  (PcO.OOl), and was blocked by yohimbine (50nM; PcO.OOl)
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(Figures 43b, 45b).
c) Dibutyryl cyclic AMP as the vasodilator
U K -14,304 alone (50nM) produced little or no response (0.05+0.01g). 
The stable, permeant cyclic AMP analogue, dibutyryl cyclic AMP (0.2mM) 
reduced the A VP-induced precontraction to 0.02+0.01 g (P<0.001). In the 
presence o f  VP and dibutyryl cyclic AMP, the response to U K -14,304 was 
increased to 0.36+0.04, an increase o f 673+140% (PcO.OOl), and was blocked 
by yohimbine (50nM; PcO.OOl) (Figures 43c, 45c).
d) Sodium nitroprusside as the vasodilator
UK-14,304 alone produced little or no response (0.11+0.03g).T he  
soluble guanylate cyclase activator SNP (0.1 |iM) reduced the A VP-induced 
precontraction to 0.02+0.01 g (PcO.OOl). In the presence o f AVP and SNP the 
response to U K -14,304 was increased to 0.75+0.05, an increase o f 876+264%  
(PcO.OOl), and was blocked by yohimbine (50nM; PcO.OOl). Further addition 
of U K -14,304 produced little or no response (Figures 44a, 46a)
When tail artery rings were precontracted with PE (0.5|iM ), SNP 
reduced this contraction to 0.14+0.06g (PcO.Ol). Subsequent addition o f UK-
14,304 produced a response o f  0.62+0.10g, an increase o f 815+217%  
(PcO.Ol), which was blocked by yohimbine (50nM; PcO.Ol). Further addition 
of U K -14,304 produced little or no response (Figures 44b, 46b)
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Figure 31. Concentration-response curves for the agonists used to precontract 
rat tail artery rings. Vasopressin (AVP; A; n = ll) ,  PE (B; n = ll)
and 5-hydroxytryptamine (5-HT; D; -A - - ,  n=8 ) were each added in a cumulative 
manner. KC1 (C; n=12) produced biphasic responses consisting of a peak (--■ --) 
then a plateau (—□ —), so each concentration was washed out when the response 
had stabilised before the next concentration was added. Each point represents the 
mean + s.e.m. of the indicated number o f observations. Where no error bars are 
shown, the errors are contained within the symbols.
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Figure 32. Trace showing potentiation o f the response to clonidine in rat tail 
artery rings. A control response to clonidine (Cion, lOnM) alone was obtained, 
then clonidine was washed out (W; a,b,c). Artery rings were precontracted with
AVP (0.4mU ml*1; a), PE (0.5|iM ; b) or KC1 (0.03M , c) then relaxed with
isobutylmethylxanthine (I, 10|iM; a,b,c). Addition o f clonidine at this point 
produced a response significantly larger than the response to clonidine alone. This 
enhanced response was inhibited by yohimbine (Y, 50nM; a,b,c). Further addition 
of clonidine (+10nM; a, b, c) produced little or no response.
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Figure 33. Potentiation of the response to clonidine in ra t tail artery  rings, in 
the presence of AVP and IBMX. A control response to clonidine alone (Cion, 
lOnM) was obtained (1), then clonidine was washed from the organ bath. Drugs 
were then added to the organ bath without being washed out, in the order shown in 
the key. AVP (0.4mU m l 1; 2) produced a contraction which was inhibited by
3-isobutyl-l-methylxanthine (IBMX, 10pM; 3). Addition o f clonidine at this point 
(4), in the presence o f AVP and IBMX, produced a response significantly larger 
than the response to clonidine alone. This enhanced response was inhibited by 
yohimbine (Yoh, 50nM; 5). Further addition o f clonidine (+10nM) produced little 
or no response (6). Each bar shows the mean ±  s.e.m. of 8 observations. Asterisks 
indicate significant differences between the responses at either end o f a horizontal 
bar (**, P<0.01; ***, P<0.001).
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Figure 34. Potentiation of the response to clonidine in rat tail artery rings, in 
the presence o f PE and IBM X. A control response to clonidine alone (Cion, 
lOnM) was obtained (1), then clonidine was washed from the organ bath. Drugs 
were then added to the organ bath without being washed out, in the order shown in
the key. PE (0.5jiM; 2), produced a contraction which was inhibited by IBMX
(10|iM ; 3). Addition of clonidine at this point (4), in the presence o f PE and 
IBMX, produced a response significantly larger than the response to clonidine 
alone. This enhanced response was inhibited by yohimbine (Yoh, 50nM; 5). 
Further addition of clonidine (+10nM) produced little or no response (6 ). Each bar 
shows the mean + s.e.m. o f 8 observations. Asterisks indicate significant 
differences between the responses at either end o f a horizontal bar (***, PcO.001).
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Figure 35. Potentiation o f the response to clonidine in rat tail artery rings in 
the presence o f KCI and IBM X. A control response to clonidine alone (Cion, 
lOnM) was obtained (1), then clonidine was washed from the organ bath. Drugs 
were then added to the organ bath without being washed out, in the order shown in 
the key. KCI (0.03M) produced a biphasic contraction consisting o f a peak then a
plateau (2), which was inhibited by IBMX (10|iM; 3). Addition o f  clonidine at this 
point (4), in the presence of KCI and IBMX, produced a response significantly 
larger than the response to clonidine alone. This enhanced response was inhibited 
by yohimbine (Yoh, 50nM; 5). Further addition o f clonidine (+10nM) produced 
little or no response (6). Each bar shows the mean + s.e.m. o f  14 observations. 
Asterisks indicate significant differences between the responses at either end o f a 
horizontal bar (**, P<0.01).
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Figure 36. Enhanced response to clonidine in rat tail artery rings, obtained in 
the presence o f prazosin. A control response to clonidine alone (Cion, lOnM) 
was obtained, then clonidine was washed from the organ bath. Drugs were then 
added cumulatively to the organ bath, in the order shown from left to right. AVP
(0.4mU mW Hnduced contraction was inhibited by IBMX (10|iM ). Addition o f  
clonidine in the presence of AVP and IBMX produced a response larger than the 
response to clonidine alone. The drugs were washed from the organ bath, prazosin 
(Praz, 50nM) added and the experiment repeated 20 minutes later. Prazosin had no 
effect on either the control response to clonidine, or on the enhanced response 
produced in the presence of AVP and IB MX. Each bar shows the mean + s.e.m. of 
8 observations. Asterisks indicate significant differences between the responses at 
either end of a horizontal bar (***, PcO.OOl).
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Figure 37. Trace showing potentiation of the response to U K -14,304 in rat tail 
artery rings. A control response to U K -14,304 (UK, 50nM) alone was obtained, 
then UK was washed out (W; a, b). Artery rings were precontracted with AVP
(0.4m U m l'1; a) or PE (0.5p.M, b) then relaxed with IBMX (I, 10|iM; a,b). 
Addition o f UK at this point produced a response larger than that to UK alone (a, 
b). This enhanced response was inhibited by yohimbine (Y, 50nM; a,b).
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Figure 38. Potentiation of the response to UK-14,304 in rat tail artery  rings, in 
the presence of AVP and IBMX. A control response to UK-14,304 (UK, 50nM) 
alone was obtained ( 1), then UK was washed from the organ bath. Drugs were 
then added cumulatively to the organ bath in the order shown in the key. AVP
(0.4mU m l1; 2) produced a contraction which was inhibited by IBMX (lOpM; 3). 
Addition of UK at this point (4), in the presence of AVP and IBMX, produced a 
response significantly larger than the response to UK alone. This enhanced 
response was inhibited by yohimbine (Yoh, 50nM; 5). Each bar shows the mean ±  
s.e.m. of 6  observations. Asterisks indicate significant differences between the 
responses at either end of a horizontal bar (***, P<0.001).
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Figure 39. Potentiation o f the response to U K -14,304 in rat tail artery rings, in 
the presence o f PE and IBMX. A  control response to U K -14,304 (UK, 50nM) 
alone was obtained (1), then UK was washed from the organ bath. Drugs were 
then added cumulatively to the organ bath in the order shown in the key. PE
(0.5pM ; 2) produced a contraction which was inhibited by IBMX (10|iM ; 3). 
Addition of UK at this point (4), in the presence of PE and IBMX, produced a 
response significantly larger than the response to UK alone. This enhanced 
response was inhibited by yohimbine (Yoh, 50nM; 5). Each bar shows the mean + 
s.e.m. of 6  observations. Asterisks indicate significant differences between the 
responses at either end of a horizontal bar (**, P<0.01; ***, P<0.001).
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Figure 40. Trace showing potentiation o f the response to clonidine, but not to
PE, in rat tail artery rings. Control responses to PE (0.2JJ.M) or to clonidine 
(Cion, 50nM) alone were obtained and washed out (W; upper trace). In the lower 
trace, a continuation o f the same experiment, artery rings were precontracted with
AVP (0.4mU ml-1) then relaxed with IBMX (I, IOjiM). Addition o f PE at this 
point, in the presence o f AVP and IBMX, produced a response which was no 
larger than the control response to PE. The response to clonidine however, was 
significantly larger than that to clonidine alone. This enhanced response was 
inhibited by yohimbine (Y, 50nM).
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Figure 41. Potentiation of the response to clonidine, but not to PE, in ra t tail 
artery rings. Control responses to PE (0.2pM) alone (1) and to clonidine (Cion, 
lOnM) alone (2) were obtained, then washed out Drugs were then added 
cumulatively to the organ bath, in the order shown in the key. AVP (0.4mU mb1;
3) produced a contraction which was inhibited by IBMX (10pM, 4). Addition of 
PE at this point (5), in the presence of AVP and IBMX, produced a response no 
larger than control. The response to clonidine however (6 ), was significantly larger 
than the response to clonidine alone. This enhanced response was inhibited by 
yohimbine (Yoh, 50nM; 7). Each bar shows the mean ± s.e.m. of 6  observations. 
Asterisks indicate significant differences between the responses at either end of a 
horizontal bar (***, P<0.001).
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Figure 42. Potentiation of the response to UK-14, 304 in rat tail artery rings 
following IBMX and AVP pretreatment. A control response to U K -14,304 (UK, 
50nM) was obtained, then UK was washed from the organ bath. Drugs were then 
added cumulatively to the organ bath, in the order shown from left to right. IBMX
(10fiM) produced no response, and AVP (0.4mU m l1) gave a small contraction in 
the presence o f IBMX. Addition o f UK in the presence o f  IBMX and AVP  
produced a response larger than that to UK alone. This enhanced response to UK  
was inhibited by yohimbine (Yoh, 50nM). Each bar shows the mean + s.e.m. o f 7 
observations. Asterisks indicate significant differences between the responses at 
either end o f a horizontal bar (**, PcO.Ol).
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Figure 44. Trace showing potentiation o f the response to UK -14,304 in rat tail 
artery rings, in the presence o f AVP (a) or PE (b) and SNP. A control response 
to U K -14, 304 (UK, 50nM; a, b) alone was obtained and washed out (W). Artery
rings were precontracted with AVP (0.4mU ml-1; a) or PE (0.5|iM; b) then relaxed
with SNP (0.1 |iM; a, b). Addition o f UK at this point, in the presence o f AVP (a) 
or PE (b) and SNP (a, b), produced a response significantly larger than that to UK 
alone. This enhanced response was inhibited by yohimbine (Y, 50nM; a, b). 
Further addition of UK produced little or no response (a, b).
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Figure 43. Trace showing potentiation of the response to a 2-adrenoceptor 
agonists in ra t tail artery rings, in the presence of AVP and different 
vasodilators. A control response to clonidine (Cion lOnM; a) or to UK-14,304 
(UK, 50nM; b, c) alone was obtained and washed out (W). Artery rings were 
precontracted with AVP (0.4mU ml*1; a, b, c) then relaxed with diltiazem (D,
2p.M; a), forskolin (F, 36nM; b) or dibutyryl cyclic AMP (cAMP, 0.2mM; c). 
Addition o f clonidine (a) or UK (b, c) at this point, in the presence o f AVP and the 
vasodilator, produced a response significantly larger than that to either clonidine 
(a) or to UK (b, c) alone. This enhanced response was inhibited by yohimbine (Y, 
50nM; a, b, c).
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Figure 45. Potentiation of the response to (X2-adrenoceptor agonists in rat tail 
artery rings, in the presence o f AVP and different vasodilators. A control 
response to clonidine (Cion, lOnM; A) or to U K -14,304 (UK, 50nM; B, C) alone 
was obtained (1) then washed from the organ bath. Drugs were then added 
cumulatively to the organ bath in the order shown in the key. AVP (0.4mU ml*1, 2) 
produced a contraction which was inhibited by a vasodilator (3) as follows:
diltiazem (2pM , A), forskolin (36nM, B) or dibutyryl cyclic AMP (cAMP, 
0.2mM; C). Addition o f clonidine (A) or UK (B, C) at this point (4), in the 
presence of AVP and the vasodilator, produced a response significantly larger than 
the response to UK alone (A, B, C). This enhanced response was inhibited by 
yohimbine (Yoh, 50nM; A, B, C; 5). Each bar shows the mean + s.e.m. of at least 
6 observations. Asterisks indicate significant differences between responses at 
either end of a horizontal bar (*, P<Q.05; **, P<0.01; ***, P<0.001).
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Figure 46. Potentiation of the response to U K -14, 304 in rat tail artery rings, 
in the presence o f AVP or PE and SNP. A control response to U K -14,304 (UK, 
50nM) alone was obtained (1), then UK was washed from the organ bath. Drugs 
were then added cumulatively to the organ bath in the order shown in the key.
AVP (0.4mU ml*1; A) or PE (0.5fiM; B) produced a contraction (2) which was
inhibited by SNP (O.lfiM, 3). Addition of UK at this point (4), in the presence of 
AVP and SNP (A) or PE and SNP (B), produced a response significantly larger 
than the response to UK alone. This enhanced response was inhibited by 
yohimbine (Yoh, 50nM; A, B; 5). Further addition o f UK (+50nM) produced little 
or no response (6). Each bar shows the mean + s.e.m. o f at least 6  observations. 
Asterisks indicate significant differences between the responses at either end o f a 
horizontal bar (**, P<0.01; ***, PcO.001).
5)Relationship between the precontraction and the enhanced response to 012- 
adrenoceptor agonists:
a) Correlations
From the experiments using IBMX as the vasodilator, the size o f the 
enhanced response to clonidine (lOnM) or to UK-14,304 (50nM) was plotted 
against the size o f the response to the precontracting agonist (AVP, 0.4mU ml-1; 
PE, 0.5pM; KCI; 0.03M). (Figures 47, 48).
C lon id in e
There was a positive correlation between the size o f  the response to the 
precontracting agonist and the size o f  the enhanced response to clonidine, with 
the following correlation coefficients (r ): VP/clonidine, r  =0.946 (PcO.OOl, 
Figure 47a); PE/clonidine, r =0.840 (P<0.01, Figure 47b); KCI (peak 
resp on se)/c lon id in e, r =0.697 (P<0.01, Figure 47c); KCI (plateau 
response)/clonidine, r =0.842 (PcO.OOl, Figure 47d).
U K -1 4 ,3 0 4
There was a positive correlation between the size o f the response to the 
precontracting agonist and the size o f the enhanced response to U K -14,304, 
with the following correlation coefficients: VP/UK, r  =0.695 (P<0.05, Figure 
48a); PE/UK, r =0.791 (P<0.05, Figure 48b).
b) Effect o f the passage of time on the enhanced response to clonidine
The experimental protocol was carried out as normal, i.e. a control 
response to clonidine (lOnM) was obtained, the drug washed from the organ 
bath and the tissue precontracted with AVP. The precontraction was relaxed 
with IBMX (lOpM), then clonidine (lOnM) added in the presence o f AVP and
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IBMX. The time between AVP/IBMX and clonidine addition was varied. 20 
minutes after the addition o f AVP, the enhanced response to clonidine was 
74.0+6.3% o f the initial response to AVP. As the time between AVP/IBMX  
and clonidine addition increased, the size of the enhanced response to clonidine 
declined, until 100 minutes after AVP addition it was only 32.8+7.5% o f the 
initial response to AVP (Figure 49).
c) Effect of the passage of time on the response to vasopressin
During the above protocol, AVP was in the organ bath for prolonged 
periods o f time, so it was important to establish whether the response to AVP 
itself varied with time. AVP (0.4ml min-O-mduced tone declined with time so 
that 120 minutes after addition the tone had fallen almost to baseline and was 
only 8.5+5% o f the tone 10 minutes after addition (Figure 49).The reduction in 
the enhanced response to clonidine with time was closely matched by the 
reduction in the response to VP with time (Figure 49).
Effect o f l -N A M E :
The role of endothelium-derived relaxing factor (EDRF)/NO production 
in this phenomenon was investigated by repeating the time-course in the 
presence o f NG-nitro-L-arginine methyl ester (L-NAME; O.lmM), an inhibitor 
of EDRF synthesis. L-NAME had no effect on the decline in the AVP response 
with time; 120 minutes after AVP addition, the A VP-induced tone in the 
presence o f L-NAME was 9.9+4.0% o f the initial response to AVP (Figure 50).
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d) Effect o f different antagonists on the enhanced response to U K -14,304
The above results indicated that the enhanced responses to (X2- 
adrenoceptor agonists were dependent on the precontraction. This was 
investigated further by assessing the abilities o f  antagonists o f  the 
precontracting agonist to inhibit the enhanced response. Control responses to 
UK-14,304 (50nM) were obtained, then rat tail artery rings were precontracted 
with AVP (0.4mU ml-1), PE (0.5|iM ) or 5-HT (50nM) and relaxed with IBMX 
(lOfiM). Addition o f UK-14,304 then produced an enhanced response, and the 
effects o f antagonists added at this point were tested.
(i) Effect of prazosin:
AVP precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.03+0.0lg).The response increased to 0.75+0.06g in the presence 
of AVP and IBMX. Addition o f the oti-adrenoceptor antagonist prazosin 
(O.lpM) had no effect on the enhanced response to U K -14,304 (0.66+0.05g  
after prazosin) (Figures 51a, 52a). The enhanced response to U K -14,304 was 
completely blocked by yohimbine (50nM; P<0.001). Further addition o f UK-
14,304 produced little or no response.
PE precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.03+0.02g).The response increased to 0.87+0.1 lg  in the presence 
o f PE and IBMX. Addition o f prazosin (0.1 pM) at this point completely 
abolished the enhanced response to UK-14,304 (P<0.001; Figures 51c, 52b). 
This is in contrast to the situation when AVP was used to precontract the tissue, 
where prazosin had no effect. Further addition o f U K -14,304 produced no 
response.
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5-HT precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.05+0.01 g).The response increased to 0.97+0.1 lg  (peak) in the 
presence o f 5-HT and IBMX, declining to 0.67 + 0.09g (plateau) at the point o f  
addition o f  prazosin. Following prazosin (O .ljiM ), the response further 
declined to 0.42+0.06g, but it is likely that this was due to the reduction in the 
enhanced response with time, rather than to the action o f  prazosin. The 
enhanced response to U K -14,304 was abolished by yohimbine (50nM; 
PcO.OOl) (Figure 52c).
(ii) Effect of the vasopressin antagonist, MCVP:
AVP precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.09+0.02g).The response increased to 1.14+0.1 lg  in the presence 
o f AVP and IBMX. Addition o f the AVP antagonist (p -m ercap to-p ,(3 -  
cyclopentam ethylene-propionyl^O-M e-Tyr2, Arg8)-vasopressin (MCVP; 
35nM) completely abolished the enhanced response to U K -14,304 (PcO.OOl; 
Figures 51b, 53a). Further U K -14,304 addition produced little or no response.
PE precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.06+0.01 g).The response increased to 0 .80+0.12g in the presence 
o f AVP and IBMX. Addition o f MCVP had no effect on the enhanced response 
to U K -14,304 (0.65+0.1 lg  after MCVP; Figures 5 Id, 53b). This is in contrast 
to the situation when AVP was used to precontract the tissue, where MCVP 
completely abolished the enhanced response to U K -14,304. The response was 
however blocked by the (X2-adrenoceptor antagonist yohimbine (50nM; 
PcO.OOl).
6 4
iii) Effect of ketanserin:
AVP precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.05+0.0 lg).The response increased to 0.79+0.04g in the presence 
o f  AVP and IBMX. Addition o f  the 5 -HT2-receptor antagonist ketanserin 
(50nM) had no effect on the enhanced response to U K -14,304 (0.67±0.05g  
after ketanserin; Figure 54a). The enhanced response to U K -14,304 was 
however blocked by the ct2-adrenoceptor antagonist yohimbine (50nM; 
PcO.OOl).
PE precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.06+0.0lg; Figure 54b).The response increased to 0.70+0.06g in 
the presence o f PE and IBMX. This enhanced response declined to 0.55+Q.05g 
following ketanserin (P<0.05), but it is likely that this was due to a reduction in 
the enhanced response with time, rather than to the action o f ketanserin. The 
enhanced response to UK -14,304 was however blocked by yohimbine (50nM; 
PcO.OOl). Further addition o f U K -14,304 (+50nM ) produced little or no 
response.
5-HT precontraction: U K -14,304 alone (50nM) produced little or no 
response (0.05+0.01 g).The response increased to 0.62+0.04g in the presence 
of 5-HT and IBMX. Addition o f ketanserin completely abolished the enhanced 
response to UK-14,304 (PcO.OOl; Figure 54c). Further UK-14,304 addition 
(+50nM) produced little or no response.
The effects o f  antagonists on the enhanced response to U K -14,304 are 
summarised in Table 4.
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Figure 47. Correlation between the size o f the response to the precontracting  
agonist and the size o f the enhanced response to clonidine in rat tail artery
rings. Artery rings were precontracted with AVP (0.4mU ml*1; A), PE (0.5p.M; B)
or KCI (0.03M; C, D) and then relaxed with IBMX (IOjiM). Subsequent addition 
o f clonidine produced a large contraction which restored the IBMX-induced 
relaxation to the level of tone produced by the precontracting agonist. Each point 
represents the response to the precontracting agonist (jc-axis) plotted against the 
response to clonidine obtained in the presence o f the precontracting agonist and 
IBMX (y-axis). r indicates the correlation coefficient for each pair o f  variables.
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Figure 48. Correlation between the size of the reponse to the precontracting 
agonist and the size of the enhanced response to UK-14,304 in ra t tail artery
rings. Artery rings were precontracted with AVP (0.4mU ml’1; A) or PE (0.5|iM;
B) and then relaxed with IBMX (IOjiM). Subsequent addition o f  UK-14,304 (UK, 
50nM) produced a large contraction which restored the IBMX-induced relaxation 
to the level of tone produced by the precontracting agonist. Each point represents 
the response to the precontracting agonist (jc-axis) plotted against the response to 
UK obtained in the presence o f the precontracting agonist and IBMX (y-axis). r 
indicates the correlation coefficient for each pair of variables.
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Figure 49. The effect o f the passage of time on the response to A V P and on the 
enhanced response to clonidine in rat tail artery rings. Responses were 
expressed as a percentage of the AVP-induced contraction 10 minutes after AVP 
addition. AVP (0.4mU ml’1) alone produced a large contraction which declined 
over time In separate experiments, tail artery rings were precontracted
with AVP and then relaxed with IBMX (IOjiM). Addition o f clonidine (lOnM) at 
this point, in the presence of AVP and IBMX, produced a large contraction (- -O ) .  
The size o f this contraction decreased as the interval between VP/IBMX and 
clonidine addition was increased. Each point represents the mean + s.e.m. o f at 
least 6 observations.
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Figure 50. The effect of L-NAME on the tim e course o f the response to AVP in 
rat tail artery rings. Responses were expressed as the percentage o f the AVP- 
induced contraction 10 minutes after AVP addition. AVP (0.4mU ml-1) produced a 
large contraction which declined ovtr time The time course was repeated
in the presence o f NG-nitro-L-arginine methyl ester (L-NAME, O.lmM; 
added to the organ bath 20 minutes before AVP. L-NAME had no effect on the 
decline of the AVP-induced contraction with time. Each point represents the mean 
±  s.e.m. of at least 6  observations. .
Figure 51. Trace showing the effect o f prazosin or a vasopressin antagonist on 
the enhanced response to UK-14,304 in rat tail artery rings. A control response 
to U K -14,304 alone (UK, 50nM) was obtained and washed out (W; a, b, c, d).
Artery rings were precontracted with either AVP (0.4mU ml'1; a, b) or PE (0.5|iM;
c, d) then relaxed with IBMX (I, 10|iM; a, b, c, d). UK in the presence o f AVP and 
IBMX (a, b) or PE and IBMX (c, d) produced a response larger than that to UK  
alone. When the vessels were precontracted with AVP (a, b) the enhanced
response to UK was not inhibited by prazosin (P, 0.1 pM; a) but was inhibited by
yohimbine (Y, 50nM; a) or by the AVP antagonist, [p -m e r c a p to -P ,p -  
cyclopentamethylenepropionyl1, O-Me-Tyr2, Arg8]-vasopressin (MCVP, 35nM;
b). When the vessels were precontracted with PE (c, d), the enhanced response to 
UK was not inhibited by MCVP (d) but was completely abolished by prazosin (c) 
or by yohimbine (d). Further addition o f UK (+10nM) produced little or no 
response (a, b, c).
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Figure 52. The effect o f prazosin on the enhanced response to UK-14,304  
in rat tail artery rings. A  control response to U K -14,304 alone (UK, 50nM) 
was obtained (1) and washed out. Drugs were then added cumulatively in the
order shown in the key. AVP (0.4mU ml-1; A), PE (0.5jiM; B) or 5-HT
(50nM, C) produced a contraction (2) which was inhibited by IBMX (10|iM; 
3). Addition o f UK at this point (4), in the presence o f AVP and IBMX (A), 
PE and IBMX (B) or 5-HT and IBMX (C) produced a response larger than the 
response to UK alone. When the vessels were precontracted with AVP (A) or 
5-HT (C), the enhanced response to UK was not inhibited by prazosin
(0.1 |iM; 5) but was inhibited by yohimbine (50nM; 6). When the vessels were 
precontracted with PE (B), the enhanced response to UK was completely  
abolished by prazosin (5), and further addition o f UK (+50nM) produced no 
response (6 ). Each bar shows the mean + s.e.m. o f  at least 6  observations. 
Asterisks indicate significant differences between responses at either end of a 
horizontal bar (♦> p<0.05; **> P<0.01; ***, PcO.OOl).
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Figure 53. The effect of a vasopressin antagonist on the enhanced response to 
U K -14,304 in rat tail artery rings. A control response to U K -14,304 (UK, 50nM) 
alone was obtained (1) and washed from the organ bath. Drugs were then added
cumulatively in the order shown in the key. AVP (0.4mU ml-1; A) or PE (0.5pM;
B) produced a contraction (2) which was inhibited by IBMX (10}iM, 3). Addition 
of UK at this point (4), in the presence of AVP and IBMX (A) or PE and IBMX  
(B), produced a response significantly larger than the response to UK alone. When 
the vessels were precontracted with- AVP (A), the enhanced response to UK was 
com p lete ly  abolished by the A VP antagonist ( p -m e r c a p to -p ,  p- 
cyclopentamethylene-propionyl1, O-Me-Tyr2, Arg8) vasopressin (MCVP, 35nM; 
5). Further UK addition (VlOnM) produced little or no response (6 ). When the 
vessels were precontracted with PE (B), the enhanced response to UK was 
unaffected by MCVP (5) but was inhibited by yohimbine (Yoh, 50nM; 6 ). Each 
bar shows the mean + s.e.m. o f at least 6 observations. Asterisks indicate 
significant differences between responses at either end of a horizontal bar (**, 
P<0.01; ***, PcO.001).
Figure 54. The effect o f ketanserin on the enhanced response to U K -14,304 
in rat tail artery rings. A control response to U K -14,304 alone (UK, 50nM) 
was obtained (1) and washed out. Drugs were then added cumulatively in the
order shown in the key. AVP (0.4mU m l-1; A), PE (0.5|nM; B) or 5-HT
(50nM; C) produced a contraction (2) which was inhibited by IBMX (10|iM; 
3). Addition o f  UK at this point (4), in the presence of AVP and IBMX (A), 
PE and IBMX (B) or 5-HT and IBMX (C) produced a response significantly 
larger than the response to UK alone. The enhanced response to UK was 
unaffected by ketanserin (50nM; 5) when AVP or PE was used to precontract 
the tissue (A, B) but was abolished by yohimbine (Yoh, 50nM, A, B; 6 ). 
Further addition o f UK (+50nM; 7) produced little or no response (B). When 
5-HT was used to precontract the tissue (C), the enhanced response to UK was 
abolished by ketanserin (5), and further UK addition produced little or no 
response (6 ). Each bar shows the mean + s.e.m. o f at least 6  observations. 
Asterisks indicate significant differences between responses at either end o f a 
horizontal bar (*, P<0.05, ***, PcO.OOl).
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Prazosin MCVP Ketanserin Yoh
AVP X ✓ X ✓
PE ✓ X X ✓
5-HT X X ✓ ✓
KC1 __ — —... ✓
Table 4. Table summarising the effects of different antagonists in inhibiting the 
enhanced response to U K -14,304 in rat tail artery  rings. V essels were 
precontracted with the agonists AVP (0.4mU ml-1), PE (0.5|iM ), 5-HT (50nM) or 
KC1 (0.03M) then relaxed with IBMX (IOjiM). In the presence o f a precontracting 
agonist and IBMX, UK-14,304 (50nM) produced an enhanced response which was 
( 1/  ) or was not ( X ) inhibited by prazosin (O.ljiM ), the AVP antagonist ((3- 
m ercapto-pjP-cyclopentam ethylenepropionyl1, O-M e-Tyr2, Arg8)-vasopressin  
(MCVP; 35nM), ketanserin (35nM) or yohimbine (Yoh, 50nM). (— ) indicates an 
agonist-antagonist combination which was not tested.
PART IV
INVESTIGATION OF THE NATURE OF THE NEUROTRANSMISSION IN 
THE RAT TAIL ARTERY
The rat tail artery receives a dense sympathetic innervation, but the 
precise nature o f the transmitter(s) involved is unclear. This part o f the study 
examined the possibility that ATP may act along with the main transmitter NA  
as a co-transmitter. Responses to electrical field stimulation were examined in 
rat tail artery rings, under a range o f conditions designed to determine the roles 
of NA and ATP in the contractile response to field stimulation.
A) THE EFFECT OF EXOGENOUS AGONISTS
1) Noradrenaline
Cumulative addition o f NA (10*9- 3x1 (HM ) produced concentration- 
dependent increases in tension (Figure 55a) with an EC50 o f 0.76+0.09fiM . 
The a  1-adrenoceptor antagonist prazosin (0.1 p.M) produced a 30-fold, 
rightward shift in the NA curve and an increase in the EC50 for NA  
(22.00+0.30|iM; P<0.01) (Figure 55a).
2) ATP
ATP (3xl0-7-3x l0 '3M) produced concentration-dependent increases in tension 
(Figure 55b). The response to ATP was rapid but was not maintained, declining 
sharply, so the concentration-response curve was carried out in the washout 
manner. A maximum response was not achieved as the highest concentration 
which could be added to the organ bath was 3mM and the response was still 
increasing, so the EC50 for ATP could not be calculated.
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B) ELECTRICAL FIELD STIMULATION
1) Effect o f tetrodotoxin
Trains o f electrical stimuli (supramaximal voltage 50V, 10Hz for Is, 
0.1ms duration, every 100s) were applied and then tetrodotoxin (TTX, O.lpM) 
added to the organ bath. TTX completely abolished the response to field  
stimulation, which was restored when TTX was washed from the organ bath 
(Figure 56).
2) Frequency-response curve
Electrical field stimulation (supramaximal voltage 50V, 10 pulses, 
0.1ms, 0.1-40Hz) produced frequency-dependent increases in tension. The 
ffequency-response curve (FRC) was biphasic, with the first peak at 5-10Hz 
and the second at 30-40Hz (Figures 57, 58).
a) Effect o f prazosin
A control FRC was obtained, then prazosin (0.1 jiM) was added to the 
organ bath and the FRC repeated 20 minutes later. In the presence o f prazosin, 
the contractile response to field stimulation was abolished at all frequencies, 
with no evidence of a residual response (Figures 57 ,58).
b) Effect of a,p-M eATP
A control FRC was obtained, then addition o f a ,p-M eA T P  (0.5|iM ) 
produced a transient contraction (0.45±Q.10g) which returned to baseline within
5-10 minutes (Figure 59). The FRC was then repeated in the presence o f a,(3— 
MeATP but was no different from control (Figures 59, 60). In some 
experiments a further addition of a,p-M eATP (+0.5fiM) was given following 
the second FRC (Figure 59). This did not produce a contraction and had no 
effect on the FRC subsequently carried o u t . Addition o f prazosin (O.ljiM) at 
this point however, abolished the contraction at all frequencies of stimulation .
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Figure 55. C oncentration-response curves to NA (A) and to adenosine  
triphosphate (ATP; B) in rat tail artery rings. Prazosin (0.1)iM) produced a 
rightward shift in the NA concentration-response curve (A). Asterisks indicate a 
significant reduction in the response to NA by prazosin (*, P<0.05; **, P<0.01; 
***, P<0.001). Each point is the mean + s.e.m. of at least 6 observations. Where 
no error bars are shown, the error bars are contained within the symbols.
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Figure 56. Trace showing the effect of tetrodotoxin on the contractile response 
to electrical field stimulation in ra t tail artery  rings. Contractions to field  
stimulation (supramaximal voltage 50V, 10Hz for Is, pulse width 0.1ms, every 
100s) were abolished by tetrodotoxin (TTX), suggesting a neural origin. The 
responses were restored when TTX was washed from the organ bath (W).
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Figure 57. Trace showing the effect o f prazosin on the frequency-response 
curve in rat tail artery rings. The upper panel shows a control frequency- 
response curve (FRC; supramaximal voltage 50V, 0.1-40H z, 10 pulses, pulse 
width 0.1ms). The lower panel is a continuation of the same experiment, where the
FRC was repeated in the presence o f prazosin (P, 0.1 fiM). Responses at all 
frequencies were abolished by prazosin.
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Figure 58. The effect o f prazosin, on the frequency-response curve (FRC; 
Supram axim al voltage 50V, 10 pulses, 0.1m s) in rat tail artery rings. The
control FRC (—• - - )  was biphasic. Prazosin (0.1 }iM) abolished the response at all 
frequencies ( ~ 0 ~ )  (**, P<0.01; P<0.001). Each point is the mean + s.e.m. of
6  observations. Where no error bars are shown, the errors are contained within the 
symbols.
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Figure 59. Trace showing the effect of a ,  (3-methylene ATP on the frequency- 
response curve in rat tail artery rings. The upper panel shows a control 
frequency-response curve (FRC; supramaximal voltage 50V, 0.1-40Hz, 10 pulses, 
pulse width 0.1ms). The middle panel shows a continuation o f  the same
experiment, where the FRC was repeated in the presence of a , |3-methylene ATP
(mATP, 0.5|iM ) which produced a transient contraction. The lower panel shows
the FRC in the presence o f a second addition o f mATP (+0.5jiM ), which did not 
produce a contraction. Responses at all frequencies were unaffected by mATP. 
Subsequent addition o f prazosin (P; 0. lfiM ) abolished the response at all 
frequencies o f stimulation.
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Figure 60. The effect o f mATP on the frequency-response curve (FRC; 
Supram axim al voltage, 10 pulses, 0.1m s) in rat tail artery rings. mATP
(0.5pM ) had no effect on the FRC. Each bar shows the mean + s.e.m. o f 6  
observations.
d) Effect o f prazosin plus yohimbine
Prazosin (0.1 pM) abolished the contractile response to field stimulation 
(Figure 65). A lower concentration o f prazosin (5nM) however, produced a 45- 
70% reduction in the field stimulation-induced contraction (0.50+ 0.01 g 
control; 0 .28+ 0 .03g follow ing prazosin 5nM; P<0.01). The remaining 
response was completely abolished by yohimbine (50nM; P<0.001) (Figures 
65, 6 6 ).
e) Effect o f a,(3-MeATP on the response to field stimulation and to ATP
Two control responses to field stimulation (50V, 10Hz for Is, 0.1ms 
duration) then a control response to ATP (3x1 (HM) were obtained, then a ,(3- 
M eATP (0.5 |iM ) added (Figure 67). a ,|3-M eA T P produced a transient 
contraction (0 .45+0.lOg) and the sequence was repeated when the a , p -  
MeATP-induced contraction returned to baseline. The response to field  
stimulation was unaffected in the presence of a ,p-M eA T P  (0.88±0.10g; c.f. 
0 .8 6 + 0 .lOg control). The response to exogenous ATP was significantly 
reduced in the presence of a , (5—Me ATP (0.17+0.06g, c.f. 0.62+0.03g control; 
P<0.01) (Figures 67, 6 8 ).
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Figure 61. The effect o f yohimbine on the contractile response to electrical 
field stim ulation in rat tail artery rings. Trains o f stimuli (Supramaximal 
voltage 50V, 10Hz for Is, 0.1ms duration, every 100s) gave reproducible 
responses, which were inhibited in the presence o f yohimbine (50nM) (♦**, 
P<0.001). Each bar represents the mean ±  s.e.m. o f at least 12 observations.
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1.5 min
Figure 62. Trace showing the effect of yohim bine on the contractile response 
to electrical field stimulation in rat tail artery rings. Yohimbine (Y, 50nM) 
reduced the height and curtailed the duration o f  the response to field stimulation 
(supramaximal voltage 50V, 10Hz for Is, pulse width 0.1m s, every 100s). 
Responses returned to the control height and duration when yohimbine was 
washed from the organ bath (W).
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Figure 63. The effects of clonidine and o f U K -14,304 on the contractile  
response to electrical field stimulation in rat tail artery rings. Field stimulation 
(Supramaximal voltage 50V, 10Hz for Is, 0.1ms duration) gave reproducible 
responses (Control; A, B). Clonidine (50nM; A) and U K -14,304 (50nM; B) 
inhibited the field stimulation-induced contraction (**, P<0.01; ***, P<0.001). 
Each bar represents the mean ±  s.e.m. of at least 12 observations.
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Figure 64. Trace showing the effects of clonidine and UK-14,304 on the 
contractile response to electrical field stim ulation in ra t tail artery  rings.
Vessels were stimulated with supramaximal voltage 50V, 10Hz for Is, pulse width 
0.1ms. Both clonidine (Cion, 50nM; a) and U K -14,304 (UK, 50nM; b) produced 
small contractions, and reduced the height and prolonged the duration o f the field 
stimulation-induced contraction. The responses returned to control height and 
duration when the drugs were washed from the organ bath (W).
P 0.1 jim
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P 5nM Y 50nM
Figure 65. Trace showing the effects of prazosin and yohimbine on the 
contractile response to electrical field stimulation in ra t tail artery  rings.
Vessels were stimulated with supramaximal voltage 50V, 10Hz for Is, pulse width 
0.1ms, every 100s. In the upper panel, the response was abolished by prazosin (P;
O.lpM). The lower panel shows the effect o f a lower concentration o f prazosin (P, 
5nM), which inhibited the contraction to field stimulation. The residual response 
was abolished by yohimbine (Y, 50nM).
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Figure 6 6 . The effect of prazosin and yohimbine on the contractile response to 
electrica l field  stim ulation  in rat tail artery  rings. Field stimulation  
(Supramaximal voltage 50V, 10Hz for Is, 0.1ms duration) gave reproducible 
control responses (C). Prazosin (5nM, P) inhibited the field stimulation-induced 
contraction (**, P<0.01). The residual response was abolished by yohimbine 
(50nM, P+Y; ***, P<0.001). Each bar represents the mean + s.e.m. o f at least 12 
observations.
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Figure 67. Trace showing the effect o f m ATP on the contractile responses to 
electrical field stimulation and to ATP in rat tail artery rings. Two control 
responses to field stimulation (S; supramaximal voltage 50V, 10Hz for Is, pulse 
width 0.1ms) were obtained, then ATP (0.3mM) added. ATP produced a transient
contraction, then was washed out (W). Addition o f mATP (0.5fiM ) produced a 
transient contraction, then the sequence was repeated in the presence o f mATP. 
mATP did not affect the response to field stimulation but inhibited the response to 
exogenous ATP.
■  Control 
□  +mATP
FS ATP
Figure 6 8 . The effect of mATP on the contractile responses to electrical field  
stim ulation and to ATP in rat tail artery rings. Control responses to field  
stimulation (FS; Supramaximal voltage 50V, 10Hz for Is, 0.1ms duration) and to 
ATP (0.3mM) are shown as black bars. Responses in the presence o f mATP
(0.5|iM ) are shown as hatched bars. mATP did not affect the field stimulation- 
induced contraction, but markedly reduced the response to exogenous ATP (**, 
P<0.01). Each bar represents the mean ±  s.e.m. of at least 6  observations.
4j) Responses to fie ld  stimulation following precontraction and subsequent 
relaxation
Previous experiments (Part III) established conditions in the rat tail 
artery for potentiating contractile responses mediated via post-junctional 0C2- 
adrenoceptors. The effects o f  clonidine, U K -14,304 and yohimbine suggested 
that these receptors may have a role in the field stimulation-induced contraction. 
Field stimulation was therefore carried out in vessels which had been 
precontracted by AVP (0.4mU ml-1) and then relaxed by IBMX (10|iM).
a) Control
Two control responses to field stimulation (Supramaximal voltage 50V, 
10Hz for Is, 0.1ms pulse width) and a control response to clonidine (50nM) 
were obtained (Figure 69a). Artery rings were then precontracted with AVP and 
relaxed with IBMX. In the presence of AVP and IBMX there was no difference 
in the height o f the response to field stimulation as compared to control 
(0 .33+0.08g and 0.42+0.09g respectively). The response was, however, 
prolonged as compared to control. Subsequent addition o f clonidine (50nM) 
produced a response greater than control (0 .83+0.22g, c.f. 0 .12+0.01 g; 
P<0.01), which was abolished by yohimbine (50nM; PcO.Ol). Field  
stimulation then produced no response.
b) Effect of prazosin
Trains o f electrical stimulation (10Hz) gave reproducible responses, 
which were completely abolished by prazosin (0.1 p.M; Figure 69b). The 
remainder o f the experiment was carried out in the presence o f prazosin. Tail 
artery rings were precontracted with AVP and relaxed with IBMX, and field 
stimulation now produced a response in the presence o f prazosin. This response 
was biphasic, with an initial spike followed by a more prolonged second
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component, and the amplitude was reduced (0.39+0.04g, c.f. 1 .15+0.0 lg  
control; PcO.OOl). Addition of yohimbine (50nM) at this point had no effect on 
the amplitude o f this revealed response, but abolished the second component o f  
the response, leaving a spike. This spike was almost completely abolished by 
addition o f a,|3-M eATP (0.5p.M).
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C) FIELD STIMULATION IN HYPERTENSIVE RATS
It has been suggested that the importance o f ATP as a co-transmitter is 
increased in hypertension (Vidal, Hicks & Langer, 1986). Contractile responses 
to electrical field stimulation were therefore investigated in tail artery rings from 
SHR and compared with responses from normotensive control rats (WKY).
1) Frequency-response curve
Electrical field stimulation (supramaximal voltage 50V, 10 pulses, 
0.1ms, 0.1-40Hz) produced frequency-dependent increases in tension. In both 
groups o f rat the frequency-response curve was biphasic with the first 
maximum at 2-10Hz, after which the response again increased from 10-40Hz 
(Figure 70). When expressed as increases in tension (g), responses in tail artery 
rings from SHR were greater than in those from WKY at all frequencies 
(P<0.05; Figure 70a). When expressed as a percentage o f the response to PE 
(10|iM) however, only responses at the lower frequencies (0.1Hz, 0.2Hz) were 
increased in hypertensive rats relative to control (0.1Hz: 18.6+3.4%  c.f. 
5.0+1.9% , P<0.05; 0.2Hz: 22.3+3.5%  c.f. 10.9+3.0% , P<0.05) (Figure 
70b).
2) Time controls
Three consecutive frequency-response curves were carried out in tail 
artery rings from hypertensive and control rats. In SHR the responses at each 
frequency diminished with each repetition (Figure 71). From 0 .1 -2Hz the 
decrease in response between the first and third curves was statistically 
significant (P<0.05). In WKY, there was no difference in response comparing 
the first, second and third curves (Figure 71).
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3) Effect o f a,P~MeATP
A control FRC was obtained, then a ,p —MeATP (lfiM ) added to the 
organ bath. This produced a transient contraction (SHR: 0.75+0. l lg ;  WKY: 
0.62+0.10g), and when this returned to baseline, a second FRC was carried out 
in the presence o f a,|3-M eA TP. Addition o f  a further lfiM  a ,p —M eA T P  
produced little or no response (SHR: 0.10±0.04g; WKY: 0.07±p.03g) and a 
third FRC was then obtained. Responses were corrected for any changes 
occurring during the time control and expressed as a percentage o f the response 
to PE (lOpM).
In SHR, a,p-M eA TP had no effect on the response to field stimulation 
at 0.5-40Hz. At 0.1-0.2Hz the response increased following the first addition 
of oc,P-MeATP (P<0.05), but returned to control following the second a ,p -  
MeATP addition (Figure 72). In WKY, a,P~M eATP had no effect on the field 
stimulation-induced contraction at any of the frequencies examined (Figure 72).
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Figure 70. Frequency-response curves in tail artery rings from SHR  
and W KY (—0 —) rats. Vessels were stimulated with supramaximal voltage 
(50V), 10 pulses, 0.1ms. When expressed as increases in tension (A), responses 
from SHR were greater than those from WKY at all frequencies (*, P<0.05). When
expressed as a percentage of the response to PE (10|J.M; B), only responses at 
0.1Hz and 0.2Hz were greater in SHR compared to WKY (*, P<0.05). Each bar 
represents the mean + s.e.m. of at least 6 observations.
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Figure 71. Time control for the frequency-response curves in tail artery rings 
from SHR (upper panel) and WKY (lower panel) rats. Three consecutive 
frequency-response curves were obtained (Supramaximal voltage 50V, 10 pulses, 
0.1ms; Curves 1-3). In SHR, the response decreased with each repetition and the 
decrease was significant between the first and third curves from 0.1-2Hz (*, 
P<0.05). In WKY, the responses were maintained with each repetition. Each bar 
represents the mean + s.e.m. of at least 6  observations.
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Figure 72. The effect of mATP on the frequency-response curve in tail artery 
rings from SHR and WKY rats. Vessels were stimulated with supramaximal 
voltage (50V), 10 pulses, 0.1ms, and responses were controlled for time. mATP
(lpM ) was added after the first (Control) curve, and a second curve (+mATP) was
carried out. A further addition of mATP (+ lpM ) was given and the third curve 
(++mATP) carried out. In SHR (upper panel), the responses at 0.1Hz and 0.2Hz 
increased following the first addition o f mATP (*, P<0.05), but returned to control 
after the second addition. In WKY (lower panel), mATP had no effect on the 
response to field stimulation at any frequency. Each bar represents the mean + 
s.e.m. of at least 6  observations.
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D) FIELD STIMULATION IN RATS PRETREATED WITH RESERPINE OR
6 -HYDROXYDOPAMINE
Reserpine and 6 -OHDA are two drugs known to inhibit sympathetic 
transmission, reserpine by depleting nerve terminals o f NA, and 6 -OHDA by 
destroying sympathetic nerve terminals. Reserpine and 6 -OH DA may 
distinguish between nerves which use only NA and nerves where the actions of 
an additional transmitter may be unaffected by NA depletion. Responses to field 
stimulation were therefore investigated in tail artery rings from rats pretreated 
with reserpine or 6 -OHDA.
1) Rat weight and systolic blood pressure
All rats were age- and weight-matched, then treated with drug or vehicle 
control. Reserpine-treated rats were significantly lighter than rats which had 
received vehicle control (235+17g, c.f. 338+1 lg ,  PcO.Ol). There was no 
difference in weight between 6 -OHDA-treated rats as compared to control 
(305+9g, c.f. 322+ 15g). Systolic blood pressure was not affected by either 
reserpine (120+10mmHg, c.f. 132+12mmHg control) or 6 -OHDA treatment 
(114+13mmHg, c.f. 125+14mmHg control).
2) Electrical field  stimulation
Field stimulation (supramaximal voltage 70V, 0.5Hz, 10Hz or 20Hz, 
pulse width 0.4ms, 10 pulses) produced a contractile response in tail artery 
rings from both reserpine- and 6-OHDA-treated rats. The shape o f the response 
was wider than control responses, and although rising sharply to a peak, did 
not return to baseline until 5-8 minutes after stimulation (Figures 73, 75, 76, 
78). The stimulation-induced contraction was not frequency-dependent, with 
responses at 0.5Hz similar to those at 20Hz (Figures 75, 76, 78). The effects of 
drugs or drug combinations were tested on this contractile response.
a) Effect of TTX
Tail artery rings from all groups o f rat were stimulated at 10Hz then 
TTX (0.1 pM) was added to the organ bath and field stimulation was repeated. 
TTX did not affect the field stimulation-induced contraction in vessels from 
either reserpine- or 6 -OHDA-treated rats (Figures 73a, 73c). Responses in 
vessels from the control groups o f rat were abolished by TTX (Figures 73b, 
73d).
b) Time control
Two responses each to 0.5H z then 20H z were obtained, then this 
stimulation sequence was repeated twice. For rats from both treatment groups 
there was no difference in response with each repetition (Figures 74a, 74b). 
Responses from the respective control groups diminished with each repetition at 
0.5Hz (P<0.05) but not at 20Hz (Figures 74a, 74b).
c) Effect of prazosin and yohimbine
Two responses each to 0.5Hz then 20Hz were obtained. Prazosin 
(0.1 pM) was added to the organ bath and ten minutes later the field stimulation 
sequence was repeated. Responses in tail artery rings from both treatment 
groups were unaffected by prazosin (Figures 75, 76, 77) but responses in 
vessels from the respective control groups were abolished (Figures 75, 76). 
Yohimbine (50nM) was then added to the organ bath and stimulation repeated 
twenty minutes later. Responses in tail artery rings from both treatment groups 
were unaffected by yohimbine (Figures 75, 76, 77).
d) Effect of a,p-M eATP
Two responses each to 0.5Hz, then 20Hz were obtained, a , (3—MeATP 
(lp M ) produced a transient contraction in vessels from treated and control 
groups, then the stimulation sequence was repeated. Responses in tail artery 
rings from all groups of rat were unaffected by a,(3-M eATP (Figures 78, 79).
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Figure 73. Trace showing the effect of TTX on the contractile response to 
electrical field stimulation in tail a rte ry  rings from ra ts  pretreated  with 
reserpine (a) or 6-hydroxy dopamine (6-OHDA; c). Each train o f stimulation 
(supramaximal voltage 70V, 10Hz for Is, pulse width 0.4ms) is represented by a
dot. TTX (O.ljiM)had no effect on responses from rats pretreated with reserpine 
(a) or 6-OHDA (c). Responses from rats pretreated with vehicle controls for 
reserpine (b) or for 6 -OHDA (d) were abolished by TTX, and restored after the 
TTX was washed out (W).
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Figure 74. Time control for the contractile response to electrical field 
stimulation in tail artery rings from rats treated with reserpine (A), 6-OHDA 
(B) or the appropriate vehicle control (Control; A, B). Vessels were stimulated 
using 70V, 0.5Hz or 20Hz, pulse width 0.4ms, 10 pulses. Two responses were 
obtained at each frequency (Response 1) and the sequence repeated twice 
(Responses 2 and 3 respectively). In the control groups, responses 2 and 3 were 
smaller than the initial response at 0.5Hz but not at 20Hz (*, P<0.05). In the 
treatment groups, there was no difference in response with each repetition, at 
either frequency. Each bar represents the mean + s.e.m. of at least 6  observations.
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Figure 75. Traces showing the effect of prazosin and yohim bine on the 
contractile response to electrical field stimulation in tail artery rings from rats 
pretreated with reserpine (a) or vehicle control (b). Each train o f stimulation 
(supramaximal voltage 70V, 0.5Hz or 20Hz, 10 pulses, pulse width 0.4ms) is 
represented by a dot. In (a), trace 1 shows responses from reserpinised rats before 
drug addition. Traces 2 and 3 are continuations o f  the experiment. Prazosin (P;
0.1 p.M) and yohimbine (Y; 50nM) had no effect on the response. In (b), trace 1 
shows responses from control rats before drug addition. Trace 2 is a continuation 
of the experiment. Prazosin abolished the response to field stimulation.
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Figure 76.Traces showing the effects of prazosin and yohimbine on the 
contractile response to field stimulation in rats pretreated with 6-OHDA (a) 
or vehicle control (b). Each train o f stimulation (Supramaximal voltage 70V, 
0.5Hz or 20Hz, 10 pulses, pulse width 0.4ms) is represented by a dot. In (a), trace 
1 shows responses from 6 -OHDA-treated rats before drug addition. Traces 2 and 3
are continuations of the experiment. Prazosin (P; 0.1 |uM) and yohimbine (Y; 
50nM) had no effect on the response. In (b), trace 1 shows responses from control 
rats before drug addition. Trace 2 is a continuation of the experiment. Prazosin 
abolished the response to field stimulation.
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Figure 77. The effect of prazosin and yohimbine on the contractile response to 
electrical field stimulation in tail artery rings from rats treated with reserpine 
(E ; A) or 6-OHDA (S3; B). Vessels were stimulated using 70V, 0.5Hz or 20Hz, 
pulse width 0.4ms, 10 pulses. Two control responses were obtained at each
frequency (C) and the sequence repeated in the presence o f prazosin (P; O.ljiM). 
Yohimbine (Y; 50nM) was then added to the organ bath and the sequence 
repeated. Neither prazosin nor yohimbine affected the field stimulation-induced 
contraction at either frequency, in either treatment group. Each bar is the mean + 
s.e.m. of at least 6 observations.
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Figure 78. Traces showing the effect of mATP on the contractile response to 
electrical field stimulation in tail artery  rings from  rats pretreated  with 
reserpine (a) or 6-OHDA (c). Each train o f stimulation (supramaximal voltage 
70V, 0.5Hz and 20Hz, 10 pulses, pulse width 0.4ms) is represented by a dot. 
Traces (b) and (d) show responses from rats pretreated with vehicle controls for 
reserpine and 6 -OHDA respectively. Responses from each group o f rat were
unaffected by mATP (ljuM).
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Figure 79. The effect of mATP on the contractile response to electrical field 
stimulation in tail artery rings from rats treated with reserpine (A), 6-OHDA (B) 
or the appropriate vehicle control (A, B). Vessels were stimulated using 70V, 0.5Hz 
or 20Hz, pulse width 0.4ms, 10 pulses Two responses were obtained at each frequency,
then the stimulation sequence was repeated in the presence o f mATP (IjiM ). The field 
stimulation-induced contraction from all groups of rat was unaffected by mATP. Each 
bar represents the mean + s.e.m. of at least 6  observations.
Discussion
1. GENERAL
Since vascular responsiveness depends on complex interactions 
between various physiological m echanism s and som etim es various 
pathological processes, it is not surprising that gaps in our knowledge exist 
concerning its regulation. This study has provided answers for some key 
questions regarding blood vessel control.
The presence o f post-junctional a 2-adrenoceptors in the rat tail artery 
was confirmed. An original experimental protocol allowed elucidation o f the 
conditions under which contractions mediated via ot2-adrenoceptors could be 
demonstrated, thus extending current knowledge o f the functional significance 
o f these receptors.
This study also established that ct2-adrenoceptors located on vascular 
smooth muscle contribute to the field stimulation-induced contraction in the 
rat tail artery, providing evidence that these receptors have a role in the neural 
regulation o f  blood vessels. This finding partially explains why some 
neurogenic contractions are prazosin-resistant, a phenomenon which has 
previously been attributed to the action o f a transmitter other than NA, for 
example, adenosine triphosphate (ATP). The present study did not find any 
direct evidence for NA/ATP sympathetic co-transmission in the rat tail artery. 
Under certain circumstances however, neurogenic contractions could be 
inhibited by desensitisation of purinoceptors. These experiments, while not 
resolving the controversial issue o f co-transmission in this vessel, provide 
valuable information on the neural control o f blood vessels.
Part o f  this study investigated the changes which occur in blood 
vessels during hypertension. Structural, mechanical and biochemical features 
were examined in a conducting and a resistance vessel, the rat aorta and tail 
artery respectively. Using this integrated approach, interesting results were
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obtained which confirm and extend previous work in this laboratory' and 
elsewhere.
2. HYPERTENSION
Arterial blood pressure is the product o f cardiac output and total 
peripheral resistance (Lund-Johansen, 1980), the latter being largely 
determined by the small arteries and arterioles, which may therefore be termed 
"resistance arteries". Blood pressure is maintained within defined limits by 
homeostatic mechanisms such as the baroreceptor reflex, or longer-term  
systems such as the renin-angiotensin-aldosterone system (Docherty, 1990). 
These mechanisms, involving neural and humoral actions at the central and 
peripheral levels, operate in the whole animal or human. Clearly, isolated 
blood vessels are not exposed to the same regulatory influences as entire 
vascular beds in the intact animal. It was therefore of interest to determine, 
under conditions where blood pressure control is deranged, i.e. hypertension, 
whether changes associated with this phenomenon are manifested at the level 
of the blood vessel itself.
The model o f  hypertension chosen for this study was the 
spontaneously hypertensive rat (SHR), a genetically hypertensive strain first 
developed by Okamoto and Aoki in 1963. The SHR is a convenient model, 
requiring no physiological, pharmacological or surgical intervention, and as 
with human primary hypertension, exhibits a slowly progressing and naturally 
developing hypertension.
There are criticisms o f  this model however, which are generally 
levelled at the fact that the SHR is not an exact replica o f human primary 
hypertension (Malik & McGiff, 1975; M cGiff & Quilley, 1981). However, 
given that both diseases are polygenetic in origin and that the control o f
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normal arterial pressure in both man and rat is multifactorial (Trippodo & 
Frohlich, 1981), it is inevitable that differences exist.
Bearing these limitations in mind, the study o f any model o f naturally- 
occurring hypertension should provide useful and important information 
regarding primary hypertension in humans. Since both structural and 
functional factors are important in the hypertension o f humans and SHR, the 
SHR was considered to be an appropriate model for the study o f vascular 
reactivity in hypertension, a major focus o f this investigation.
This study demonstrated that the blood pressure o f the spontaneously 
hypertensive rats was indeed elevated in relation to the normotensive control 
strain, Wistar Kyoto (WKY), as measured by the tail cuff method. This 
method, which is non-invasive, produces a reliable measurement o f systolic 
blood pressure highly comparable to direct readings from the rat carotid artery 
(Bunag, 1973). This change in the resting blood pressure was associated with 
a number of interesting changes in the blood vessels.
Structural changes in blood vessels during hypertension
Aortic and tail artery rings from SHR were heavier than those from 
WKY, despite being cut to the same standard length, indicating a structural 
alteration. Transverse sections o f tail artery (proximal and distal) and aorta 
were then examined further using light microscopy.
There was no difference in the wall thickness o f the proximal tail 
artery from SHR and WKY rats, which was unexpected considering the 
increase in weight o f the SHR vessels. Moreover, the area o f the medial layer 
was actually reduced in proximal tail artery sections from hypertensive rats as 
compared to control. These observations are apparently conflicting, but may 
be explained if  there is an increase in the number o f cells within the same 
volume or area, i.e., an increase in tissue density. This suggestion is supported
by evidence from the photographs of the histological sections. The number of 
smooth muscle layers is increased in the proximal and indeed distal tail artery 
o f SHR compared to those o f WKY rats, and it appears that these cell layers 
are much more densely packed. It is therefore proposed that smooth muscle 
hyperplasia occurs in the tail artery o f spontaneously hypertensive rats, along 
the entire length o f the vessel. These results are consistent with previous 
observations that in a typical resistance vessel, increases in both the size and 
number o f  m yocytes contributes to the hypertrophy associated with 
hypertension (Mulvany, Baandrup & Gundersen, 1985; Lever, 1986; Lyall, 
Lever & Morton, 1988).
In this study, vessel thickening occurred in the aorta o f  SHR as 
compared to WKY, confirming the findings o f previous workers (Limas, 
Westrum & Limas, 1980). It was not possible to determine in this study if  the 
wall thickening in SHR aorta was due to hypertrophy or to hyperplasia. 
However, evidence in the literature indicates that aortic medial hypertrophy in 
SHR is due primarily to cellular hypertrophy rather than to hyperplasia 
(Owens, Rabinovitch & Schwartz, 1981; Owens, 1985; Owens, 1987).
An important structural feature o f blood vessels in hypertension is the 
ratio of the wall thickness to lumen diameter (W/r) (Folkow, 1978; 1982; 
1993). This study demonstrated that in the rat tail artery, the wall thickness to 
lumen ratio was increased in hypertensive animals compared to controls, 
along the entire length o f the vessel. In proximal regions this was a 
consequence o f  a reduced lumen diameter, while in distal regions, both vessel 
thickening and lumen reduction contributed to the increased W/r. This is in 
contrast to the aorta, where there was no difference in W/r between vessels 
from SHR and those from WKY, since wall thickness and lumen diameter 
both increased.
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The haemodynamic consequences o f alterations in the wall thickness 
to lumen diameter ratio become apparent when the law o f Laplace is 
considered (Folkow, 1993). According to Laplace's Law, the perfusion 
pressure in a blood vessel (P) is proportional to the wall tension (T) and wall 
thickness (W), and inversely proportional to the radius of the lumen (r), ie.
P = T x W/r.
Clearly then, when W/r is increased, there is an exaggerated increase 
in perfusion pressure for any given degree o f muscle contraction. The 
response o f a blood vessel to a given vasoactive stimulus can therefore be 
augmented by this structural amplification factor.
It is likely that such a change in the geometry o f a blood vessel will 
have a more profound effect on the response to a vasoactive agent if  measured 
as the change in perfusion pressure in a perfused vessel, rather than as the 
isometric tension change in an artery ring. In this study therefore, responses to 
NA were measured using these two different methods, to determine if  the 
technique used to record responses could affect the results obtained. This was 
indeed found to be the case, as will be demonstrated. Ring preparations were 
used for the most part however, as tension recording provides a more direct 
measure o f muscle contraction, uncomplicated by geometric factors.
Responses to vasoconstrictors and vasodilators in blood vessels during 
hypertension
This study demonstrated that blood vessels from rats which were 
genetically predisposed to have hypertension do indeed respond differently to 
both vasoconstrictors and vasodilators than do vessels from normotensive 
control animals. In addition, the type o f changes seen depend on which vessel 
is being studied. In the rat tail artery, there was an increase in response to the 
vasoconstrictors phenylephrine (PE), NA and UK-14,304 in SHR compared to
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WKY, while the responses to the vasodilators SNP and isoprenaline were 
decreased. In contrast, the opposite pattern was found in the aorta, where 
aortic rings from SHR were markedly less responsive to PE than were aortic 
rings from WKY rats. Responses to carbachol and to sodium nitroprusside 
were enhanced in aortic rings from SHR compared to control, while 
interestingly, there was no difference in isoprenaline-induced relaxation 
between the two groups of rat.
What are the possible explanations for the differences in the 
responsiveness both between the aorta and tail artery, and between vessels 
from hypertensive and normotensive animals?
The present experiments demonstrated that PE produced weaker 
contractions in aortic rings from SHR than in those from W KY. This is 
consistent with the results of several other studies, which have found impaired 
contractile responses to NA in aortae from SHR as compared to their WKY 
controls (Konishi & Su, 1983; Sim & Singh, 1987) and agrees with previous 
studies carried out in this laboratory (Morrison, 1988; Aidulis et al.. 1990). 
Interestingly, the latter two studies also showed a similar impairment o f KC1- 
induced contraction in aortic rings from SHR. KC1 contracts arteries by a non- 
receptor mechanism, depolarising the smooth muscle cell membrane and 
opening voltage-dependent calcium channels. The subsequent rise in 
intracellular free calcuim levels ([Ca2+]i) initiates the calcium-calmodulin 
cascade leading to activation o f the contractile proteins, and to blood vessel 
contraction.
It is therefore possible that the mechanism responsible, at least in part, 
for a reduced contraction in SHR aortae lies at a level distal to receptor 
stimulation.
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Evidence in the literature indicates that there is indeed a defect in the 
force generating ability of vascular smooth muscle from hypertensive animals, 
and that this is associated with vascular hypertrophy. Berner and co-workers 
(1981) described an increase in intermediate filaments in the rabbit portal- 
anterior mesenteric vein resulting from partial ligation o f the vein. This was 
accompanied by a decrease in the number and distribution o f  myosin  
filaments. It is conceivable therefore that the hypertrophic cells express 
different isoforms of contractile proteins, thus producing less maximal force. 
Alternatively, Papageorgiou & Morgan (1991) showed that in the aorta, 
hypertrophy was accompanied by the presence o f polyploidy and that 
maximal force generation was less than normal. Polyploid cells may possess 
unique physiological properties (Schwartz, Campbell & Campbell, 1986) 
which could account for the reduced force production o f hypertrophic smooth 
muscle.
In the present study on hypertension, tissue responses were corrected 
on a tissue weight basis. Hypertrophy however is not only associated with 
changes in contractile material but also with increased connective tissue or 
tissue water (Heagerty, Ollerenhaw & Swales, 1986). It is possible therefore 
that if  this correction were inappropriate, it may have contributed to the 
apparent reduction in the contractile response o f  aortic rings from SHR. This 
is unlikely however, as even before responses from SHR were divided by the 
increased tissue weight, the absolute tension developed was still less than that 
developed in WKY aortic rings.
The present investigation also showed that in the aorta, while the 
response to the vasoconstrictor PE was reduced in hypertension, the responses 
to vasodilators, both endothelium-dependent and directly-acting, were 
enhanced in the SHR. This increase in responsiveness applied only to
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vasodilators whose actions are mediated via cyclic GMP, i.e. carbachol and 
SNP, but not to isoprenaline, whose actions are mediated via cyclic AMP.
Carbachol is a cholinergic agonist less susceptible to breakdown by 
acetylcholinesterase than is the endogenous compound, ACh (Rang & Dale, 
1991). Carbachol relaxes blood vessels by the same mechanism as 
acetylcholine, which activates muscarinic receptors on the endothelial cells to 
liberate a compound identified as nitric oxide (NO; Palmer, Ferridge & 
Moncada 1987).
This labile substance diffuses to the vascular smooth muscle cells 
where it activates the soluble enzyme guanylate cyclase (Dinerman, 
Lowenstein & Snyder, 1993). This increases synthesis o f cyclic GMP, which 
relaxes the smooth muscle by a number o f mechanisms ( Dinerman, 
Lowenstein & Snyder, 1993).
The results of the present study, where responses to the endothelium- 
dependent vasodilator carbachol were enhanced in the aorta of SHR, do not 
agree with previous studies which showed that endothelium-dependent 
relaxations were impaired during chronic hypertension (Lockette, Otsuka & 
Carretero, 1986; Luscher & Vanhoutte, 1986). Indeed, the latter study 
described a vasoconstrictor substance, possibly prostanoid in origin, released 
from aortic endothelial cells in the SHR in response to ACh (Luscher & 
Vanhoutte, 1986). There was no evidence o f such an endothelial-derived 
constricting agent released in response to carbachol in this study. It is not clear 
why the results of the present study differ from the findings o f previous work 
(Lockette, Otsuka & Carretero, 1986; Luscher & Vanhoutte, 1986), as all 
these investigations involved the same blood vessel, the aorta, and one model 
o f hypertension, the SHR. However, it is possible that other differences in the 
experimental design of the studies may account for the different results. For 
exam ple, Luscher and Vanhoutte (1986) reported a reduced maximum
contraction in response to NA in aortic rings from SHR compared to those 
from WKY, agreeing with the findings o f the present study. However, for 
relaxation studies these workers then precontracted aortic rings from SHR and 
WKY to the same absolute level (1.4g), then carried out concentration - 
response (relaxation) curves to ACh. Consequently, aortic rings from SHR 
were precontracted to 50% of their maximal response to NA, whereas those 
from WKY were precontracted to only 25% of their maximal response. It may 
therefore have been more difficult for ACh to overcome a relatively greater 
contraction in the SHR, leading to a reduced ACh response for this reason. In 
the present study such a situation did not arise because tissues were always 
precontracted to 75% of the maximal contractile response to PE, obtained in 
each individual tissue.
This study demonstrated that cyclic GMP-mediated relaxations are 
enhanced in aortic rings from SHR. In addition, endothelial disruption has 
been reported to produce greater potentiation of NA-induced vasoconstriction 
in vessels from deoxycorticosterone acetate (DOCA)-hypertensive rats than in 
normotensive controls (King & Webb, 1988), implying that the ability o f the 
endothelium to limit vasoconstriction is enhanced in the DOCA form of 
hypertension. Clearly then, the generalisation that dilator responsiveness is 
impaired in hypertension (Webb, 1984) is not valid. An earlier study in this 
laboratory (Morrison, 1988) showed that relaxations to SNP at the higher end 
o f the concentration-response curve were enhanced in aortic rings from SHR 
compared to those from WKY rats, agreeing with the results o f  the present 
investigation. Furthermore, Morrison (1988) also showed that this enhanced 
relaxation was associated with increased cyclic GMP levels in response to 
SNP in the SHR. It is possible therefore that SHR aortae have an enhanced 
ability to accumulate cyclic  GMP, and that increased levels o f  this
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biochemical second messenger may underlie the enhanced mechanical 
response to nitrovasodilators in aortic rings from SHR.
An interesting study by Moncada et al.. (1991) demonstrated increased 
nitrovasodilator-stimulated relaxations and cyclic GMP levels in rat 
vasculature, both in vivo and in vitro, following endothelial denudation or 
treatment with inhibitors o f  NO synthase. Furthermore, response to 
isoprenaline or to 8-bromo-cyclic GMP were unchanged following these 
procedures. The authors concluded that a specific supersensitivity to 
nitrovasodilators developed after the removal o f endogenous NO. It is 
tempting therefore to speculate on the role o f this phenomenon in 
hypertension. If diminished NO occurs in hypertension (Dinerman, 
Lowenstein & Snyder, 1993) then soluble guanylate cyclase, the intracellular 
"receptor" for NO (Moncada, Radomski & Palmer, 1988), may become up- 
regulated. Such a situation would be analogous to the post-junctional 
supersensitivity o f denervated tissues (Cannon & Rosenblueth, 1949), 
observed after removal of a basal mediator tone. This would be consistent 
with the findings of the present study, where only relaxations to SNP and to 
carbachol, but not to isoprenaline, were enhanced in aortic rings from SHR 
compared to those from WKY.
The rat tail artery was used in this investigation as an example o f a 
resistance vessel, and it was found that the pattern o f response to vasoactive 
agents in hypertension in this vessel was the opposite o f that obtained in the 
aorta. In the rat tail artery, mechanical responses to the vasoconstrictors NA  
and PE, and to a lesser extent U K -14,304, were increased in the SHR 
compared to control. However, relaxations to the vasodilators SNP and 
isoprenaline were reduced in vessels from hypertensive rats compared to 
control.
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An important observation of this study, which must be borne in mind 
when interpreting the results, was that all rat tail artery rings were 
endothelium-denuded, as indicated by the lack o f response to the endothelium- 
dependent vasodilator carbachol (Figure 26b). This was found in tail artery 
rings from both hypertensive and normotensive rats, and presumably was a 
consequence o f the small size o f the vessel, where the insertion o f two wires 
into the lumen resulted in substantial endothelial damage despite careful 
dissection. Alternatively, or in addition, the presence o f wires in the lumen 
may have reduced the access o f drugs to the endothelial layer while leaving 
access to the muscle layers unaffected, but this is unlikely. It may therefore 
have been better to carry out this part o f the study on a myograph, rather than 
in a 25ml organ bath, as the insertion o f much finer wires (40fim diameter) 
into the vessel lumen would have permitted investigation o f endothelium- 
dependent responses in a Vessel o f this size.
There have been studies on the effects o f vasoconstrictors, mainly NA, 
in tail arteries from spontaneously hypertensive rats. Unfortunately, many 
different experimental protocols have been used (helical strips, perfused 
segments and ring preparations), in the absence and presence o f drugs which 
inhibit various adrenergic and non-adrenergic processes (cocaine, 6 - 
hydroxydopamine (6 -OHDA), propranolol, indomethacin). Consequently, the 
results in the literature encompass both an increased (Medgett, Hicks & 
Langer, 1984) or decreased (Webb, Vanhoutte & Bohr, 1981) maximum  
response to NA in the tail artery o f the SHR. Similarly, the EC50 for NA has 
been reported to be increased (Mulvany et al... 1982), reduced (Hermsmeyer, 
1976) or unchanged (Fouda et al... 1987) in the isolated tail artery o f SHR 
compared to WKY.
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Pari of the present study was therefore designed to illustrate how the 
way in which an experiment is carried out can influence the results obtained. 
It was shown that in the rat isolated tail artery the increase in isometric tension 
in response to NA was greater in artery rings from SHR compared to those 
from WKY. However, when tension responses were expressed as a percentage 
o f the maximum, this difference disappeared, giving identical concentration- 
response curves for SHR and WKY . This observation indicates that the 
adrenoceptor affinity for NA in the rat tail artery is unchanged in the SHR. 
When responses to NA were measured as increases in perfusion pressure 
following lumenal perfusion of NA, the response to the highest concentration 
o f  NA was much greater in SHR compared to WKY. Consequently, when 
these values were expressed as a percentage o f the maximum response 
achieved, the concentration-response curve for SHR lay to the right o f that for 
WKY. Careful interpretation o f this result is therefore required, as this would 
seem to indicate subsensitivity to NA in the SHR, but it merely reflects that 
the response in the SHR is a much smaller fraction o f an increased maximum 
response in the perfused vessel, which is perhaps amplified by structural 
alterations leading to an increased wall-to-lumen ratio.
In this study, the increased contractile response to PE and NA in rings 
o f rat tail artery from SHR was associated with an increase in the maximum 
response compared to control. This is therefore suggestive o f a change beyond 
agonist-receptor interaction. Such a distal event may be PI hydrolysis, since 
this second messenger pathway is known to exist in the rat tail artery where 
both NA and adrenaline caused an increase in [3-H ]-inositol phosphate 
accumulation (Fox, Abel & Minneman, 1985; Nally, 1990).
This study demonstrated that NA produced a concentration-dependent 
increase in PI hydrolysis in tail arteries from both hypertensive and control 
rats. In addition, NA was shown to produce a greater stimulation o f PI
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hydrolysis in SHR compared to WKY, at a concentration (1 0 ‘5M) which 
produced an increase in the contractile response in tail artery rings from 
hypertensive rats relative to control. Furthermore, unstimulated, basal levels 
o f inositol phosphates were enhanced in SHR relative to control. Indeed, it has 
been shown that the activity o f phospholipase C, the enzyme which cleaves 
PtdInsP2 and initiates the cycle o f inositol phosphate hydrolysis, is enhanced 
in the vascular wall of SHR (Uehara et al... 1988).
It seems likely therefore, that increased (basal and stimulated) PI 
hydrolysis has a role in the vascular abnormalities associated with 
hypertension. In addition to the increased InsP3 produced, which liberates 
Ca2+from intracellular stores (Berridge, 1987) and may therefore mediate 
enhanced contraction, concomitant raised DAG levels may have a role in the 
vascular hypertrophy associated with hypertension (Marin, 1993). Aalkjaer 
(1990) showed that protein kinase C stimulation by DAG activates Na+ - H+ 
exchange on the vascular smooth muscle membrane, increasing cell alkalinity. 
This rise in intracellular pH is thought to be a stimulus for cell growth (Owen, 
1984), and it has recently been shown that activity o f the Na+ - H+ antiporter 
is increased in cultured vascular smooth muscle cell from stroke-prone SHR 
(Kobayashi et al... 1990). Therefore, increased membrane phosphoinositide 
hydrolysis may be involved in both the increased contractile responses and 
vascular hypertrophy in hypertension observed in this study.
It is important to note however, the temporal characteristics o f the 
increased PI response. Heagerty, Ollerenshaw & Swales (1986) showed that in 
rat aorta from 5-week old SHR, both basal and NA (10-4 M)-stimulated [3H]- 
inositol phosphate accumulation were enhanced relative to WKY, but by 19 
weeks basal levels were similar, whereas NA-stimulated accumulation was 
reduced in SHR aortae relative to WKY. It was proposed that increased PI
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hydrolysis is an important signal in the early stages of hypertension (Heagerty, 
Ollerenshaw & Swales, 1986; Maclver et al.. 1993). In addition, different 
patterns o f PI hydrolysis in hypertension may occur, depending on the type of 
blood vessel (Vila, MacRae & Reid, 1991, Maclver et al.. 1993) or model of 
hypertension studied (Maclver et al.. 1993).
Compared to the a  j-adrenoceptor agonists NA and PE, there is little 
evidence available concerning the action o f  a 2-adrenoceptor agonists on PI 
hydrolysis. In the present study, the increased mechanical response to the 
alpha2-agonist U K -14,304 in tail artery rings from SHR compared to those 
from WKY was less marked than the increase observed with NA or PE. 
Indeed, the apparent enhanced response to U K -14,304 in SHR tail artery rings 
disappeared when the increase in tissue weight in hypertension was accounted 
for. Furthermore, previous work in this laboratory (Dowell, 1990) showed that 
there was no difference in the contractile response to KC1 in tail arteries from 
SHR and WKY rats, following correction for the increased tissue weight in 
SHR.
In the present investigation therefore, combining evidence from 
histological, biochemical and mechanical studies, the following hypothesis is 
proposed; that the increased contractile response to adrenergic agonists in tail 
artery rings from SHR can be explained, at least in part, by a combination of 
changes in vascular structure and an enhancement o f the second messenger 
system underlying ai-adrenoceptor-mediated contraction, i.e. PI hydrolysis.
The present study showed that, in contrast to the rat aorta, two 
vasodilators with different mechanisms o f action (SNP and isoprenaline) had a 
reduced ability to relax tail artery rings from SHR compared to those from
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WKY. SNP is metabolically degraded within the vascular smooth muscle cell 
to liberate NO, which raises cyclic GMP levels by direct activation o f soluble 
guanylate cyclase. Isoprenaline increases cellular cyclic AMP via activation of 
62-adrenoceptors on the smooth muscle cell membrane leading to adenylate 
cyclase stimulation.
Defects at any level in the pathways o f the generation or effects of  
these cyclic nucleotides are possible, and have not been described specifically 
for the rat tail artery in the literature as yet. A study by Silver, Michalak & 
Kocmund (1985) o f several rat blood vessels found that in the rat tail artery, 
basal protein kinase A (PKA) activity was found to be similar between SHR 
and WKY rats. Unfortunately however, the study did not measure either 
relaxation or PKA activity stimulated by isoprenaline or forskolin in the rat 
tail artery. The present study therefore is important as it represents one of the 
first reports concerning relaxation o f the rat tail artery, and in particular, the 
impaired relaxation o f a resistance vessel in hypertension.
An interesting observation in the present investigation was that 
isoprenaline was unable to completely relax tail artery rings from both 
hypertensive and normotensive rats. The endothelium-dependent vasodilator, 
carbachol, was unable to relax vessels from either group o f rat, suggesting that 
these preparations were endothelium-denuded. The results with isoprenaline 
may be connected to this observation.
Recent studies in conduit arteries support a role for the endothelium  
and NO in B-adrenoceptor-mediated relaxation (Kamata, Miyata & Kasuya, 
1989; Gray & Marshall, 1991), but there is some disagreement (Moncada et 
al, 1991). A detailed study in rat mesenteric resistance arteries however, 
revealed that in this vessel, Bi-adrenoceptor activation causes relaxation via  
NO release from the endothelium (Graves & Poston, 1993). It is possible 
therefore, that the failure o f isoprenaline to fully relax PE-constricted tail
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arteries from SHR and WKY resulted from endothelial damage during tissue 
manipulation, and consequent removal o f a putative site o f action for 
isoprenaline.
SNP-induced relaxation o f  SHR tail artery rings was reduced 
compared with rings from WKY. In the aorta the opposite pattern was shown 
and it was suggested that the increased responsiveness to SNP in SHR may 
have been due to increased sensitivity o f guanylate cyclase. Clearly then, if  
such a phenomenon exists, it may be vessel-specific, with not all vascular 
beds becoming supersensitive to NO in hypertension.
In any case, it appears that relaxation in the rat aorta and tail artery are 
differently affected in hypertension, as is the vasoconstriction. This is perhaps 
not surprising when the different natures of these vessels are considered. The 
aorta is a large elastic artery specialised for conducting blood flow. The tail 
artery of the rat is a much smaller vessel, specialised for contracting, and is 
highly innervated. Although some workers consider the tail artery as a conduit 
vessel, it is clearly regulated differently from the aorta in hypertension, and is 
certainly more representative of a resistance vessel than the aorta.
In summary, this study showed that in SHR compared to WKY, aortic 
rings were less responsive to vasoconstrictors, but more responsive to 
vasodilators. The rat tail artery however, was more responsive to 
vasoconstrictors, primarily those which activate PI hydrolysis, and showed a 
reduced ability to relax. In addition, although vessel thickening was observed 
in SHR aortae, an increase in the wall to lumen ratio was only observed in the 
tail artery from SHR. Thus, it appears that the changes which occur in the tail 
artery in hypertension are consistent with mechanisms which are associated 
with an increase in peripheral resistance and hence blood pressure.
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3. RESPONSES TO FIELD STIMULATION AND VASOCONSTRICTORS 
IN TAIL ARTERIES FROM RATS OF DIFFERENT AGES
Preliminary experiments with normotensive Wistar rats o f different 
ages demonstrated that there was a positive correlation between rat age and 
weight, and that systolic blood pressure tended to increase with age. This 
latter observation was not statistically significant, but it is likely that a greater 
separation o f age groups or a larger population would have yielded a 
significant correlation. Indeed, in most large scale studies o f the human 
population, systolic blood pressure tends to increase with age throughout life 
(Robertson, 1989).
Initial experiments suggested that isolated, perfused tail arteries from 
older rats were more responsive to exogenous NA than were vessels from 
younger rats (Figure 5). It is possible that this may reflect a thickening o f the 
vascular walls, which is known to occur with ageing in rats (Docherty, 1990). 
However, this is unlikely since there was no difference in responsiveness 
when tail arteries were cannulated at both ends and perfused with NA (Figure 
7>*
The possibility that the route o f administration o f exogenous NA may 
have led to a difference in response between vessels from older and younger 
rats was considered. In the first set o f experiments (when responses from older 
rats were greater than those from younger rats), tail arteries were cannulated at 
one end and the NA solution, which was perfused luminally, was allowed to 
superfuse over the muscle surface. In such a situation, the NA would perhaps 
be more susceptible to neuronal uptake than when a second cannula carried 
the perfusing NA out o f the organ bath without allowing superfusion. If 
uptake 1 decreases with age, a reduction in this inactivation mechanism for
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NA may therefore partly explain the increase in response in older animals. 
Although the evidence for a decline in neuronal uptake with age is equivocal 
(Docherty, 1990), there is evidence that in the rat tail artery, the uptake 
blocker cocaine had a reduced ability to potentiate responses to adrenergic 
nerve stimulation in ageing (Duckies, 1987), indicating reduced uptake. This 
might also explain the observation in this study that a greater response to field 
stimulation was obtained in tail arteries from older rats compared to responses 
in those from younger rats.
When the single cannulation experiment was repeated to investigate 
this phenomenon further, surprisingly there was now no difference in the 
response to exogenous NA with age (Figure 11). There was however a small 
difference in the set-up, as an additional heating coil was introduced between 
the NA reservoir and the cannula. It is known that temperature can influence a 
number o f processes involved in vascular control, for example in the dog 
saphenous vein, increases in a 2-adrenoceptor- and ATP-mediated constriction 
were shown when the temperature was reduced from 37°C to 24°C. (Flavahan 
and Vanhoutte, 1986). In addition, some o f these processes are affected by 
age, for example both pre- and post-junctional (X2-adrenoceptor-mediated 
effects decrease with age in the rat tail artery (Buchholz et al.. 1992).
However, it is unlikely that the addition o f  a heating coil to the 
perfusing NA solution created a temperature difference sufficient to account 
for the experimental result, especially since each preparation was in a Krebs- 
filled organ bath maintained at 37°C.
Caution must therefore be exercised in interpreting these results, and 
although a number o f interesting observations have been made, no firm 
conclusions can be drawn from these experiments on the effects o f age on 
vascular control.
4. a l p h a 2- a d r e n o c e p t o r - m e d i a t e d  c o n t r a c t i o n s  in
VASCULAR SMOOTH MUSCLE
The involvement o f post-synaptic a 2-adrenoceptors in the regulation 
of the responsiveness of vascular smooth muscle is an area o f research which 
has generated increasing interest over the last few years. As both a i-  and a 2- 
adrenoceptors can mediate vasoconstriction in most vascular beds 
(Timmermans, Chiu & Thoolen, 1987), much o f the interest has focused on 
possible alterations in receptor number and affinity in hypertension. However, 
the evidence to date has been unconvincing (Michel, Brodde & Insel, 1990; 
Marin, 1993). Using EC50 concentrations for NA, PE and U K -14,304 as an 
index of adrenoceptor affinity, the present study showed no evidence of 
altered adrenoceptor number or affinity in either the aorta or tail artery from 
hypertensive rats as compared to control. In addition, the a 2-adrenoceptor 
antagonist, yohimbine, produced rightward shifts o f the lower end o f the UK- 
14,304 concentration-response curves in both SHR and WKY rat tail arteries, 
indicating that contractions to the lower concentrations o f U K -14,304 were 
indeed mediated by a 2-adrenoceptors. However, the rightward shifts were of 
equal magnitude between the two groups o f  rat, suggesting no altered a 2- 
adrenoceptor density or affinity in hypertension.
In this study, experiments in normotensive Wistar rats with the a 2- 
adrenoceptor agonist clonidine, and the more selective compound U K -14,304, 
revealed that the rat tail artery contracted in response to these agents in a 
concentration-dependent manner. However, in the proximal tail artery, only 
the responses to low (< 10-7M) concentrations o f clonidine were reduced by 
the a 2-adrenoceptor antagonist yohimbine. In distal segments o f the vessel, 
U K -14,304 produced a biphasic curve. This became monophasic in the
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presence of yohimbine, which markedly reduced the lower part o f the curve, 
and resembled the control U K -14,304 concentration response curve o f  the 
proximal tail artery. These results are similar to findings in the dog mesenteric 
vein, where U K -14,304 produced a biphasic concentration-response curve, the 
lower end o f which was blocked by the ot2-adrenoceptor antagonist 
rauwolscine (Shimamoto et al.. 1992). Hence, it seems likely that only 
contractions to low concentrations o f  U K -14,304 are mediated via  a?-  
adrenoceptors in the rat tail artery. This may be explained by binding studies 
in the dog mesenteric vein, which revealed that UK -14,304 exhibited a 10-fold 
difference in affinity for displacing [3H]- rauwolscine or [3H]-prazosin from 
membranes (Daniel et al.. 1991). Thus, U K -14,304 in higher concentrations 
can bind to ai-adrenoceptors. However, the ot2- vs. o ti-ad ren ocep tor  
selectivity o f U K -14,304, as demonstrated in a variety of functional in vitro 
assays, is much higher than the 10-fold difference detected by the radioligand 
binding experiment (Shimamoto et al.. 1992). U K -14,304 can therefore be 
regarded as a potent and selective a 2-adrenoceptor agonist (Cambridge, 1981).
It is noteworthy that in the present study, U K -14,304 was more potent 
in distal regions o f  the rat tail artery than in more proximal sections, with a 
threshold o f 0.1 nM in distal compared to a 3-10nM in proximal regions. This 
is in agreement with a previous report in the rat tail artery which showed that 
adrenaline was more potent in distal than in proximal segments. In addition, 
the 012-adrenoceptor antagonist idazoxan was more effective in distal than in 
proximal regions against adrenaline-induced constriction (Rajanayagam & 
Medgett, 1987). Therefore, it is likely that smooth muscle ot2-adrenoceptors 
are more prevalent in the distal than in the proximal end o f the rat tail artery. 
This may have functional significance in the thermoregulatory properties o f  
the rat tail, where cooling has been shown to enhance oc2-adrenoceptor- 
mediated constriction (Harker et al.. 1991). Such a receptor distribution would
favour constriction of the more distal regions o f the vascular bed in response 
to a drop in temperature, thus conserving heat nearer to the body.
Potentiation o f  alpha2 -adrenoceptor-mediated contractions in the rat tail 
artery
It is only relatively recently that ot2-adrenoceptors have been accepted 
as mediators o f vascular smooth muscle contraction. This has partly arisen 
because these receptors have often proved to be "elusive" and evidence for 
their existence is derived from functional studies, in which various techniques 
have been used to "uncover" them. For example, in the rabbit saphenous 
artery, (X2-adrenoceptor-mediated responses were only revealed when the 
vessel was stimulated with an agonist which acted via a different receptor 
system (Dunn, McGrath & Wilson, 1991). These observations raise several 
questions, especially about what the term "uncover" means. For example, are 
ot2-adrenoceptor recognition sites literally uncovered by these treatments, or 
are they present in the membrane but normally not coupled to the intracellular 
mechanism, through which they operate, until [Ca2+]i is raised? A third 
possibility is that these receptors are normally present in the membrane and 
are coupled, but special conditions are required to demonstrate their existence 
and functional capacity. This study examined the third possibility and 
considered the conditions required to "uncover" the (X2-adrenoceptor-mediated 
contractile mechanism in the rat tail artery.
An experimental protocol was established, based on previous 
investigations which had revealed ot2-adrenoceptor-mediated responses 
following vascular preconstriction (Templeton, 1988; Templeton et al. 1989; 
MacLean & McGrath, 1990). The present study investigated whether the 
ability o f  a contractile agonist to enhance a 2-ad ren ocep tor-m ed iated
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contractions was determined by its mechanism of action. It was shown that 
responses to low concentrations of clonidine (lOnM) or to U K -14,304 (50nM) 
were enhanced in the presence o f AVP, PE or 5-HT, agonists known to 
increase [Ca2+]i by causing PI hydrolysis (Cobbold et al.. 1990). However, 
responses to clonidine (lOnM) were also enhanced in the presence o f KC1, 
which depolarises vascular smooth m uscle cells  causing Ca2+ entry. 
Therefore, stimulation o f the PI cycle by a precontracting agonist is not 
essential in producing enhanced a 2-adrenoceptor-mediated responses. This 
finding is consistent with a previous report on the rat tail artery, where 
contractions to the (X2-agonist B-HT 920 were augmented in the presence of 
either KC1 or prostaglandin F2tt (Harker et al.. 1991).
It must be noted however, that an important difference exists between 
the present study and -previous reports concerning (X2-ad ren ocep tor  
"uncovering" in blood vessels. That is, in the present study, preconstriction 
was relaxed by a vasodilator before addition o f the <X2-agonist to the tissue. 
The working hypothesis underlying this protocol was based on the finding that 
in a wide variety o f tissues (platelets, neuroblastoma cells, renal cortex cells, 
pancreatic islet B-cells), inhibition of adenylate cyclase has been proposed as 
the primary a 2-adrenoceptor coupling mechanism (Ruffolo et al.. 1991). 
Clearly then, the capacity o f  clonidine or U K -14,304 to activate 0C2- 
adrenoceptors would be more apparent if  adenylate cyclase was stimulated. 
Studies have shown that adenylate cyclase can be activated by Ca2+ (Harrison, 
Hewlett & Gnegy, 1989). It is possible then that during the precontraction, 
which elevates intracellular Ca2+ levels, adenylate cyclase is activated. This 
therefore would provide an opportunity for an <X2-adrenoceptor agonist to 
exert its effect in inhibiting the enzyme and may partially explain why 0 .2 - 
adrenoceptor-m ediated contractions are better observed fo llow ing  
preconstriction. In this investigation, IBMX was used to amplify the adenylate
cyclase/cyclic AMP-mediated inhibitory mechanism, by inhibition o f cyclic 
nucleotide phosphodiesterase.
IBMX however is a relatively non-specific compound, as it inhibits the 
phosphodiesterases which metabolise cyclic GMP as well as cyclic AMP, and 
possesses a number o f other actions unrelated to its phosphodiesterase 
activity, such as inhibition o f agonist-induced prostaglandin synthesis (Spry e l 
al, 1985). Subsequent experiments revealed that responses to UK -14,304 were 
also enhanced following AVP-induced preconstriction which was relaxed by 
more specific agents. These were forskolin, which activates adenylate cyclase 
(Seamon & Daly, 1983), SNP, which activates guanylate cyclase following 
metabolic activation to NO in vascular smooth muscle (Kowaluk, Seth & 
Fung, 1992), and the stable, cell-permeant cyclic AMP analogue, dibutyryl 
cyclic AMP.
The results of the present study suggest that, in the described protocol, 
the effect o f (X2-receptor stimulation is to reverse the effect of the vasorelaxant 
used to inhibit the precontraction. Knowing the mechanism of action o f the 
vasodilator, whose effects were shown to be reversed by clonidine or UK- 
14,304, may therefore provide information on the mechanisms stimulated by 
ot2-receptor activation.
It is clear from these results therefore that the enhanced responses to 
clonidine and to UK-14,304, obtained in the presence o f AVP and any one of 
these vasorelaxants, does not simply result from inhibition o f adenylate 
cyclase via 0C2-receptors. This is because clonidine and U K -14,304 reversed 
the effects of vasodilators which do not rely on adenylate cyclase activation to 
relax blood vessels. The reversal o f forskolin-induced relaxation by UK- 
14,304 is consistent with inhibition o f adenylate cyclase by ot2-adrenoceptor 
stimulation. It does not however rule out the possibility that U K -14,304 
opposed the effects of the cyclic AMP synthesised during forskolin-induced
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adenylate cyclase activation. The results with dibutyryl cyclic AMP indicate 
that ot2-adrenoceptor stimulation can indeed oppose the effects o f cyclic AMP, 
rather than (or in addition to) its synthesis. In addition, results with SNP, the 
guanylate cyclase activator, indicate that a 2-adrenoceptor activation can 
reverse either the synthesis, or more likely the effects, o f cyclic GMP.
To understand how a 2-adrenoceptor activation may reverse cyclic 
nucleotide-mediated relaxation in the rat tail artery, it is important to 
understand how the cyclic nucleotides can cause vascular smooth muscle 
relaxation. Currently, cyclic GMP is thought to relax muscle by reducing 
[Ca2+]i, via activation o f PKG, but the mechanism by which PKG acts is still 
not understood (Lincoln & Cornwell, 1993). Mechanisms which have been 
reported include (1) Inhibition o f InsP3 generation (Rapoport, 1986); (2) 
stimulation o f intracellular Ca2+ sequestration (Lincoln, 1983); (3) Reduced 
phosphorylation of myosin light chain (Rapoport, Draznin & Murad, 1983); 
(4) Inhibition o f voltage- and receptor- operated Ca2+ channels (Godfraind, 
1986; Lincoln, 1989); (5) stimulation o f membrane Ca2+-ATPase (Fiscus, 
1988) and (6 ) increase o f K+ permeability through K+ channels causing 
membrane hyperpolarisation (Komori & Suzuki, 1987; Lincoln & Cornwell, 
1993).
Many o f these actions are similar to, or shared by, the actions o f cyclic 
AMP in relaxing vascular smooth muscle. This is perhaps not surprising when 
it is considered that, in addition to activating PKA, cyclic AMP can also 
activate PKG under physiological conditions (Jiang et al.. 1992; Lincoln & 
Cornwell, 1991). It is likely that cyclic AMP regulates smooth muscle 
relaxation, at least in part, by activating PKG.
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How then can a 2-adrenoceptor activation reverse the powerful 
relaxations induced by cyclic nucleotides in the smooth muscle o f the rat tail 
artery? Little is known about 012-adrenoceptor coupling in the vasculature to 
date (Aburto, LaJoie & Morgan, 1993). Although inhibition o f adenylate 
cyclase has been demonstrated in many cell types following (X2-receptor 
activation (Ruffolo et al.. 1991), this mechanism does not explain many o f the 
physiological effects of ot2-receptor stimulation (Aburto, LaJoie & Morgan, 
1993). Other signal transduction pathways for a 2-adrenoceptors include 
mobilisation of intracellular Ca2+ (Nielsen et al.. 1992; Michel et al.. 1989), 
modulation o f Ca2+ channels and Ca2+ influx (Timmermans * Chiu & Thoolen, 
1987; Daly et al.. 1990) and activation o f the Na+-H+ antiporter (Limbird, 
1988). This latter effect has been shown to increase vascular tone by a Ca2+- 
dependent mechanism (Marin, 1993). Such mechanisms activated by <X2- 
adrenoceptors could conceivably cause contraction, and have the potential to 
oppose the inhibitory mechanisms o f the cyclic nucleotides. It must be 
remembered however that in the present study, rat tail artery rings were first 
precontracted; both processes, contraction and relaxation, must be considered 
together in producing the conditions required to reveal 0C2-adrenoceptor- 
mediated responses.
Several observations in this study showed that the potentiated 
responses to the (X2-agonist were dependent on the initial precontraction. 
Firstly, positive correlations were demonstrated between the size o f  the 
response to the precontracting agonist (AVP, PE or KC1), and the size o f  the 
enhanced response to clonidine or U K -14,304 obtained in the presence o f  the 
precontracting agonist and IBMX. Secondly, the size o f  the enhanced (X2- 
mediated response decreased as the time between vessel pretreatment (AVP 
and IBMX) and UK-14,304 addition increased; this was strongly paralleled by 
the reduction in the response to AVP alone with time. Finally, the enhanced
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responses to U K -14.304, obtained in the presence of a precontracting agonist 
(AVP, PE or 5-HT) and IBMX, were abolished by an antagonist selective for 
the precontracting agent (MC-AVP, prazosin, or ketanserin, respectively). 
This is similar to an observation by Zimmerman & Kraft (1979), who found 
that the facilitatory effect o f A ll on 012-adrenoceptor responses in the rabbit 
isolated saphenous vein was blocked by the A ll receptor antagonist, saralasin.
An important finding o f this study is that raised tone per se is not 
necessary for the "uncovering” o f post-junctional (X2-adrenoceptors, since (X2- 
stimulation produced a large response when vasodilators (IBMX, forskolin, 
SNP or dibutyryl cyclic AMP) reduced the A VP-induced tone to basal levels.
Several studies have demonstrated that 0C2-receptor mediated responses 
were unmasked following elevation o f vascular tone (Furuta, 1988; Templeton 
et al.. 1989; MacLean & McGrath, 1990). However, post-junctional (X2- 
receptor-mediated contractions have also been revealed in the presence o f  
concentrations o f agonists which did not cause contraction by themselves 
(Sulpizio & Hieble, 1987; Dunn, McGrath & Wilson, 1989). Therefore, it 
seems that the conditions currently operating within the vascular smooth 
muscle cell are more important than the absolute level o f tone produced. 
Vascular tone is a net result o f the sum o f positive and negative influences. It 
would appear that, following the protocol o f the present study, the vascular 
smooth muscle cell is "primed", with excitatory and inhibitory mechanisms in 
balance, and that this balance is upset by the stimulation o f a 2-adrenoceptors. 
It may be that the "potentiators" in this and other studies produce a particular 
pattern o f effects on the signalling process which selectively synergises with 
the coupling involved in a 2-adrenoceptor-activated processes.
Several pieces o f evidence from this study demonstrated that the 
enhanced contractions to clonidine or to U K -14,304 were mediated by
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adrenoceptors o f the 012-subtype. Low concentrations of clonidine (lOnM) and 
U K -14,304 (50nM) were used which were sub-threshold or just threshold for 
contraction, and which lay on the yohim bine-sensitive part o f the 
concentration-response curve. Therefore, the large contractions observed 
following pretreatment were unlikely to have been due to a non-selective a i-  
adrenoceptor stimulation. In addition, all enhanced responses were inhibited 
by a low concentration o f yohimbine (50nM) likely to be selective for (X2- 
adrenoceptors. Moreover, even if  clonidine or U K -14,304 did act on oti- 
adrenoceptors, the enhanced response was unaffected by prazosin, showing 
the potentiation to be mediated by 012-adrenoceptors. The only case where the 
enhanced response to U K -14,304 was prazosin-sensitive, was when the 
precontracting agonist was PE. Furthermore, responses to the oti-adrenoceptor 
agonist phenylephrine were not potentiated in the present investigation. This 
finding agrees with the results o f Templeton et al. (1989), who demonstrated 
that responses to UK -14,304, but not those to PE, were enhanced following 
AVP-induced preconstriction in the rat tail artery. Indeed, several other studies 
support a preferential interaction between A ll and responses mediated via  
post-junctional ct2-adrenoceptors rather than ai-adrenoceptors (Schumann & 
Lues, 1983; Dunn, McGrath & Wilson, 1991; Dunn et al.. 1991a).
An interesting study by Xiao and Rand (1989) revealed that 
vasoconstrictor responses in the rat tail artery to AVP, KC1, NA and PE were 
enhanced by 012-adrenoceptor agonists. In addition, Shepperson (1984) 
demonstrated potentiation o f a PE-induced contraction by U K -14,304 in a 
non-vascular smooth muscle preparation, the nictitating membrane o f the cat. 
Evidently then, the ability o f an agonist response to be potentiated does not 
depend on its ability to stimulate (X2-receptors.
Indeed, these findings prompt a new or alternative interpretation o f the 
results in the present study. In this study, responses to AVP, 5-HT, PE and
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KC1 were inhibited by vasorelaxants, i.e. responses to the agonists at this point 
were minimal. Subsequent stimulation of a 2-adrenoceptors (by clonidine or 
U K -14,304) then produced a large contraction which was sensitive to an 
antagonist o f the precontracting agent. It could be argued therefore that 
stimulation o f a 2-adrenoceptors potentiated the response to the precontracting 
agonist, which was minimal in the presence o f the vasorelaxant. It is possible 
therefore that the enhanced response, which was certainly triggered by (X2- 
receptor activation, was a continuation of the precontraction, which had been 
"interrupted'' by the vasorelaxant.
Because o f the apparently reciprocal nature o f the potentiation, it is 
probable that the two receptor types involved reside on the same cells, and 
interact at the level o f a common post-receptor site in the events leading to 
contraction. A mechanism which is becoming increasingly recognised as 
important in ot2-receptor-mediated signal transduction is the influx o f  
extracellular Ca2+ (Aburto, LaJoie & Morgan, 1993; Daly et al.. 1990) via  
both dihydropyridine-sensitive and dihydropyridine-resistant Ca2+ channels 
(Dunn et al.. 1991b). It is perhaps not surprising therefore that such a wide 
variety o f agents, in the present study and in the literature (AVP, PE, 5-HT, 
KC1, NA, A ll, Bay K 8644) can potentiate (X2-adrenoceptor-m ediated  
contractions. All o f these agonists elevate intracellular Ca2+ levels by 
intracellular release and/or membrane translocation. The Ca2+ which enters 
the cell following ct2-receptor stimulation may then synergise with the Ca2+ 
raised by the agonists, to produce an enhanced activation o f the contractile 
proteins.
This proposal however is too general to explain why, for example, 
responses to PE cannot be potentiated by AVP (Templeton et al. 1989; present 
study). A further property o f  ot2-agonists is the ability to increase the Ca2+-
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sensitivity of the contractile apparatus in vascular smooth muscle (Aburto, 
LaJoie & Morgan, 1993). These authors showed that significantly elevated 
force could be maintained in the presence o f resting [Ca2+]i levels. It is 
possible therefore that in the present experiments, when resting tone (and 
presumably resting [Ca2+]i levels) was basal following preconstriction and 
relaxation, ot2-receptor activation increased the contractile apparatus 
sensitivity such that tone was restored. This would indeed imply that the 012- 
agonist enhanced the response to the precontracting agent, rather than the 
reverse. Sensitisation o f the contractile apparatus by ot2-receptor stimulation 
however does not explain why U K -14,304 or clonidine produced little or no 
contraction when added alone.
It seems then that the present explanations are insufficient to account 
for potentiation of a 2-adrenoceptor-mediated responses both in this study and 
in the literature. It is clear that synergy occurs between responses mediated by 
(X2-receptors and other receptor types. What is not evident as yet is exactly 
where this synergy occurs, in the pathways leading to vascular smooth muscle 
contraction.
This study has thus given an insight into the complex nature o f the 
regulation o f vascular smooth muscle by post-junctional (X2-adrenoceptors. 
The results emphasise the dynamic nature o f the events within the vascular 
smooth muscle cell, illustrating interactions involving a wide variety of agents 
to create conditions in the cell such that the final response is effected.
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5. NEUROTRANSMISSION IN THE RAT TAIL ARTERY
One o f the major vascular control systems addressed in this study was 
the nature o f the neurotransmission in the rat tail artery. This vessel receives a 
dense adrenergic innervation, but the question o f whether ATP functions as a 
co-transmitter together with the main transmitter NA in this vessel remains 
unresolved.
In this study, exogenous addition o f both NA and ATP produced 
contraction in the rat tail artery, fu lfilling one o f  the criteria for a 
neurotransmitter (Eccles, 1964) and confirming the findings o f other studies 
(Bao, Erikson & Stjame, 1989c; Bao, 1993; Dalziel et al.. 1990). Responses to 
exogenous NA and ATP were inhibited by prazosin and a ,P -M eA T P  
respectively, indicating that they were mediated via ai-adrenoceptors and P^- 
purinoceptors respectively. a,p-M eA TP produced an initial contraction as it 
is in fact a potent agonist. Its blocking action is thought to arise from 
desensitisation o f the P2*-purinoceptor (Meldrum & Burnstock, 1983; 
Sneddon & Burnstock, 1984b; Kennedy, Saville & Burnstock, 1986).
Electrical field stimulation produced a ffequency-response curve (0.1- 
40Hz) which appeared biphasic, reaching a plateau at 5-10 Hz, with responses 
increasing again at the higher frequencies, 20-40Hz. It is possible that this 
increased response at higher frequencies is due to an action by neuropeptide Y  
(NPY). NPY is often co-stored with NA in the large dense cored vesicles 
(LDVs) o f sympathetic nerve endings (Stjame, 1989), and can be co-released 
with NA by nerve stimulation (Lundberg et al.. 1984). NPY by itself produces 
little or no contractile response (MacLean & McGrath, 1990; Bao, 1993), but 
has been shown to potentiate the response to field stimulation at 20 Hz in the 
rat tail artery (Bao, 1993). In addition, there is some evidence that high-
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frequency stimulation favours the secretion of neuropeptide-containing 
vesicles (Stjarne, 1989). Unfortunately however, the lack o f antagonists 
specific for NPY to date meant that this possibility was not investigated 
further in the present study, and must therefore remain speculative.
Contractile responses to field stimulation at supramaximal voltage 
(50V) and 0.1ms pulse duration in tail artery rings from Wistar rats were 
shown to be abolished by TTX, confirming that responses were neurogenic in 
origin. Thus these stimulation parameters (50V, 0.1ms) did not result in direct 
activation o f the smooth muscle, and were used throughout the study.
Field stimulation-induced contractions were abolished at all 
frequencies (0.1-40Hz) by prazosin (0.1 pM), with no evidence o f  a residual 
response. In contrast, a,p-M eATP had no effect on any part o f the frequency- 
response curve. The possibility that P2*-receptors were not desensitised was 
ruled out by the observation that repeated addition o f a ,P -M eA T P  did not 
produce a response apart from the initial transient contraction, but subsequent 
frequency-response curves remained unaffected by a ,p -M eA T P . These 
results therefore suggest that the field stimulation-induced contraction in rat 
tail artery rings is mediated solely by NA acting on post-synaptic oii- 
adrenoceptors. However, experiments with a lower concentration o f prazosin 
(5nM), revealed a prazosin-resistant component, which was completely  
abolished by yohimbine (50nM), indicating the involvement o f post-junctional 
(X2-adrenoceptors in the response to sympathetic stimulation in the rat tail 
arteiy. This conclusion was supported by the observation that yohimbine alone 
caused a small but significant reduction in the amplitude o f  the response. 
Indeed, it is likely that this inhibitory effect o f  yohimbine on post-junctional 
(X2-adrenoceptors was underestimated, due to the well-documented pre- 
synaptic action o f yohimbine to increase transmitter release by blockade of
auto-inhibition (Starke, 1981). These results support the growing awareness 
that the a 2-adrenoceptors are both (l)located on vascular smooth muscle and 
(2 )involved in the contractile response to sympathetic nerve stimulation 
(Rajanayagam, Medgett and Rand, 1990; Medgett, 1985). Previously, it was 
generally accepted that a 2-adrenoceptors were mainly located on nerve 
terminals, and any post-junctional a 2-adrenoceptors were extrasynaptic, 
mediating responses to circulating catecholamines, whereas neurally-released 
NA acted on post-junctional ai-receptors (Timmermans & Van Zwieten, 
1982; Jie et al.. 1987). However, recent data indicate that both a i -  and 012- 
adrenoceptors mediate contraction in response to sympathetic nerve 
stimulation in human and rat resistance vessels (Ohyanagi, Faber & Nishigaki, 
1991; Parkinson et al.. 1992), confirming the results of the present study.
In addition to the 012-adrenoceptor antagonist yohimbine, the (X2- 
receptor agonists clonidine and U K -14,304 also reduced the amplitude o f  
the field stimulation-induced contraction in the present study. This is probably 
as a consequence o f the well-documented role o f presynaptic (^-receptor 
activation to reduce transmitter output (Starke, 1981; Starke, 1987). However, 
increasing evidence indicates that clonidine and UK-14,304 may also decrease 
transmitter release by activating presynaptic imidazoline binding sites 
(Kalsner, 1985; Gothert and Molderings, 1992).
The ct2-receptor agonists clonidine and UK-14,304, and the antagonist 
yohimbine, although all reducing the amplitude o f the response, had different 
effects on the duration o f the field stimulation-induced response, which was 
prolonged by clonidine and U K -14,304, but curtailed slightly by yohimbine.
It is possible that this reflects the proposed effects o f a 2-receptor 
stimulation on Ca2+ influx on vascular smooth muscle, which may somehow  
act to facilitate or prolong the post-synaptic response to released transmitter.
107
However, this must remain purely speculative in the absence of data on 
presynaptic transmitter output.
Conditions previously described in this study which potentiated post- 
synaptic <X2-receptor-mediated contractions, i.e. precontraction with AVP and 
subsequent relaxation by IBMX, were shown to prolong the response to field 
stimulation at 10 Hz. In the presence o f prazosin, at a concentration which 
abolished control stimulation-induced contractions, a field stimulation- 
induced contraction was revealed following AVP and IBMX pretreatment. 
This prazosin-resistant contraction was biphasic, with an initial spike followed 
by a more prolonged contraction. Yohimbine abolished the second phase, 
indicating that an a 2-adrenoceptor-mediated contraction had been uncovered 
in response to field stimulation, in a manner analogous to the response to 
exogenous 012-agonists as previously described. Interestingly however, the 
prazosin- and yohimbine-resistant spike which remained was abolished by 
a,p~M eA T P . This therefore suggests that ATP is indeed released from 
sympathetic nerves in the rat tail artery, and under certain circumstances, can 
mediate contraction.
Since the effects o f  neurally-released ATP were only revealed 
follow ing blockade o f ai-adrenoceptors and conditions conducive to 
observing post-synaptic a 2-mediated effects, it is possible that a 2-receptor 
activation facilitated the contractile effects o f  ATP. This proposal is consistent 
with the findings o f Xiao & Rand (1989), who demonstrated that contractions 
to ATP in the rat tail artery were enhanced by U K -14,304. However, in the 
present study, the contraction to ATP (i.e. that inhibited by a,p-M eA TP) was 
not dependent on (X2-receptor activation since it persisted in the presence o f  
yohimbine. Presumably, AVP and IBMX create conditions in the cell such 
that both CC2- and ATP-mediated contractions are potentiated in a similar 
manner.
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In this study, responses to field stimulation were investigated in tail 
artery rings from SHR and WKY rats. Frequency-response curves from both 
groups o f rat were biphasic, as was described for Wistar rats. Responses at all 
frequencies were greater in vessels from hypertensive rats compared to 
control, when expressed as the absolute tension developed. However, when 
responses were expressed as a percentage o f the maximum response to PE, 
only the responses at the lower frequencies (0.1 & 0.2 Hz) were increased in 
SHR relative to control. Therefore, the increase in response at frequencies 
above 0.2 Hz can be explained by the increase in both tissue weight and 
responsiveness to a i-adrenergic stimulation in the SHR previously  
demonstrated in this study.
These observations suggest that there is some component other than 
a  i-adrenoceptor-mediated contraction which contributes to the field  
stimulation-induced motor response in the SHR. Previous reports have 
suggested that the role of post-junctional (X2-receptors in neurogenic 
contraction is increased in hypertension (Medgett, Hicks & Langer, 1984). In 
addition, studies have shown that the receptors involved in the field  
stimulation-induced contractions in the rat tail artery vary with the stimulation 
parameters, such that the (X2- component is greater at lower frequencies (Bao, 
Eriksson & Stjame, 1990). The results from this study with Wistar rats show 
that <X2 -adrenoceptors mediate part o f  the field stim ulation-induced  
contraction at higher frequencies, since yohimbine inhibited the response to 
trains o f stimuli at 10 Hz. It is possible therefore, that an a 2- component exists 
at all frequencies o f stimulation in tail artery rings from normotensive (Wistar, 
WKY) and hypertensive (SHR) rats, but is increased in SHR relative to WKY  
only at lower frequencies. However, this conclusion must remain speculative, 
as the effects o f adrenergic antagonists were not assessed in SHR or .WKY 
rats.
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The purinoceptor desensitising agent a,P~MeATP had no effect on the 
frequency-response curve in WKY tail artery rings, consistent with the results 
obtained in Wistar rats. This agrees with findings in other tissues where a,(3- 
MeATP had no effect on the end-organ response to field stimulation (Duval, 
Hicks & Langer, 1985; Allcom et al.. 1985). In contrast, the response to the 
lowest frequency o f stimulation (0.1 Hz) was enhanced by oc,p—MeATP in tail 
artery rings from hypertensive rats. This implies that ATP released from 
nerves upon electrical stimulation is inhibitory to contraction, and agrees with 
findings by Bao, Eriksson & Stjame (1990) and Bao (1993) in tail artery rings 
from normotensive Sprague-Dawley rats. This is surprising in view o f the 
recognised electrical effects o f ATP (exogenous and endogenous); in the 
guinea pig vas deferens, ATP produces a fast excitatory junctional potential 
(e.j.p.) which is abolished by a,(3-MeATP (Sneddon & Bumstock, 1984b).
Bao et al. (1990) concluded from the effects o f a ,p -M eA T P  that 
despite a reduction in the amplitude and duration o f the contraction, ATP 
accelerated the onset o f the contraction. This may be because neurally- 
released NA produces a small, slow and long-lasting depolarisation (Cheung, 
1984), and the cumulative effects o f ATP and NA may cause the membrane 
potential to reach the threshold for firing a propagated muscle action potential, 
which is one mechanism for triggering a fast contraction (Holman and 
Surprenant, 1980).
The explanation for the increase in amplitude o f field stimulation- 
induced contractions by a,p-M eATP in the present study remain unclear. 
Previous studies in the rat tail artery have shown that a ,p-M eA T P had no 
effect on the overflow o f [3H]-NA caused by nerve stimulation (Vidal, Hicks 
& Langer, 1986; Bao, Eriksson & Stjame, 1990). In addition, neurogenic 
contraction was unaffected by the adenosine antagonist, 8 -PS0T (Bao, 
Eriksson & Stjame, 1990). It is unlikely therefore that neurally-released ATP
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autoinhibits transmitter release, either via pre-junctional P2;rreceptors or 
following metabolism to adenosine to act on pre-junctional adenosine 
receptors.
The use o f a,p-MeATP can be criticised as a suitable tool to assess the 
role of transmitter ATP, since some effects o f a,p-M eATP may be unrelated 
to P^-receptors (Wiklund & Gustafsson, 1988), and can inhibit responses to 
substances other than ATP. However, a,p-M eATP was used in this study as it 
allows comparison with other work in the rat tail artery, and is generally 
accepted to be the most suitable compound available as yet.
In an attempt to avoid reliance on antagonist specificity to delineate 
the neurotransmitter profile, this study therefore employed an additional 
approach. If co-transmission o f NA and ATP does occur in the rat tail artery, 
then depletion o f the NA stores should reveal a residual response, which 
should be resistant to a-adrenoceptor blockade. Experiments in normotensive 
rats pretreated with reserpine to deplete sympathetic nerve terminals o f NA 
did indeed reveal a residual response to field stimulation, which was resistant 
to both prazosin and yohimbine. However, this contraction was also resistant 
to TTX and therefore was not due to the action o f  neurally released 
transmitter. This non-neurogenic contraction was probably produced by direct 
stimulation o f the smooth muscle, since smooth muscle sensitivity to a variety 
o f agents has been reported to increase following reserpine pretreatment 
(Nasseri et al.. 1985). Similar results were obtained in rats pretreated with 6 - 
OHDA, which destroys sympathetic nerve terminals. These findings are 
consistent with the work o f Vidal, Hicks & Langer (1986), where reserpine 
pretreatment in SHR and WKY rats revealed a purinergic component in the 
hypertensive rats only.
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The results o f the present investigation therefore support the 
conclusion that NA is the main sympathetic transmitter in the rat tail artery. 
The role, if  any, o f ATP as a sympathetic cotransmitter in this vessel is minor. 
ATP may become more important as a transmitter in certain circumstances, 
for example in the presence o f agents which potentiate its effects, or in the 
pathological condition o f hypertension.
6 . CONCLUSIONS
This study has investigated many o f the aspects o f vascular control, 
and has explored how the responsiveness o f vascular smooth muscle can be 
regulated. A variety o f techniques (mechanical, biochemical and structural) 
were used, and interesting and useful information was gained from this 
integrated approach. It was demonstrated that ot2-adrenoceptors exist on the 
smooth muscle o f the rat tail artery, under conditions which may occur in  
v ivo , for example in the presence o f vasopressin. In addition, post-junctional 
ct2-adrenoceptors were shown to contribute to the contraction o f this vessel 
following sympathetic stimulation. The role o f ATP as a cotransmitter with 
NA in the rat tail artery was only apparent in hypertensive rats, and to a very 
minor extent.
Hypertension was associated with other interesting changes in the 
vasculature, such that in a resistance vessel (the rat tail artery), responses to 
vasoconstrictors were increased while those to vasodilators were reduced. In 
contrast, the opposite pattern was found in the aorta, a conducting vessel, 
where vasoconstrictor responses were reduced while vasodilator responses 
were enhanced.
112
Perhaps one of the most important conclusions o f this investigation is 
that the circumstances in which an experiment is carried out has such a 
profound effect on the observed results, which must be interpreted 
accordingly.
Thus, this investigation has answered many o f  the questions 
surrounding blood vessel control. However, several other intriguing problems 
were raised during the course o f the study. For example, how exactly do 
agents such as AVP and PE or NA synergise with ot2-receptor agonists; how 
important is NA/ATP co-transmission in disease states such as hypertension, 
and does this contribute to the pathology o f the disease? Such questions may 
therefore provide the basis o f further research on the mechanisms o f vascular 
responsiveness, and their relevance in both human and animal physiology and 
pathology.
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